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ABSTRACT 
A growing body of evidence has highlighted the sexual side effects of 
selective serotonin reuptake inhibitor (SSRI) medication. Whilst most of the 
research has focused on the prevalence and treatment of sexual 
difficulties relating to SSRI medication, little is known about how individuals 
cope with the sexual side effects. This thesis explores ten women’s 
experiences of coping with the sexual side effects of SSRI medication. Using 
Interpretative Phenomenological Analysis as the research approach, four 
broad themes emerged from the data including i) searching; ii) suffering in 
silence; iii) trying to resolve; and iv) accepting what is. The themes provide 
an insight into the different strategies used by women to cope with the 
sexual side effects and highlight the importance of contextualising these 
difficulties as part of an overall approach to improve treatment and 
management. The findings emphasise the need to recognise and address 
psychological, social and cultural factors, which may have an influence on 
how women cope with sexual side effects, and underline the need for a 
multidisciplinary approach that moves beyond biomedical interventions.  
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GLOSSARY OF TERMS 
Mental Health Problem: In this study, the term ‘mental health problem’ 
describes a wide spectrum of mental health and behavioural disorders that 
can vary in severity and duration. Mental health problems are characterised 
by some combination of abnormal thoughts, emotions, behaviour and 
relationships with others. Examples include depression, mood disorders and 
anxiety disorders.  
Phenomenology: A qualitative research approach concerned with 
understanding the lived experience of individuals or groups of people.  
Reflexivity: A process that challenges the researcher to explicitly examine 
how his or her research agenda and assumptions, personal beliefs, and 
emotions enter into their research. 
Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs are a type of 
antidepressant used to treat depression and other anxiety disorders including 
panic disorder, obsessive-compulsive disorder and post-traumatic stress 
disorder.   SSRIs available in Australia include citalopram (Cipramil), 
ecitalopram (Lexapro), fluoxetine (Prozac), fluvoxamine (Luvox), paroxetine 
(Aropax) and sertraline (Zoloft).  
Side Effect: A side effect is an effect, whether therapeutic or adverse, that is 
secondary to the one intended.  In this study, the term predominantly 
describes the adverse effects of SSRI medication. 
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CHAPTER 1: 
Introduction and Background 
1.1 Introduction 
Female sexual difficulties are commonly associated with antidepressant 
therapy and are most frequently reported by women using selective serotonin 
reuptake inhibitors (SSRIs). Sexual difficulties often present as loss of desire, 
arousal difficulties or anorgasmia and are a common cause of non-
adherence to medication. As pleasurable sexual activity is an important 
component of intimate relationships, sexual side effects may also adversely 
affect social and emotional wellbeing. To date, there is a paucity of research 
on women’s self-reported experiences of sexual difficulties, in particular the 
impact such difficulties have on their sexual selves and everyday life. To 
address this gap, this study used Interpretative Phenomenological Analysis 
(IPA) as the research approach to explore the lived experience of coping with 
sexual difficulties amongst women who had been taking SSRI medication for 
at least three months. This chapter provides a background to the study and 
outlines the researcher’s position and interest in the topic. The aim, research 
question and objectives of the research are stated, followed by a discussion 
of the significance and limitations. The chapter concludes by providing an 
overview of the thesis organisation. 
1.2 Background 
From a public health perspective, mental health problems have been 
identified as leading contributors to the non-fatal burden of disease in 
Australia. According to O’Brien (2012), these problems have moved from the 
third to the first largest cause of disease burden in disability-adjusted life 
years (DALY) over the past decade. Whilst it is frequently asserted that 
mental health problems are increasing globally in advanced Western 
countries, critics have argued there is insufficient evidence to report an 
increase, citing difficulties with accurate measurement and the expanding 
boundaries of psychiatric disorder (Busfield, 2012; Richter & Berger, 2013). 
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Such claims could be correct; however, what cannot be disputed are the 
increasing levels of antidepressant use. In the last decade, Australia has 
seen a 58.2% increase in psychotropic prescribing, with antidepressants 
being the most commonly prescribed psychotropic drug (Stephenson, 
Karanges & McGregor, 2013). Indeed, a recent study revealed that Australia 
had the second highest rate of antidepressant use of the 34 Organisations for 
Economic Co-operation and Development (OECD) nations (Karanges, 
Stephenson & Mc Gregor, 2014). Furthermore, research conducted by the 
Australian Longitudinal Study on Women’s Health  (ALSWH) 2008 noted 
antidepressant medications account for 10% of the Pharmaceutical Benefits 
Scheme (PBS) budget each year, and that women aged 30–39 were the 
most common users of antidepressant medication in Australia (Hollingworth, 
Burgess, & Whiteford, 2010).  
Mental health problems have increasingly been identified as a gendered 
problem in Australia and other Western countries, with a number of studies 
reporting higher prevalence rates in women (Hollingworth et al., 2010; Paige, 
Korda, Kemp, Rodgers & Banks, 2015; Zhang et al., 2010). Driven by what 
O’Brien (2012, p. 573) refers to as ‘recovery oriented service provision’, 
women with such problems in Australia and other liberal democracies are 
encouraged to be actively involved in their own care and recovery, and 
ensure choices do not inappropriately burden the health system. Indeed, the 
2008 Australian National Mental Health Policy reiterated the focus and 
importance of recovery, and highlighted the value of tracking progress to 
achieve required outcomes, including a return to productivity (Commonwealth 
of Australia, 2009). Fullagar (2009) argued that current mental health policy 
in Australia is underpinned by a governmental imperative focusing on a 
biomedical approach to treatment aimed at alleviating symptoms and seeking 
to restore chemical imbalances in the brain. Such approaches, she pointed 
out, ‘normalise’ antidepressant use whilst maximising individual functioning 
and social productivity (Fullagar, 2009, p. 390). Furthermore, feminist 
researchers highlight how the expansion of biopower through pharmaceutical 
markets and recovery oriented mental health policy has led to increasing 
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rates of diagnosis and prescription of antidepressant medication for women 
(Godderis, 2010; Ussher, 2011). 
Despite contextual factors such as gendered inequity, motherhood and other 
psychosocial issues being identified as contributors to higher levels of mental 
health problems in women, a biomedical, individual focused approach to 
recovery continues to dominate (Fullagar & O’ Brien, 2013). Although the 
effectiveness of antidepressant use for depression remains controversial 
(Fournier, DeRubeis, Hollon, Dimidjian, Amsterdam, Shelton & Fawcett, 
2010; Parker, 2009), antidepressants remain pivotal in treatment, despite 
concerns about the efficacy and/or tolerability of such drugs (Stephenson et 
al., 2013). Whilst there has been increased interest in, and investment into 
non-pharmacological approaches, for example, the introduction of the 
Medicare Benefits Schedule (MBS) to improve access to psychologists and 
counsellors, antidepressant use in Australia continues to rise (Stephenson et 
al., 2013).  
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly 
prescribed antidepressant in Australia and are routinely referred to as the 
newer antidepressants (Stephenson et al., 2013). SSRIs differ from older 
antidepressants such as monoamine oxidase inhibitors (MAOIs) and tricyclic 
antidepressants (TCAs) in their chemical structure and method of action; 
moreover, the side effects of this newer medication are more easily tolerated 
making these a first-line treatment for anxiety and depression disorders 
(Moret, Isaac & Briley, 2009). Whilst SSRIs have better tolerability, they are 
not devoid of side effects. Of note, sexual side effects have been frequently 
reported, with prevalence rates exceeding 50% being cited in a number of 
studies (Serretti & Chiesa, 2009; Williams, Baldwin, Hogue, Fehnel, Hollis & 
Edin, 2006; Williams, Edin, Hogue, Fehnel & Baldwin, 2010). Although it 
remains difficult to obtain accurate prevalence statistics given sexual 
difficulties may occur for a number of reasons, it is becoming evident that 
sexual side effects are more common than initially perceived. 
Concerns about the impact of sexual side effects have prompted an 
emerging body of research; indeed, numerous studies have focused 
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specifically on treating and managing such difficulties in women in an attempt 
to improve quality of life and increase adherence to medication (Fooladi, Bell 
& Davis, 2012; Safarinejad, 2011). Strategies proposed to treat and manage 
these side effects include drug holidays, natural supplements, augmenting 
antidepressant treatment with other medications including buproprion and 
sildenafil, and switching antidepressants (Fooladi et al., 2012; Rizvi & 
Kennedy, 2013). According to a recent Cochrane review, augmenting 
antidepressant treatment with buproprion at high levels offered the most 
promising strategy for treating women; however, the authors called for more 
evidence to guide the specific treatment and management of sexual 
difficulties (Taylor, Rudkin, Bullemor-Day, Lubin, Chukwujekwu & Hawton, 
2013). 
A number of scholars have critiqued the biomedical approach to sexuality 
research (Farrell & Cacchioni, 2012; Moynihan, 2003; Tiefer, 2012); however, 
this approach has dominated much of the research into SSRI related sexual 
difficulties (Clayton, Croft & Handiwala, 2014; Taylor et al., 2013). One major 
criticism of this approach is that it fails to consider the social and cultural 
construction of sexual experience. To date, there is a dearth of research on 
women’s self-reported experiences of female sexual difficulties, in particular 
the impact such difficulties have on their sexual selves and everyday life. As 
such, a growing body of feminist qualitative research within sexual health has 
begun to  ‘raise up women’s diverse voices’ (Tiefer, 1995, p. 201) and to 
focus on the lived experiences of women, recognising that such approaches 
capture experiences which could not be encapsulated within a biomedical 
model (Marriott & Thompson, 2008; Sutherland, 2012; Svedhem, Eckert & 
Wijma, 2013).  
Without question, there is a need for further research to explore women’s 
experiences of coping with the sexual side effects of SSRI medication and to 
provide insight into strategies that may be helpful to women. Whilst the 
findings from this study are important for women, the findings also hold 
particular relevance for clinicians, therapists and other health professionals 
who have contact with women experiencing the sexual side effects of SSRIs. 
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Additionally, the findings illuminate new directions for future research within 
this field.  
1.3 Researcher’s position 
My interest in this field stems from my experiences of coping with the sexual 
side effects of SSRI medication and from my professional role as a sexuality 
educator. This study arose out of a growing realisation that little, if any, 
attention had been paid to the topic of how women cope with the sexual side 
effects of SSRI medication. My theoretical orientation stems from my 
experience of working in the sexuality field for more than ten years. As such, 
my understanding of sexual difficulties has been informed by the 
biopsychosocial approach to health and illness. This approach recognises 
that biological, psychological and social influences impact on how individuals 
cope with health related problems. 
1.4 Research aim, question and objectives 
The aim of this research was to improve understanding of the coping 
experiences of women who were experiencing SSRI-related sexual 
difficulties that were causing problems or distress to them and/or their 
partners. 
This research aimed to address the following question: 
“What are the lived experiences of coping with sexual difficulties amongst 
heterosexual women who take SSRI medication?” 
The specific objectives of the study were to: 
 Explore the lived experience of coping with sexual difficulties amongst 
heterosexual women who had been taking SSRI medication for at 
least three months.  
 Characterise the types of strategies used to cope with the sexual 
difficulties arising from SSRI use in order to assist women who are 
experiencing such difficulties.  
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 Provide recommendations to inform the professional practice of 
clinicians, therapists and other relevant health professionals. 
1.5 Ethics process 
Approval for this study was gained from Curtin University Human Research 
Ethics Committee, approval code HR 94/2012 (Appendix A). Given the 
sensitive nature of the research topic, a number of processes were put into 
place with due regard for the women’s welfare, confidentiality and anonymity. 
These processes included the provision of an information sheet which outlined 
what to expect from the study (Appendix C); a list of topics to be included in 
the interview schedule (Appendix E) and a copy of the informed consent form 
(Appendix D).The issue of consent was revisited at the start of each interview 
and women were encouraged to ask questions about the process. 
Confidentiality was assured throughout the study (as noted in the participant 
information sheet) and pseudonyms were used to de-identify each woman. 
Furthermore, extra time was allocated at the end of each interview to provide 
an opportunity to debrief with the researcher. Additionally, as the research 
involved sensitive issues, each woman was provided with a list of local support 
services, and a list of appropriate telephone helplines.  
1.6 Significance of the study 
The study was significant for a number of reasons. Firstly, it aimed to 
increase understanding of this complex, under-researched phenomenon and 
complement the existing body of quantitative research around sexual 
difficulties associated with SSRI use.  This research sought to further the 
traditional biomedical discourse, by obtaining women’s subjective accounts of 
their sexual difficulties, thereby creating new knowledge and understanding 
of how women cope with the sexual side effects of SSRIs. Secondly, by 
exploring the lived experience of women coping with sexual difficulties, the 
study aimed to increase understanding of the complex interaction among the 
various psychological, cultural and social factors that potentially influence 
coping strategies. Finally, for this study, women were purposefully recruited 
from the general population in an attempt to capture the phenomenon of 
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coping irrespective of whether women sought help for their problems. As 
previous qualitative studies have predominantly recruited women from clinical 
populations, the voices of women who have not sought help for sexual 
difficulties are notably absent from the research literature.  
1.7 Limitations of the study 
There are a number of limitations to this study, including the homogeneity 
and self-selected nature of the sample. The women in the study were 
purposefully homogenous to enable the exploration of the phenomenon of 
coping with SSRI-related sexual difficulties across a particular target group 
(heterosexual, in a relationship, under 45 years old); however, this resulted in 
an over representation of highly educated women. It is also probable the 
women who chose to participate in the study had reached a stage of 
adjustment, as they were willing to talk openly about their coping 
experiences; women who were struggling to cope may not be represented 
here. It is recognised that this study does not represent the experiences of all 
women who experience SSRI-related sexual difficulties; however, the 
purpose was not to generalise, but to provide a detailed exploration of 
experiences from an individual perspective. 
As the aim of the study was to explore the lived experience of coping with 
sexual side effects rather than ‘prove’ sexual difficulties were attributable to 
SSRIs, a further limitation relates to accepting women’s self-reports of sexual 
difficulties without supporting medical evidence. In this study, a medical 
diagnosis was not sought; each woman brought her own understanding and 
identification of what sexual difficulties meant to her. How women interpreted 
their sexual difficulties was more important than investigating whether SSRIs 
were the cause of their difficulties as women viewed their lived experiences 
through this particular lens.  
1.8 Thesis organisation 
This is a thesis by publication (series of published papers). It is organised 
into seven chapters as follows: 
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Chapter 1 provides an introduction and background to the study. This 
chapter includes the rationale for the study, the research question and 
objectives.  Ethical considerations, the significance of the study and the 
limitations were also outlined in this chapter. 
Chapter 2 presents an overview of the literature in two discrete sections. The 
first section defines the term sexual difficulty, discusses current classification 
schemes and provides an overview of how sexual difficulties impact on 
women. The second section provides an overview of SSRIs, including a 
history of the medication, its uses, and the side effects associated with this 
medication. Sexual side effects are explored in depth, followed by an 
overview of treatment and management approaches. 
Chapter 3 outlines the methodological approach and methods used for this 
study. This chapter presents the research question, aims and objectives of 
the study, and provides insight into the research design, methodology and 
methods of data collection and analysis. The chapter concludes by 
discussing matters relating to reliability and validity, and addresses the issue 
of reflexivity. 
Chapters 4–6 are post-print copies of the text from each published paper. 
Publisher copyright information and permissions are provided in Appendices 
F and G. The following is an outline of the list of published papers associated 
with this thesis: 
O’Mullan, C, Doherty, M, Coates, R & Tilley, PJM. (2014). Women’s 
experiences of coping with the sexual side effects of antidepressant 
medication. Psychology and Health, 29 (12), 1388–1406. 
http://dx.doi.org/10.1080/08870446.2014.940951 
This paper presents the overall findings from the study and reports on 
the four broad themes emerging from the study. 
 O’Mullan, C, Doherty, M, Coates, R & Tilley, PJM. (2014). Searching for 
answers and validation: Australian women’s experiences of coping 
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with the adverse sexual effects of antidepressants. Australian Journal 
of Primary Health, http://dx.doi.org/10.1071/PY13172 
This paper presents the findings from one specific theme ‘Searching’. 
The paper discusses and contextualises the findings for general 
practitioners (GPs). 
O’Mullan, C, Doherty, M, Coates, R & Tilley, PJM (2015).  Accepting what is: 
an approach for managing the long-term sexual side effects of 
selective serotonin reuptake inhibitors (SSRIs) in women. Sexual and 
Relationship Therapy, 
http://dx.doi.org/10.1080/14681994.2015.1032236 
This paper presents the findings from one specific theme ‘Accepting 
what is’. The paper discusses and contextualises the findings for sex 
and relationship therapists and offers suggestions for working with 
women on long-term medication. 
Chapter 7, the final chapter of this thesis, brings together the three papers by 
summarising the findings. This chapter also provides recommendations for 
practice and further research.  
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CHAPTER 2: 
Women, Sexual Difficulties and Selective 
Serotonin Reuptake Inhibitors (SSRIs): 
A Review of the Literature 
2.1 Introduction 
This chapter provides a review of the literature to document the extent of 
existing information relating to heterosexual women, SSRIs and sexual 
difficulties. The first section provides an overview of sexual difficulties in 
women; it explores the literature pertaining to definitions and classifications, 
and discusses the prevalence and impact of sexual difficulties. This section 
also explores the research relating to how women cope with such difficulties. 
Currently, female sexual difficulties relating to desire, arousal, orgasm and 
pain are grouped under the term ‘sexual dysfunction’ in the most recent 
Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM V) 
(American Psychiatric Association, 2013) and the tenth version of 
International Classification of Diseases and Related Health Problems (ICD-
10) (World Health Organisation, 1993). As ‘sexual dysfunction’ is a contested 
term that aligns with a medicalised view of sexual difficulties, in this study, 
the term ‘sexual difficulty’ will be used where appropriate, rather than ‘sexual 
dysfunction’.  
The second section of this chapter reviews the literature relating to SSRIs. A 
history and overview of SSRI use is discussed, followed by a brief review of 
the general side effects associated with this medication. Finally, the specific 
sexual side effects are explored in detail with a particular focus on treating 
and managing the sexual side effects in women. 
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2.2 Female sexual difficulties – An overview 
2.2.1 Definition and classification 
The biomedical model 
The current medical classification of ‘sexual dysfunction’ was developed by 
the American Psychiatric Association (APA) for the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) in 1980, and revised with minor changes 
in 1987, 1994 and 2000 (APA, 1980,1987,1994, 2000). The most recent 
DSM (DSM V) was published in 2013 (APA, 2013). The DSM is one of two 
major classification systems used to define female sexual dysfunction (FSD), 
and until its most recent iteration, relied heavily on the Human Sexual 
Response Cycle (HSRC) model developed by Masters and Johnson (1966); 
as such, it aligns closely with medical model thinking. Likewise, the ICD-10 
classification system developed by the World Health Organisation (1993) is 
modelled closely on the HSRC; however, the definition of sexual dysfunction 
includes organic causes and is therefore not specifically limited to psychiatric 
disorders. According to the HSRC model, the female sexual response cycle 
consists of four successive phases – excitement, plateau, orgasm and 
resolution.  This hypothesis was subsequently modified by Kaplan (1977) and 
Lief (1977) who proposed what is now referred to as ‘sexual desire’ as an 
integral first phase of the sexual response. The resulting triphasic model 
conceptualised three relatively independent phases consisting of sexual 
desire, excitement and orgasm (Kaplan, 1979). However, recent evidence 
shows that many facets of women's sexual function are at variance with 
these two models; indeed, critics have argued against these linear and 
genitally focused models of sexual function, on the basis that they mirror the 
male sexual response (Basson, 2001; Tiefer, 2010).  
It is not surprising that over the past two decades, these models have come 
under increased scrutiny. In response to concerns regarding the limitations of 
existing linear models, a number of alternative models have been put forward 
(Fisher, Aron, Mashek & Brown, 2002; Janssen, Everaerd, Spiering & 
Janssen, 2000; Perelman, 2009). According to Hayes (2011, p.130), whilst 
these models have endeavoured to unify factors that promote or inhibit 
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sexual response, they do not accurately ‘define the stages of sexual 
response itself’. In 2001, however, Rosemary Basson proposed a circular 
model that redefined the phases of the female sexual response and their 
relationship to each other (2001). In contrast to the linear models, she argued 
that motivation for commencing sexual activity was complex and it could 
commence for a number of reasons other than desire. Indeed, she argued 
that a significant number of women did not report spontaneous desire; once 
sexual activities commenced, however, increasing arousal could lead to 
desire for a continuation of sexual activities. This ‘responsive’ sexual desire 
could then feed back to increase levels of arousal, thereby eliciting a circular 
response. Her model also recognised that phases of the sexual response 
might overlap in time; desire and arousal, for example, might happen in 
unison rather than one preceding the other. Whilst alternative models of the 
female sexual response have been proposed, both Hayes (2011) and Meana 
(2010) have highlighted the lack of consensus as to which approach best 
describes women’s sexual responses. The most likely conclusion to date is 
that there is a diversity of responses. 
It is now recognised that there have been substantial advances in knowledge 
and understanding of women’s sexual responses since the penultimate ICD 
revision (WHO, 1993) and indeed, since previous editions of the DSM (APA, 
1980, 1987, 1994, 2000). Whilst the sexual disorders and sexual health 
categories are currently being revised for the ICD-11 (WHO, 2015), the 
recent DSM V (APA, 2013) draws upon updated knowledge and supports 
more recent models of sexual response. This new edition recognises that 
women’s sexual responses may not be analogous to men’s, and therefore 
moves away from the former, linear model of diagnostic categories (APA, 
2013). As such, the resulting diagnostic categories have been simplified and 
there are now three female sexual dysfunctions (sexual interest/arousal 
disorder, female orgasmic disorder, and genito-pelvic pain/penetration 
disorder) as opposed to the five listed previously. In order to make a 
diagnosis, it is important to note that the disorder must be deemed to have 
caused considerable distress. Although the DSM V is viewed as 
advancement in terms of establishing specific diagnostic criteria for the 
13 
different genders (Sungur & Gunduz, 2013), debate continues whether there 
is enough evidence to combine female hypoactive desire dysfunction and 
female arousal dysfunction into a single syndrome called sexual interest 
/arousal disorder. Clayton, DeRogatis, Rosen and Pyke (2012) and Sarin, 
Amsel and Binik (2013) have argued that the new criteria are 
counterproductive and exclude a large number of women with low desire and 
arousal. 
Despite recent changes to the DSM V, the classification of women’s sexual 
difficulties continues to be widely critiqued for privileging the biomedical and 
ignoring the interpersonal and contextual factors influencing sexuality and its 
difficulties (Farrell & Cacchioni, 2012; McHugh, 2006; Tiefer, 2012). 
Notwithstanding the increased interest in female sexual difficulties and 
advances in sexual medicine, Hall and Graham (2012) have argued that the 
continued focus on the biological basis of such difficulties has little to offer 
women who have sexual difficulties.  Furthermore, feminist scholars and 
social scientists have argued that female sexual difficulties remain 
entrenched in a male dominated, medically based and commercially centred 
view; thereby, discounting how the context of women’s lives impact on their 
sexual self (Moynihan, 2003; Nicolson & Burr, 2003; Tiefer, 2012). In order to 
contest the biomedical model used in classification systems, a group of 
feminist scholars, therapists and researchers collaborated under the 
leadership of Leonore Tiefer to form a working group referred to here as the 
New View Working Group (NVWG). This group draws on human rights 
documents from the World Health Organisation and the World Association for 
Sexual Health to conduct research and produce commentary that critiques 
current classifications and advocates for women-centred definitions of sexual 
difficulties (Tiefer, Hall & Tavris, 2002; Wood, Koch & Mansfield, 2006). 
Moving beyond a biomedical model – A New View 
Since its inception in 2000, the NVWG have published a number of research 
articles and have proposed the development of a new classification system 
for sexual concerns based on women’s real life experiences (Tiefer et al., 
2002, Wood et al., 2006). Of note, the NVWG suggested replacing the term 
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‘sexual dysfunction’ with ‘sexual problem’ and defined ‘problem’ as 
experiencing discontent or dissatisfaction with any aspect (emotional, 
physical or interpersonal) of sexual experience (Kashak & Tiefer, 2001, p.5).  
According to Tiefer (2001), this definition avoided categorising any one 
pattern of sexual experience as normal and acknowledged the findings that 
women are often more concerned about intimacy or relationship problems as 
opposed to lack of physical sensation. As such, the New View classification 
framework is women-centred and subjective in order to avoid the 
universalisation and biological reductionism of the classification systems 
such as the DSM (Tiefer, 2002; Tiefer et al., 2002). It moves away from the 
DSM’s genital and mechanical blueprint of female sexual difficulties, and 
aims to closely resemble women’s own concerns through the adoption of a 
biopsychosocial approach that locates women’s sexual difficulties within a 
sociocultural and relational context (Tiefer et al., 2002). 
The New View classification identifies four categories that are interrelated in 
women’s lived experiences, namely: i) sociocultural, political or economic 
factors; ii) partner and relationship factors; iii) psychological factors, and 
finally iv) medical factors (Tiefer et al., 2002). Although designed for 
researchers, clinicians and sexuality educators to provide insight into factors 
that may affect women’s sexuality, Nicolson and Burr (2003) pointed out that 
that the New View classification may be of interest to women themselves. 
Despite the publication of a number of commentaries detailing the usefulness 
of this framework for researchers and clinicians (Kaschak & Tiefer, 2001), the 
publications have been limited to single case studies and clinical 
impressions. Whilst the New View classification scheme has been tested in 
one study (Nicholls, 2008) and shows potential as a new framework for 
classifying female sexual difficulties, it is important to note that the sample 
was self-selected, focused only on women aged 18–35 years, and did not 
adequately represent women from different cultures and sexual minority 
groups. Further research is required for the New View classification to be 
considered as a viable framework; however, it does offer a starting point for 
researchers, clinicians and educators, and it also encourages women to 
define their own sexual difficulties. 
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2.2.2 Prevalence, impact and coping  
Prevalence 
Despite increasing scientific interest in ‘Female Sexual Dysfunction’ (FSD), 
the true prevalence remains a contentious issue and is difficult to estimate. 
The most often quoted study relating to prevalence has been by Laumann, 
Paik and Rosen (1999) who sampled 1749 women and reported that 43% 
experienced sexual dysfunction. Whilst a number of worldwide population 
based studies have reported a wide range of prevalence estimates (Bancroft, 
Lotus & Long, 2003; Christensen, Gronbaek, Osler, Pedersen, Graugaard & 
Frisch, 2011; Nazareth, Boynton & King, 2003), such studies are not without 
limitations and need to be interpreted with caution. Previous studies have 
been critiqued for producing widely inflated estimates by i) failing to use 
stringent definitions of FSD; ii)  using different measures and timeframes  for 
symptoms;  iii) not including ‘sexual distress’ as a criterion (Graham, 2010; 
Hayes, Dennerstein, Bennett & Fairley, 2008; Mc Cabe & Goldhammer, 
2013). What is indicated from the literature is that attempts to research the 
prevalence of sexual difficulties in women are highly problematic.  
In a comprehensive review, Hayes, Bennett, Fairley and Dennerstein (2006) 
used data from previous prevalence studies to assess female sexual 
difficulty/dysfunction.  Amongst women with any sexual difficulty, prevalence 
rates for sexual desire disorder ranged from 16% to 75% (mean 64%), 16% 
to 48% (mean 35%) for orgasm disorder, 12% to 64% (mean 31%) for 
arousal disorder, and from 7% to 58% for sexual pain (mean 26%). Whilst 
their review highlighted wide variance between prevalence estimates, one of 
the more noteworthy findings to emerge was that the prevalence of sexual 
difficulties decreased when sexual distress was included as a criterion. This 
is consistent with findings from more recent studies where a sexual distress 
component of FSD was included in the outcome measure (Hayes et al., 
2008; Giraldi & Kristensen, 2010; Shifren, Monz, Russo, Segreti & Johannes, 
2008).  
According to current definitions, sexual difficulties must have a significant 
negative impact on the woman's psychological status and everyday life 
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(defined as sexual distress) in order to be characterized as FSD (APA, 2013). 
The distress criterion was first added to the DSM IV in 1994 with the 
statement, ‘the disturbance causes marked distress or interpersonal 
difficulties’ (APA, 1994, p.513). These criteria stipulated that if the sexual 
difficulty did not sufficiently concern the individual or directly contribute to 
relationship problems, it was not diagnosable as a sexual dysfunction (APA, 
1994, p.513). Since its inclusion in the DSM, the distress criterion has 
remained controversial and has been increasingly disputed (Hendrickx, Gijs 
& Enzlin, 2013). Clinicians and scholars such as Meana (2010) believe it is 
important to maintain the criterion so that women who are satisfied with their 
level of sexual function are not pathologised. Others have argued against the 
inclusion of distress as it is not based on empirical evidence and may 
compromise scientific rigour (Althof, 2000; Waldinger & Shweitzer, 2006).  
Despite the ongoing debate relating to inclusion or exclusion of the distress 
criterion, in the most recent ICD-11 revisions, and in the DSM V, personal 
distress remains a key factor in defining FSD (APA, 2013; WHO, 2015). 
Although further academic debates will undoubtedly advance the discourse 
relating to distress and FSD, on a practical level, the inclusion of distress 
remains an important way to distinguish between a sexual difficulty and a 
normal variation.  
Impact of sexual difficulties 
Since sexuality is implicit in psychological wellbeing, quality of life and 
interpersonal satisfaction (Bancroft, 2009), it is not surprising that sexual 
difficulties have the potential to impact on the psychological and personal 
wellbeing of women and their partners. A number of studies have linked 
psychological distress, low self–esteem, and relationship conflict to sexual 
difficulties among women (Bancroft et al., 2003; Bond, Weerakoon & 
Shuttleworth, 2012; Burri, Rahman & Spector, 2011; Svedhem, Eckert & 
Wijma, 2013); however, much of the research has been conducted within a 
positivist framework using empirical investigations to measure and examine 
psychological distress. Whilst such studies are important, the nuanced 
experiences of women are not adequately captured, thereby limiting the 
17 
ability to explore and understand sexual difficulties from an individual 
perspective. However, over the past decade, a small number of researchers 
have used qualitative approaches to explore the impact of biopsychosocial 
factors on women’s sexual experiences (Lavie-Ajayi & Willig, 2005; Marriott & 
Thompson, 2008; Svedhem et al., 2013).  
Whilst the psychological impact of female sexual difficulties has been 
captured in a number of ways, symptoms such as anxiety and depression are 
commonly used as measures (Brauer, ter Kuile & Laan, 2009; Gates & 
Galask, 2001). According to the literature, the findings are contradictory; 
whilst some studies report that women with sexual difficulties experience high 
levels  of psychological distress including depression, anxiety and hostility 
(Brauer et al., 2009; Gates & Galask, 2001; Wylie, Hallam-Jones, & 
Harrington, 2004), other studies found no association (Payne, Binik, Pukall, 
Thaler, Amsel & Khalife, 2007; Reissing, Binik, Khalif, Cohen & Amsel, 
2003). Bond et al. (2012) pointed out that this lack of agreement may be 
attributed to lack of conformity in sampling or methodology, or as a result of 
women experiencing distress without any psychological symptoms. They also 
noted that while psychological distress may result from sexual difficulties, it 
was likely that some women have psychological distress prior to the onset of 
these difficulties.  
Findings from a qualitative study undertaken by Mitchell, King, Nazareth and 
Wellings (2011), provide further insight into why some women feel distressed 
by their sexual difficulties whilst others do not.  According to their study, three 
factors, namely, the severity of the problem, the perceived causes of the 
problem, and the partnership context, are influential in determining 
successful adjustment and diminishing distress. Whilst these findings are not 
able to be generalised given the sample was purposively heterogeneous, 
earlier research also supported the contention that the partnership context is 
particularly important with respect to how women adjust to their sexual 
difficulties (Bancroft, et al., 2003; Hayes et al., 2008). These findings have 
highlighted the importance of acknowledging and addressing interpersonal as 
well as individual distress.  
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A number of studies have explored the interpersonal impact of sexual 
difficulties in women. In quantitative research, the Dyadic Adjustment Scale 
(DAS) is considered to be the gold standard in measuring relational distress 
(Spanier & Cole, 1976); this validated instrument evaluates a number of 
measures including satisfaction with the expression of sex and affection in a 
relationship, shared interests, values and the level of interpersonal tension. 
Interestingly, studies measuring relationship distress, within the context of 
female sexual difficulties, have shown how interpersonal factors such as 
levels of communication and intimacy play an important role in helping 
women to adjust to sexual difficulties (Pazmany, Bergeron, Oudenhove, 
Verhaeghe & Enzlin, 2013; Smith & Pukall, 2014; Stephenson & Meston, 
2010). Moreover, in a study examining predictors of distress in a sample of 
987 women, Bancroft et al. (2003) reported that women expressed greater 
concern about the potential impact of sexual difficulties on intimate 
relationships rather than the personal distress of the sexual difficulty.  
The qualitative research clearly highlights women’s concerns relating to the 
impact of sexual difficulties on intimate relationships (Marriot & Thompson, 
2008; Hinchliff, Gott & Wylie, 2012; Svedhem et al., 2013). Though these 
studies are not generalisable, they do provide a detailed exploration of 
experiences from an individual woman’s perspective. In Marriot and 
Thompson’s (2008) study, which focused on the sexual and relationship 
consequences of eight women living with vulval pain, women felt distressed 
over their inability to participate in sex and consequently experienced 
shameful feelings about the pain.  Furthermore, women felt the quality of 
their sex life had an overall impact on the quality of the relationship. In a 
recent study, Svedhem et al. (2013) explored eight women’s experiences of 
living with vaginismus. The central theme of ‘sense of failure’ revealed how 
women’s experiences were influenced by the prevailing discourse about sex. 
Similarly, Hinchliff et al.’s (2012) study of women’s attempts to renegotiate 
sexual difficulties also highlighted the impact of living up to heterosexual 
constructed sexual norms; many women reported feeling frustrated and 
inadequate as a sexual partner. 
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Although the impact of sexual difficulties is well documented, women are 
generally reluctant to seek help for sexual difficulties (Shifren, Johannes, 
Monz, Russo, Bennet & Rosen, 2009; MacDowall et al., 2010). As such, it is 
necessary to explore how women, when faced with such difficulties, 
essentially cope with the situation. 
Coping with sexual difficulties 
Definitions as to what constitutes ‘coping’ vary; moreover, coping strategies 
have been classified in a number of different ways (Brandtstädter & Renner, 
1990; Lazarus & Folkman, 1984; Zeidner & Endler, 1996). Typically, 
researchers view coping in two ways, as a trait or style (person-based 
approach, dispositional) or as a process (environment-based approach, 
situational) (Carpenter & Scott, 1992; Lazarus, 1993). The style approach 
treats coping behaviours and activities as relatively stable in the process of 
dealing with stress; personality characteristics determine coping activities 
(Aldwin, 2007; Carpenter, 1992). The process approach, however, 
emphasises coping as an effort to manage changing stress and contexts 
(Lazarus, 1993; Lazarus & Folkman, 1984). Indeed, Lazarus and 
Folkman define coping as ‘constantly changing cognitive and behavioural 
efforts to manage specific external and/or internal demands that are 
appraised as taxing or exceeding the resources of the person’ (Lazarus and 
Folkman, 1984, p.141). This definition is particularly suited to exploring 
coping strategies associated with sexual difficulties given that coping seeks 
to manage rather than master a stressful situation. 
Although a number of conceptual models have been proposed to guide 
research into ways of coping, the literature reported that strategies employed 
by women with sexual difficulties appeared to fit into the categories proposed 
by Lazarus and Folkman (1984), namely problem-focused and emotion- 
focused strategies; and by Zeidner & Endler (1996), specifically active-
cognitive and active-behavioural strategies. According to Lazarus and 
Folkman (1984), problem-focused coping refers to strategies that individuals 
use to change their circumstances; this may include information seeking, 
solution generation, and taking direct action to change a stressful event. 
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Emotion-focused coping involves an individual’s efforts to alter her/his own 
experience of negative emotion, seek support from others, and avoid 
stressful situations. Although Zeidner and Endler (1996) use different 
terminology, there is considerable overlap with the strategies put forward by 
Lazarus and Folkman (1984). According to Zeidner and Endler, active-
cognitive coping strategies are defined as internal processes; these may 
include, for example, positive reassessment, finding inner strength, and 
acceptance. Active-behavioural coping strategies are defined as external 
behaviours and examples include professional help seeking and/or problem-
solving.  
To date, a small number of studies have investigated how women cope with 
sexual difficulties, though no studies could be located which investigated 
specifically how women cope with the sexual side effects of antidepressants. 
The focus of these studies relates to sexual difficulties arising from cancer, 
chronic illness or specific sexual health problems such as vulvodynia or 
sexual pain (Kilic, Unver, Bolu & Demirkaya, 2012; Marriot & Thompson, 
2008; Sutherland, 2012; Tang, Lai & Chung, 2010). Such studies highlighted 
an important link between adaptive coping and better sexual outcomes. 
Furthermore, many findings underscored the importance of combining 
individual coping efforts with support at the relationship level. One study that 
specifically examined Lazarus and Folkman-type coping strategies on sexual 
outcomes for Chinese women with gynaecological cancer (Tang et al., 2010), 
found that spousal support had the most salient influence on sexual 
satisfaction. Findings from other studies also highlight the importance of 
supportive relationships and open and honest communication between 
partners as part of adaptive coping efforts to manage sexual difficulties 
(Mitchell et al., 2011; Rosen, Bergeron, Sadikaj, Glowacka, Delisle & Baxter, 
2014, Tang et al., 2010).  
Despite consensus that supportive relationships and effective communication 
between partners play a key role in helping women to cope with sexual 
difficulties, some women chose avoidant coping strategies, such as suffering 
in silence and shouldering the burden alone (Esmail, Munro & Gibson, 2007; 
Hinchliff et al., 2012; Tang et al., 2010). Esmail et al.’s study of women living 
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with Multiple Sclerosis revealed that women often went to great lengths to 
buffer their partners from the full impact of their problems; indeed, many 
women continued to have intercourse in spite of pain or fatigue, at times 
driven by guilt or fear of abandonment. Hinchliff et al. (2012) reported that 
women with sexual pain also used strategies to avoid intimate situations, not 
only to protect their partner but also to protect themselves from the 
consequences associated with actively rejecting their partner. A tendency to 
avoid sexual interaction and intimacy was also reported by Sutherland 
(2012), in a qualitative study exploring women’s experiences of sexual pain.  
A number of studies report that strategies employed by women involve 
adjusting one’s definition of sexual activity and changing expectations about 
sex (active-cognitive coping).  Reese, Keefe, Somers and Abernethy (2010, 
p.793) argued that a notion of sexuality which adopts more ‘flexible sexual 
cognitions and behaviours’, may help couples to cope with sexual difficulties. 
A number of studies focusing on sexual challenges in cancer survivors 
supported this notion of coping flexibly by redefining sexuality and 
renegotiating intimacy (Gilbert, Ussher & Perz, 2010; Street, Couper, Love, 
Bloch, Kissane & Street, 2010). Moreover, in a qualitative study undertaken 
by Mitchell et al. (2011), it was reported that a flexible definition of ‘good-
enough sex’, as well as a flexible stance toward the importance of sex, has 
the potential to enhance the process of adjusting to sexual difficulties. In 
research undertaken by Kaler (2006) and Svedhem et al. (2013), some 
women actively challenged traditional discourses around heterosexual 
norms; by questioning idealistic expectations of sex, such women were able 
to reframe their sexual difficulties and move forward.  
Finally, some women employed problem-focused strategies and attempted to 
resolve or minimise the impact of sexual difficulties. Whilst some women 
sought help from health professionals, most studies highlighted women’s 
attempts to self-manage the difficulty (Hinchliff et al., 2012; Holt & Slade, 
2003; Sutherland, 2012). This is consistent with other research reporting that 
the majority of women respond to sexual difficulties without seeking formal 
help (Moreira, Glasser, King, Duarte & Gingell, 2008; Shifren, Johannes, 
Monz, Russo, Bennett & Rosen, 2009). Although the sensitive nature of the 
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topic may deter women from sharing practical strategies in a research 
setting, a small number of studies have reported on behavioural self-
management strategies adopted by women. These have included attempts to 
adjust sexual positioning, the use of sexual enhancement products such as 
lubricants, and being more open to sexual creativity within the relationship 
(Herbenick, Reece, Hollub, Satinsky & Dodge, 2008; Svedhem et al., 2013). 
Unfortunately, not all problem-focused strategies were adaptive. For some 
women, the disruptive and potentially detrimental impact of sexual difficulties 
led to engagement in compensatory or potentially addictive behaviours such 
as drug and alcohol use (Kilich et al., 2012, Sutherland, 2012).  
2.2.3 Summary of female sexual difficulties 
In order to help women with sexual difficulties, it is important for clinicians, 
therapists and other relevant health professionals to have a clear 
understanding of current evidence-based debates within this field. As this 
section has revealed, the classification of female sexual difficulties is strongly 
influenced by a biomedical model. The current classification scheme has 
been critiqued for adopting a medically-based and commercially-centred view 
of sexual difficulties; as such, it has been argued that interpersonal and 
contextual factors influencing sexuality and its difficulties have been largely 
ignored. As highlighted by the literature, women’s experiences of managing 
sexual difficulties are strongly influenced by the prevailing discourse about 
sex. Accordingly, there have been calls for a new classification scheme 
based on a biopsychosocial model that enables women to define what 
constitutes a sexual difficulty, and locates women’s sexual difficulties within 
an interpersonal and social context. 
Whilst the prevalence of sexual difficulties remains a contested issue, what 
cannot be contested is the impact of sexual difficulties on psychological 
wellbeing, quality of life and interpersonal satisfaction. What is clear from the 
literature is women do not frequently seek help for sexual difficulties; indeed, 
they employ a variety of coping strategies in an attempt to self-manage their 
difficulties. Although there is a dearth of literature relating to how women 
cope with the sexual side effects of antidepressants, the literature does 
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reveal an important link between adaptive coping and improved sexual health 
outcomes. 
The following section provides an overview of SSRIs; it provides a history of 
the medication, its uses, and the side effects associated with the most 
commonly prescribed SSRIs. Lastly, the sexual side effects in women are 
explored in depth, followed by an overview of treatment and management 
approaches.  
2.3 SSRIs: An overview 
The introduction of fluoxetine, an SSRI, in the late 1980s, revolutionised 
therapy within the field of mental health and led to a new classification of 
antidepressants. Since the release of fluoxetine (Prozac®) by Eli Lilly, a 
number of other SSRIs have been released including: Sertraline (Zoloft®), 
followed shortly by Paroxetine (Paxil®), Citalopram (Celexa®) and 
Escitalopram (Lexapro®) and most recently Fluvoxamine (Luvox®). Whilst 
there are differences among the most commonly used SSRIs, it is widely 
accepted that SSRIs exert their therapeutic effect in depression and anxiety 
by increasing levels of serotonin in the synapse (Stephenson, Karanges & 
McGregor, 2013). Whilst the precise mechanisms of action differ for each 
SSRI, it is assumed the medication works by blocking the reuptake of 
serotonin in the synapses of the brain, thereby increasing the synaptic 
concentration of serotonin levels in the brain (Stahl, 1998). 
SSRIs rapidly became the first-line treatment for a range of mental health 
problems in Australia and around the world (Nurnberg, 2001). In addition to 
depressive disorders, SSRIs are also approved as first line treatments for 
generalised anxiety disorders, panic disorder, agoraphobia and post- 
traumatic stress disorder (Bandelow et al., 2012). Off-label uses have 
included premature ejaculation (Hatzimouratidis et al., 2010), irritable bowel 
syndrome (Rance, Lindner & Ford, 2014), chronic fatigue syndrome (Thomas 
& Smith, 2006) and migraine and tension type headaches (Moja, Cusi, Sterzi 
& Canepari, 2005).  Early research, including a number of meta-analyses 
(Anderson & Tomenson, 1994; Steffens, Krishnan & Helms, 1997), 
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highlighted the improved safety, tolerability and efficacy of the SSRIs when 
compared with that of older antidepressants. Lieberman (2003), in his study 
of the history of antidepressants, viewed the introduction of SSRIs as a 
turning point in the treatment of anxiety and depression, making the 
treatment and management of  anxiety and depression in primary care the 
norm, rather than the exception. 
SSRIs remain the dominant category of antidepressant dispensed in 
Australia, their use doubling between 2000 and 2011 (Stephenson et al., 
2013). According to Sansone and Sansone (2010), this level of unrivalled 
popularity potentially relates to a number of factors, including the broad 
clinical efficacy associated with this medication, and their relatively minor 
side effects. The dispensing data for the six most commonly used SSRIs, 
show sertraline as the most popular SSRI in Australia, arguably as a result of 
greater tolerability (Stephenson et al., 2013), followed by escitalopram, which 
has been increasing in popularity since its introduction in 2004. According to 
Hollingworth et al. (2010), women are the most common users of 
antidepressant medication in Australia. This is not surprising given that a 
number of studies report higher prevalence rates of anxiety and depression 
in Australian women (Hollingworth et al., 2010; Paige, Korda, Kemp, Rodgers 
& Banks, 2015, Zhang et al., 2010). 
Despite the popularity of such medications, the extent to how well these 
newer antidepressants actually work remains a controversial topic in the field 
of mental health.  In recent years, questions have been raised with respect to 
efficacy and/or tolerability of the newer antidepressants (Karanges & 
McGregor, 2011; Mackin & Thomas, 2011). With respect to efficacy, a series 
of meta-analyses have been published, concluding that newer 
antidepressants such as SSRIs were only effective for individuals diagnosed 
with severe depression (Kirsch, Deacon, Huedo-Medina, Scoboria, Moore & 
Johnson, 2008), and more recently, that antidepressants have relatively 
modest effects when compared with a placebo over the same period 
(Fournier et al., 2010). Such findings are not new; indeed, these findings 
confirm what has been previously reported (Khan, Leventhal, Khan & Brown, 
2002; Thase et al., 2002). According to Thase, Larsen and Kennedy (2011), 
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recent findings have attracted considerable attention in the media and have 
raised questions about the usefulness of these medications. Questions are 
also being asked about tolerability; whilst SSRIs are generally well tolerated, 
they have not been devoid of side effects (Moret, Issac & Briley, 2009). As 
noted by Gartlehner et al. (2008), one in six individuals discontinued 
treatments in randomised controlled trials as a result of adverse effects. 
2.3.1 Side effects of SSRIs 
According to Cascade, Kalali and Kennedy (2009), debates around the side 
effects of antidepressants have existed for years and attempts to minimise 
side effects and increase adherence to medication have ensured that 
research into side effects has retained a prominent focus. Whilst measures of 
non-adherence are rarely reported in the anxiety and depression literature 
specifically (Taylor, Abramowitz & McKay, 2012), a number of studies have 
concluded that adherence is problematic, with nearly 50% of users 
discontinuing antidepressant therapy prematurely as consequence of 
medication side effects (Fawzi, Abdel-Mohsen, Hashem, Moussa, Coker & 
Wilson, 2012; Sansone & Sansone, 2010; van Geffen, Hermsen, Heerdink, 
Egberts, Verbeek-Heida & van Hulten, 2011). In the context of mental health, 
non-adherence to antidepressant medication places individuals at high risk of 
relapse; this is considered a significant public health concern, particularly as 
antidepressants are often taken for extended periods of time (Fooladi, Bell & 
Davis, 2012).   
Commonly reported short-term side effects of SSRIs include nausea, 
vomiting, diarrhoea, dry mouth, headache and dizziness (Hatcher & Arroll, 
2012).  Similarly, frequently reported longer term side effects, such as weight 
gain and sexual difficulties have also been reported (Cascade et al., 2009; 
Seretti & Mandelli, 2010). The weight gain attributed to SSRI use has also led 
to concerns about increased diabetes risk with long-term use (Andersohn, 
Schade, Suissa & Garbe, 2009). While the list is not exhaustive, emerging 
research also suggests SSRIs increase the risk of upper gastrointestinal (GI) 
tract bleeding (De Abajo, Montero, Garcia Rodriguez & Madurga, 2006; Loke, 
Trivedi & Singh, 2008) and pose particular problems for the elderly, including 
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increased risk for falls and bone fractures (Coupland, Dhiman, Morriss, 
Arthur, Barton & Hippisley-Cox, 2011; Richards et al., 2007).  Additionally, in 
the past five years, studies have questioned the safety of SSRI use during 
pregnancy, documenting adverse neonatal outcomes including low Apgar 
scores, respiratory and metabolic dysfunction, and mild central nervous 
system disorders (Jensen, Gron, Lidegaard, Pedersen, Andersen & Kessing, 
2013; Tuccori et al., 2010). 
Although the physical side effects of SSRIs have been widely documented, 
an emerging body of evidence indicates SSRIs may also contribute to 
adverse emotional effects. Whilst findings should be interpreted with caution 
as there are no large epidemiological studies on this topic, Marazziti et al.  
referred to a phenomenon in the scientific literature known as ‘SSRI induced 
indifference’ (2014, p.151). The initial link between emotional blunting and 
SSRI use was put forward by Opbroek et al. (2002); however, their findings 
did little to confirm this given that side effects could be attributed to the 
residual symptoms of depression. The relationship between emotional 
blunting and SSRIs has since been explored by a number of authors; indeed, 
it has been reported that SSRI use can contribute to apathy and reduced 
motivation (Goldsmith & Moncrieff, 2011; Price, Cole & Goodwin, 2009), 
inability to cry (Van der Veen, Jorritsma, Krijger & Vingerhoets, 2012) and an 
‘increased disconnection’ between the users of SSRIs and their worlds (Teal 
2009, p. 19). Given the connection between emotions and romantic 
relationships, there is also speculation the emotional blunting associated with 
SSRI use may impair relationship satisfaction through the dulling of emotions 
(Meyer, 2007) and impact on feelings of love and attachment towards the 
partner (Marazziti et al., 2014). 
Sexual difficulties have also been reported as an established side effect of 
SSRIs. According to Safarinejad (2011), sexual difficulties remain an 
underestimated but important problem. An increasing number of studies have 
highlighted the adverse impact of SSRI-related sexual difficulties for both 
genders with respect to adherence to medication, relationships with intimate 
partners and quality of life (Clayton, Croft & Handiwala, 2014; Meyer, 2007; 
Seretti & Chiesa, 2009). Although sexual difficulties may not be a pressing 
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issue during the early phase of SSRI treatment, this can emerge as a 
substantial problem once individuals are stabilised on medication.   
2.3.2 Sexual side effects of SSRIs 
As sexual difficulties may occur for a number of reasons, it remains difficult to 
obtain accurate prevalence statistics of SSRI-related sexual difficulties 
(Clayton & Balon, 2009; Safarinejad, 2011). According to a recent Cochrane 
review (Taylor, Rudkin, Bullemore-Day, Lubin, Chukwujekwu & Hawton, 
2013), prevalence studies in this field have exhibited a number of 
methodological problems, including the frequent absence of comparison 
groups or baseline assessments, and inconsistent definitions of sexual 
dysfunction between studies.  Whilst studies have shown that other factors 
such as depression, sociocultural factors and physical comorbidities also 
contribute to sexual difficulties (Schweitzer, Maguire and Ng, 2009; 
Wernecke, Northey & Bhugra, 2006), the relationship between the intake of 
SSRIs and sexual side effects has been demonstrated convincingly (Graf, 
Walter, Metzger & Abler, 2014; Segraves, 2007). Furthermore, what is 
becoming evident is that sexual side effects are more common than initially 
perceived, with numerous studies reporting prevalence rates of over 50% 
(Chen, Yang, Lee, Yeh, Lu & Chen, 2008; Montejo et al., 2010; Williams et 
al., 2006). 
SSRI-related sexual side effects in women are certainly not a recent 
phenomenon. Whilst initial research appeared to focus on sexual side effects 
in men or mixed gender populations (Hsu & Shen, 1995; Jacobsen, 1992; 
Montejo-Gonzalez et al., 1996), two early retrospective reviews focused 
specifically on sexual difficulties in women, revealing a higher rate than 
previously thought (Aldrich, Cook & Pedersen, 1996; Shen & Hsu, 1995). 
Shen and Hsu’s (1995) study, which analysed the clinical records of 110 
women, revealed that 35 women reported sexual difficulties including desire 
disorder and anorgasmia; similar findings were reported a year later by 
Aldrich et al. (1996). In 1997, Modell, Katholi, Modell & DePalma compared 
the sexual side effects of fluoexetine, paroxetine and sertraline. Whilst the 
results of their study concluded there were no differences amongst the three 
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SSRIs, it was noted that sexual side effects in women appeared to be the 
rule rather than the exception. Likewise, results from the first longitudinal 
study of sexual side effects and SSRIs reported that 57% of women 
experienced sexual difficulties; anorgasmia was reported as the most 
common sexual side effect (Zajecka, Mitchell & Fawcett, 1997). Although one 
small scale study (n=15) found that SSRIs improved sex drive and 
psychological arousal in women (Piazza, 1997), by the end of the 1990s, the 
relationship between SSRIs and sexual side effects in women was well 
established.  
Whilst all of the SSRIs induce sexual side effects to some extent, studies 
suggest the prevalence and type of sexual difficulty depends on the particular 
medication. Findings from a meta-analysis related to antidepressant-
emergent sexual difficulties revealed that out of seventeen antidepressant 
medications, the SSRIs, namely sertraline, citalopram, paroxetine, and 
fluoxetine, demonstrated some of the highest rates of sexual difficulties 
across both genders, with amounts of 80.3%, 78.59%, 71.48%, and 70.6% 
respectively (Serretti & Chiesa, 2009).  In that study, escitalopram was found 
to be significantly associated with a lower risk of sexual difficulties in women 
compared to other SSRIs, a finding consistent with a later study undertaken 
by Sidi, Asmidar, Hod & Guan (2012). In contrast, a systematic review 
undertaken by Reichenpfader et al. (2014), observed that both escitalopram 
and paroxetine showed a statistically significantly higher risk of sexual 
difficulties than other newer antidepressants. However, that study noted that 
the comparative risk between SSRIs could not be adequately assessed. 
As noted earlier, there is some evidence that certain types of SSRI are 
associated with specific sexual difficulties. In the analysis undertaken by 
Seretti and Chiesa (2009), desire disorders were commonly reported by 
women taking fluoexetine and paroxetine (74.39% and 72.89% respectively); 
arousal disorders were reported by women taking paroxetine and sertraline 
(83.96% and 82% respectively); and finally orgasmic difficulties were 
experienced more frequently by women taking paroxetine and sertraline 
(44.84% and 44.22% respectively). These findings are consistent with data 
reported by recent studies; indeed, fluoexetine has been associated with up 
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to 50% higher rates of desire disorder in women when compared to other 
SSRIs (Khazaie, Rezaie, Payam & Najafi, 2014; Sidi et al., 2012).   
While the precise mechanism by which SSRIs cause sexual difficulties has 
not been determined, a seminal paper published by Gitlin (1994), suggested 
there may be a number of possible mechanisms. These included: i) non-
specific neurologic effects that globally impair behaviour including sexual 
function; ii) specific effects on brain systems mediating sexual function; iii) 
specific effects on the sexual organs through altering neurotransmitter 
concentrations at specific sites; and finally iv) direct or indirect effects on 
hormone levels that adjust sexual function. According to Clayton (2003), it 
was probable that antidepressants impact several of these physiologic 
substrates of sexual function. While it is beyond the scope of this thesis to 
provide a detailed discussion of the neurobiology of antidepressant related 
sexual difficulties, the reader is referred to two papers for more information 
(Gitlin, 1994; Graf et al., 2014). 
2.3.3 Treatment and management of sexual side effects  
As women have higher levels of SSRI use (Hollingworth et al., 2010), a 
number of studies have focused specifically on treating and managing the 
female sexual difficulties associated with SSRIs (Fooladi et al., 2012; 
Safarinejad, 2011; Zhang et al., 2010). While such studies have explored a 
number of approaches including, but not limited to dose reduction, switching 
antidepressant and adjunctive therapy, according to a recent Cochrane 
review, the evidence to support these is somewhat limited (Taylor et al. 
2013). Consequently, Taylor et al. have called for more evidence to guide the 
treatment and management of SSRI-related sexual difficulties in women. This 
section will review the current strategies proposed for managing female 
sexual difficulties associated with SSRI use including: i) improving the 
therapeutic alliance ii) waiting for spontaneous remission iii) drug holidays iv) 
dose reduction v) switching antidepressant and finally, vi) adjuvant therapy. 
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Improving the therapeutic alliance 
Despite increasing attention on the importance of communicating with 
individuals and ensuring informed consent when prescribing SSRIs (Gopal, 
Cosgrove, Shuv-Ami, Wheeler,Yerganian & Bursztain, 2012; van Servellen, 
Heise & Ellis, 2011), research has shown that treatment emergent sexual 
difficulties are infrequently discussed in primary care settings. A number of 
prohibitive factors have been identified for this lack of communication 
including personal discomfort, lack of time or expertise and/or the belief that 
treatment options are limited (Goldstein, Lines, Pyke & Scheld, 2009; Quinn, 
Happell & Browne, 2011; Shifren et al., 2009). Furthermore, Quinn et al. 
(2011) revealed that fear of non-adherence to medication has led to the 
deliberate withholding of information about sexual side effects, despite 
findings revealing that such knowledge can actually improve adherence rates 
(Smith & Henderson, 2000).  Given that women have been generally 
reluctant to seek help for sexual difficulties (MacDowall et al, 2010; Shifren, 
Johannes, Monz, Russo, Bennett & Rosen, 2009), it is not surprising that 
women who take antidepressants are unlikely to report such adverse effects 
(Kikuchi, Uchida, Suzuki, Watanabe & Kashima, 2011). 
As part of an overall strategy to improve the management of female sexual 
difficulties, there have been calls to strengthen the therapeutic alliance 
between clinicians/health professionals and women (Kikuchi et al., 2011) to 
ensure women are actively involved in making informed decisions relating to 
medication that may affect sexual function (Quinn et al., 2011; van Servellen 
et al., 2011). According to Roesch and Weiner (2001), having an explanation 
for an illness or health condition, can have a positive impact on adjustment. 
Happell, Manias and Roper (2004), concurred and reported that individuals 
who were informed of adverse drug effects reported feeling better prepared 
and less likely to be alarmed when an untoward effect occurred.   
Similarly, a number of qualitative studies involving women with mental health 
problems have also revealed that withholding information about adverse drug 
effects can increase distress and isolation, and potentially damage 
therapeutic relationships (Gray, White, Schulz & Abderhalden,  2010; Quinn 
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et al., 2011). Although these findings have not been validated and may not 
be representative of all women, it is suggested that open and honest 
communication between clinicians/health professionals and women, in 
addition to collaborative decision-making may provide an opportunity to 
improve the treatment and management of sexual difficulties. 
Waiting for spontaneous remission 
In many cases, treatment regimes may be short; hence, one management 
strategy is to endure the sexual side effects until treatment ends, or ‘wait and 
see’ if sexual side effects resolve themselves. Although one study reported 
complete remission of sexual difficulties in 30% of participants at the end of a 
six month period (Haberfellner & Rittmannsberger, 2004), the limited 
research to date suggests spontaneous remission of sexual side effects is 
uncommon. In an earlier descriptive, clinical study undertaken by Shen and 
Hsu (1995), only three of 33 cases (11%) of female sexual side effects 
remitted spontaneously within three months of beginning treatment. Montejo- 
González and colleagues (1996) reported similar results in a mixed gender 
study of 344 participants. Whilst the percentage breakdown for each gender 
is not reported, at the end of a six-month study, only 5.8% of participants 
experienced a complete remission of their sexual dysfunction, 12.8% 
displayed moderate improvement and 81.4% displayed no improvement at 
all. A later study by Montejo, Llorca, Izquierdo and Rico-Villademoros (2001), 
concurred, reporting that spontaneous remission occurs in less than 10% of 
participants after six months of treatment. 
Drug holidays 
Drug holidays have been recommended in the past as part of a management 
strategy for sexual side effects (Rothschild, 1995), but without much 
evidence to support their use. Drug holidays involve brief interruptions in drug 
treatment (i.e. discontinuation of the drug two to three days before 
anticipated sexual activity); however, this practice could potentially put the 
individual at risk for withdrawal symptoms as well as a relapse of their 
psychiatric condition (Balon & Segraves, 2008; Shelton, 2005). Whilst 
Rothschild’s (1995) study found that the majority of the 30 participants on 
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SSRIs experienced ‘much’ or ‘very much’ improved functioning related to 
desire and orgasm for at least half of the drug holidays, significantly better 
results were found with paroxetine and sertraline. Rothschild hypothesised 
this was due to the shorter half-lives of these medications although the 
placebo effect could not be ruled out.  
The potential for discontinuation symptoms to occur shortly after missing 
doses, especially for those SSRIs with shorter half-lives such as paroxetine 
and sertraline remains a complicating factor, especially given the potential for 
depressive symptoms to worsen (Baldwin & Foong, 2013; Balon & Segraves, 
2008). As a drug holiday is a precursor to sexual activity, Higgins, Nash and 
Lynch (2010, p. 148) argued that the mechanisation of scheduling sexual 
activity may increase ’performance anxiety’ thereby potentially compounding 
the situation. Furthermore, drug holidays also carry the risk of the individual 
experiencing medication related withdrawal symptoms and may prevent the 
person from engaging in sexual activity (Keltner, McAfee & Taylor, 2002). In 
addition to a deterioration of depressive symptoms, other authors have 
highlighted how drug holidays may complicate and potentially add to existing 
sexual difficulties. 
Dose reduction 
There is some evidence that antidepressant related sexual difficulties may be 
dose related, hence a reduction in daily dose is commonly adopted as a first 
line approach to management (Balon & Segraves, 2008). Over the past two 
decades, a number of studies have explored dose reduction across a range 
of commonly prescribed SSRIs (Barton et al., 2010; Benazzi & Mazzoli, 
1994; Montejo-Gonzalez et al., 1996, Shen & Hsu, 1995; Sidi et al., 2012). In 
an early study exploring the clinical records of women on SSRIs (Shen & 
Hsu, 1995), seven out of nine participants who experienced a dose reduction, 
experienced remission of sexual side effects whilst retaining clinical benefit. 
Of these participants, four were treated with paroxetine, three with fluoxetine.  
In  Montejo-González et al.’s 1996 investigation of 344 participants treated 
with either fluoexetine, sertraline, fluvoxamine or paroxetine, of the thirty 
participants who experienced dose reduction, 73% experienced ‘some’ or 
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‘quite a lot’ of improvement in sexual functioning when the dose was 
decreased to 50% (Montejo-Gonzalez et al., 1996). Furthermore, there was 
no statistically significant correlation between increased dosage and severity 
of sexual dysfunction. This led the authors of that study to suggest that, 
above certain threshold dosages, individuals develop sexual dysfunction 
regardless of any dose increases.   
Other recent studies concur, with outcomes suggesting that antidepressant-
associated sexual difficulties may indeed be dose-related. In a study 
involving 254 postmenopausal women treated with citalopram (Barton et al., 
2010), sexual difficulties worsened in women who took 30 mg as opposed to 
10 mg.  Likewise, in a study of 112 females prescribed either escitalopram or 
fluoexetine, Sidi et al. (2012), reported that women on medium to higher doses 
of medication were statistically more likely to experience sexual difficulties. 
With respect to paroxetine dosage, two studies found that sexual difficulties 
were affected by dose (Ballenger, Wheadon, Steiner, Bushnell & Gergel, 1998; 
Rizvi & Kennedy, 2013). In Ballenger et al.’s (1998) study involving 278 
participants, it was noted that female genital disorders (this term was not 
defined by the authors), increased when paroxetine dosage increased from 10 
mg to 20 mg. In Rizvi and Kennedy’s single case study, a reduction in 
paroxetine dose from 60 mg to 40 mg led to an improvement in sexual 
difficulties (particularly anorgasmia) in a 45-year-old woman. Whilst the 
literature suggests that reducing the dosage of particular SSRIs may be an 
option for some women, Baldwin and Foong (2013), recommended caution is 
applied to avoid the onset of withdrawal symptoms or worsening of 
depressive symptoms.   
Switching antidepressant  
An increasing number of studies have shown that switching antidepressants 
may give the potential benefits of continuing to manage the depressive 
illness while reducing the potential for sexual difficulties (Clayton, Croft & 
Handiwala, 2014; Reichepfader et al., 2014; Rudkin, Taylor & Hawton, 2004; 
Watanabe et al., 2011; Zajecka et al., 2002). In a systematic review of 
strategies for managing sexual difficulties, Rudkin et al. (2004) reported that 
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a switch from sertraline to nefazodone (SRI) was significantly less likely to 
result in re-emergence of the sexual dysfunction and was not associated with 
any worsening depression. Ferguson et al. (2001) and Zajecka et al. (2002) 
also suggested that nefazodone has minimal or no negative impact on sexual 
functioning. 
In Zajecka et al.’s (2002) study involving 681 participants, nefazodone was 
combined with psychotherapy; all treatment groups showed increase in 
sexual functioning over a twelve-week period, which led the authors to 
conclude that combined treatment significantly improved sexual functioning 
compared to psychotherapy alone.  Ferguson et al.’s (2001) single blinded 
study, which compared individuals who were taking nefazodone with those 
taking sertraline, also appeared promising; over an eight-week period, 76% 
of individuals on sertraline experienced sexual difficulties compared to 26% 
on nefazodone. Whilst other studies have reported improved sexual 
functioning with this nefazodone (Fieger, Kiev & Shrivastava, 1996; Rudkin et 
al., 2004), this drug is not widely recommended due to its high risk of liver 
damage (heptotoxicity). Consequently, the sale of this medication has been 
discontinued in Australia (Moll & Brown, 2011). 
According to a current review of antidepressant treatment and sexual 
difficulties undertaken by Clayton, Croft and Handiwala et al. (2014), aside 
from nefazodone, other promising antidepressants include mirtazapine and 
buproprion. To date, a few studies have reported that mirtazapine (a 
noradrenergic and specific serotonergic antidepressant) can increase sexual 
functioning; however, it should be noted that most studies have been small, 
open labelled trials or case reports (Gelenberg, Delgado & Nurnberg, 2000; 
Koutouvidis, Pratikakis & Fotiadou, 1999). In the study undertaken by 
Gelenberg et al., nineteen men and women were switched to mirtazapine 
because of sexual side effects experienced whilst taking an SSRI. The 
findings from their study revealed that participants taking mirtazapine over a 
six-week period experienced a statistically significant improvement in sexual 
functioning. Similar results were reported in an open label study involving five 
female participants (Koutouvidis et al., 1999). A number of studies have 
nevertheless suggested a cautious approach be adopted when prescribing 
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mirtazapine for women as the significant weight gain and other side effects 
associated with this medication have led to a premature discontinuation 
(Hirschfeld, 2003; Michelson, Kociban, Tamura & Morrison, 2002). 
Bupropion, an antidepressant that has dopamine-enhancing properties has 
been found to have less impact on sexual functioning when compared to 
most other antidepressants (Clayton et al., 2002; Nieuwstraten & Dolovich, 
2001; Reichenpfader et al.. 2014). In a systematic review of the literature 
undertaken by Nieuwstraten and Dolovich (2001), they reported that 
bupropion caused significantly less sexual difficulties and improved 
satisfaction with sexual functioning compared to SSRIs. One year later, this 
finding was confirmed by Clayton et al. (2002), in a USA-based cross 
sectional study involving 4534 women and then later in a meta-analysis 
conducted by Gartlehener et al. (2011). More recently, a systematic review of 
63 studies, involving more than 23,000 participants, also reported that taking 
bupropion resulted in a statistically significant lower risk of sexual difficulties 
when compared to other newer antidepressants (Reichenpfader et al., 2014). 
Whilst a recent Cochrane review investigating strategies for managing sexual 
difficulties (Taylor et al., 2013) found that the evidence to support most 
strategies was limited, the authors did comment that the addition of 
bupropion as an adjuvant therapy appeared to be the most promising 
strategy for women experiencing sexual side effects. 
Adjuvant therapy 
A number of adjuvant compounds have been proposed for managing and 
treating SSRI associated sexual difficulties in women. However, according to 
Baldwin, Palazoo and Masdrakis (2013), and Taylor et al. (2013), relatively 
few compounds have been subject to rigorous evaluation. In the Cochrane 
review undertaken by Taylor et al. (2013), 22 randomised control trials 
investigated the addition of medication to treat sexual difficulties; however, 
most trials involved single case studies. To date, a few trials indicate 
probable efficacy for testosterone (Amiaz et al., 2011), sildenafil (Nurnberg, 
Hensley, Heiman, Croft, Debattista & Paine, 2008) and tadalafil (Segraves et 
al., 2007).  However, with respect to female sexual difficulties, bupropion 
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holds the most promise (Clayton, Warnock, Kornstein, Pinkerton, Sheldon-
Keller & McGarvey, 2004; Safarinejad, 2011; Taylor, Rudkin & Hawton, 
2005). Although various drugs with different compounds, for example, 
olanzapine, mirtazaine, yohimbine and Gingko Biloba have been evaluated, 
such studies have not demonstrated any statistically significant benefits 
(Kang, Lee Kim & Cho, 2002; Michelson et al., 2002; Wheatley, 2004).  
As mentioned previously, the addition of bupropion as an adjuvant therapy 
appears to be the most promising strategy for women. According to Taylor et 
al (2013), there are now five trials with 579 participants comparing the effect 
of augmenting antidepressant treatment with bupropion or placebo (Clayton 
et al., 2004; Debattista, Solvason, Poirier, Kendrick & Loraas, 2005; Masand, 
Ashton, Gupta & Frank, 2001; Safarinejad, 2011). Of these, one study 
involving 46 women reported a significant increase in enhancement of sexual 
desire and frequency of sexual activity amongst women taking 150 mg of 
bupropion twice a day (Clayton et al., 2004). In a larger placebo-controlled 
study involving 218 women (Safarinejad, 2011), similar results were reported 
with the addition of 150 mg of bupropion twice a day; again, the most 
significant improvement related to an increase in sexual desire. Of note, 
whilst no serious adverse effects were observed in the studies undertaken by 
Clayton et al. (2004) or Safarinejad (2011), the authors did note that a higher 
number of women withdrew from the treatment group due to adverse effects 
such as headaches, insomnia and dry mouth. Whilst bupropion was reported 
to be a promising strategy for most women in these trials, not all women were 
able to tolerate the resulting side effects. 
2.3.4 Summary of SSRIs 
In summary, the literature review relating to the sexual side effects of SSRIs 
reports a number of notable findings.  Firstly, although prevalence rates of 
sexual side effects are difficult to obtain, it appears the rates are 
underestimated and are more common than initially perceived. Secondly, it 
has been reported that SSRIs affect all aspects of the female sexual 
response cycle, though each aspect is affected to varying degrees. Whilst 
certain types of SSRIs seem to be associated with specific sexual difficulties, 
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the research suggests that paroxetine and fluoexetine are commonly 
associated with anorgasmia and/or desire disorders in women. Finally, the 
literature identifies six strategies to assist with the treatment and 
management of SSRI-related sexual side effects, these include including 
improving the therapeutic alliance, waiting for spontaneous remission, drug 
holidays, dose reduction, switching antidepressant and adjuvant therapy. 
Whilst the addition of bupropion as an adjuvant therapy shows promise for 
some women, the evidence to support other approaches is limited. There 
have been calls for more research to guide the treatment and management 
of SSRI-related sexual difficulties in women. 
2.4 Chapter summary 
As highlighted by the literature review, female sexual difficulties arising from 
the use of SSRIs are an important but underestimated problem. Whilst the 
actual prevalence of such difficulties remains a contested issue, what is clear 
from the literature is that the sexual side effects of SSRIs influence 
adherence to medication, and impact on psychological wellbeing and quality 
of life. To date, most of the research has been within a positivist framework 
and is understood through a biomedical lens.  Although such studies are 
important, the nuanced experiences of women are not adequately captured, 
thereby, limiting the ability to explore and understand sexual difficulties from 
an individual perspective. In line with calls for more research into the 
treatment and management of SSRI-related sexual difficulties in women, 
there is a need to capture and explore women’s experiences of coping with 
sexual difficulties using a qualitative approach in order to complement the 
emerging body of quantitative research within this field. 
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CHAPTER 3: 
Methodology and Methods 
‘Sex research should raise up women’s diverse voices, not pre-impose an 
existing paradigm’ Tiefer (1995, p.194).  
 
3.1 Introduction 
Over the past decade, a number of scholars have challenged the biomedical 
approach to sexual difficulties and have highlighted the need for qualitative 
research to capture the unique lived experiences of women (Farrell & 
Cacchioni, 2012; Lavie-Ajayi & Willig, 2005; Tiefer, 2012). Indeed, Tiefer 
(1995, p. 194) called for sexuality research to ‘raise up women’s diverse 
voices’, to ensure real life experiences are captured. Smith, Flowers and 
Larkin (2009) argued that Interpretative Phenomenological Analysis (IPA) is 
particularly suited to exploring sexuality and sexual experiences; it can 
further existing understandings that have emerged from medical or 
pathological approaches and provide more authentic insight into how social 
and cultural contexts influence sexual behaviour.  
This chapter provides a discussion of the methodological approach used for 
this study. It restates the research aim, question, and objectives of the study; 
it also provides insight into the research design, methodology, data collection 
methods and data analysis techniques. Following on, the chapter discusses 
Yardley’s (2008) four broad principles for assessing the quality of qualitative 
research, which include sensitivity to context, commitment and rigour, 
coherence and transparency, and impact and importance. The chapter 
concludes by addressing the issue of reflexivity. 
3.2 Research aim, question and objectives 
The aim of this research was to improve understanding of the coping 
experiences of women who were experiencing SSRI-related sexual 
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difficulties that were causing problems or distress to them and/or their 
partners. As such, the research question was stated as: 
“What are the lived experiences of coping with sexual difficulties amongst 
heterosexual women who take SSRI medication?” 
The specific objectives of the study were to: 
 Explore the lived experience of coping with sexual difficulties amongst 
heterosexual women who had been taking SSRI medication for at 
least three months.  
 Characterise the types of strategies used to cope with the sexual 
difficulties arising from SSRI use in order to assist women who are 
experiencing such difficulties.  
 Provide recommendations to inform professional practice amongst 
clinicians, therapists and other relevant health professionals. 
Ethical approval for this study was gained from Curtin University Human 
Research Ethics Committee, approval code HR 94/2012 (Appendix A). 
3.3 Research design 
Crotty (1998, p.5) referred to the research design as the ‘plan or proposal to 
conduct research’, which involves the intersection of philosophy, strategies of 
inquiry and specific methods. He suggested a framework for the research 
process consisting of four elements: epistemology, theoretical perspective, 
methodology and methods. Epistemology is the theory of knowledge; it 
defines what kind of knowledge is possible and legitimate. The theoretical 
perspective is the philosophical position that grounds the choice of 
methodology. The methodology refers to the strategy that links the selection 
of research methods to the desired outcomes. The methods are the 
techniques used to gather and analyse data related to the research question 
or hypothesis (Crotty, 1998). Crotty’s framework enables researchers to 
understand and conceptualise the philosophical and theoretical perspectives 
that underpin a research project, and to consider how the different elements 
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inform and influence each other throughout the research process. Using 
Crotty’s (1998) framework, the four elements are outlined in the following 
sections to justify the choice of methodology and method used for this study. 
3.3.1 Epistemology: Social constructionist position 
This research assumed a social constructionist epistemological position. 
According to Freeman and Mathison (2009, p.1), a social constructionist 
position is grounded in a belief that there is ‘no objective reality’ and that 
beliefs and knowledge about the world are actively constructed and mediated 
by the social, historical, institutional, and economic environment. A social 
constructionist position also recognises that research participants are active 
in the co‐construction of meaning and understanding. Although 
phenomenological approaches emphasise the richness and complexity of 
lived experience, Cosgrove (2000) argues that social constructionism offers a 
way to deconstruct the stories that are told by women and to generate 
meaningful information about their lived experience. Whilst IPA is concerned 
with detailed accounts of individual experience, Smith et al., (2009) 
emphasise that IPA also subscribes to social constructionism (through 
concerns about how context is implicated in an individuals lived experience), 
albeit to a lesser extent than discursive psychology or discourse analysis. 
In this study, social constructionism provides a useful epistemological 
framework to explore women’s experiences of sexual difficulties: it does not 
see women’s stories as a straightforward way to obtain access to their ‘inner 
experiences’, rather it problematizes women’s subjective accounts and 
understands that meaning is constructed (Cosgrove, 2000, p.257). As 
emphasised by Tiefer et al. (2002), it is important to locate women’s sexual 
difficulties within a sociocultural context, hence this epistemology was 
compatible with the research aim of uncovering the lived experiences of 
women who were coping with the sexual side effects of SSRI medication. 
The philosophical focus was on the women’s socially constructed reality, 
interpreting the experience from their words, their experience of the world, 
their interactions and the settings where the experience occurred. 
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3.3.2 Theoretical perspective: Interpretive 
This research adopted an interpretive theoretical perspective. Crotty argued 
that an interpretive stance is closely linked to the epistemological position of 
constructivism, and looks for culturally derived and historically situated 
interpretations of the social life-world (Crotty, 1998). As this research 
explored women’s experiences, and co-constructed the meaning of such 
experiences based on cultural, historical and social perspectives, an 
interpretive stance was most appropriate. Consistent with this approach, the 
researcher was central to the study and played a key role in helping 
participants make sense of their experiences. As such, it is important to 
acknowledge that researchers bring a lens through which they interpret the 
data.  
 
In this study, the researcher had prior experience of coping with the sexual 
side effects of SSRIs and a professional background in the field of sexuality. 
Consequently, the researcher held a worldview that aligned closely with a 
biopsychosocial perspective of health and illness; that is, psychological and 
social factors must also be included along with the biological factors when 
attempting to understand health and illness experiences (Engel, 1981). 
Whilst the biopsychosocial model of health is contested and has several 
limitations (Tavakoli, 2009), it is still considered to be a useful framework to 
explore and understand the lived experience of health and illness.  
 
Furthermore, the researcher held an established feminist worldview. Whilst 
there are many forms of feminist thought, the lens through which this 
research was conceptualised and analysed aligns closely with Crotty’s 
position (1998); that is, a feminist worldview prioritises women’s voices, and 
attempts to understand the context and lives of women by understanding 
power relations and how these impact on individual lived experience.  
3.3.3 Methodology: Interpretative Phenomenological Analysis (IPA) 
IPA has been gaining attention as a flexible and inductive phenomenological 
research approach, which allows the researcher to move beyond a 
biomedical model of disease and illness to explore self-reported experiences 
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and meanings individuals assign to those experiences (Brocki & Wearden, 
2006; Smith et al., 2009). Therefore, IPA was congruent with the positioning 
of this research as social constructivist and interpretative, and offered an 
appropriate methodological approach to explore women’s lived experiences 
of coping with the sexual side effects of SSRI medication. Whilst Dorothy 
Smith’s (1990) ‘feminist standpoint theory’ was considered as a methodology 
to give voice to women and to situate their concerns within a social and 
cultural context, her approach highlighted the importance of collective 
experiences rather than individual experiences. As such, it has been critiqued 
for its focus on social groupings and for failing to ‘allow agency space to 
individual women as subjects’ (Walby, 2001; Yuval-Davis, 2013, p. 3).  
Phenomenological research is derived from philosophy, and was developed 
as a philosophical method of inquiry by the German philosopher Edmund 
Husserl (Koch, 1995). Husserl rejected the view that empirical science held 
the key to understanding the world, instead stressing the importance of the 
‘life world’ or lived experience and the quest for the essences of things 
(eidetic reduction). According to Finlay (2009, p. 18), whilst 
phenomenologists generally agree a return to embodied, experiential 
meanings is central to the approach, many research methodologies and 
approaches are labelled as phenomenological despite stemming from 
‘different philosophical values, theoretical preferences and methodological 
procedures’. For example, van Manen’s (1990) lived experience human 
science inquiry approach and Smith’s (1996) IPA approach are labelled as 
interpretative; van Manen, however, is particularly interested in the 
phenomenological investigation of everyday practice, whereas Smith’s IPA is 
concerned with the microanalysis of individual experiences and nuances 
arising from such an experience.  
IPA as a phenomenological approach was specifically developed by 
Jonathan Smith in the 1990s. In his seminal paper (Smith, 1996), he argued 
for an accessible research approach to capture the experiential and 
qualitative dimensions of health psychology. As a qualitative research 
approach, IPA is committed to the examination of how individuals make 
sense of major life experiences; since its inception, IPA has become of one 
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of the most commonly used qualitative methodologies in psychology (Smith, 
2011). It draws on theoretical ideas from phenomenology and hermeneutics, 
and is idiographic in its commitment to analyse each individual’s experience 
in detail (Smith et al., 2009). It is also theoretically underpinned by symbolic 
interactionism, and recognises that individuals construct meaning within their 
social and personal world (Biggerstaff & Thompson, 2008; Smith et al., 
2009).  
Being phenomenological, IPA is concerned with exploring lived experience 
and the meanings individuals attach to their experiences. IPA is strongly 
influenced by the phenomenological perspective of Heidegger which 
considers the person as ‘embodied and embedded in the world, in a 
particular historical, social and cultural context’ (Shinebourne, 2011, p. 18).  
According to Larkin, Watts and Clifton (2006) Heidegger’s phenomenology is 
consistent with a contextualist position; hence, an understanding of the 
individual cannot emerge in isolation from the person’s context. Heidegger 
also recognises that ‘the meaning of phenomenological description as a 
method lies in its interpretation’ (Heidegger, 1962, p. 37). As highlighted by 
Shinebourne (2011), Heidegger considers the interpretive process integral to 
revealing what is conscious and what remains hidden with regards to an 
individual’s lived experience.  
The second key influence upon IPA is hermeneutics. Hermeneutics is the 
theory of interpretation; as such, the analysis involves an interpretative 
endeavour between the researcher and the participant. According to Smith et 
al. (2009), the researcher is trying to make sense of the individual trying to 
make sense of her/his experience. This is referred to as a ‘double 
hermeneutic’; that is, ‘the individual’s meaning-making is considered first 
order, while the researchers sense-making is second order’ (Smith et al., 
2009, p.36). As part of this process, the analysis proceeds in a circular 
fashion. This often requires the researcher to revisit earlier findings as new 
results emerge. Smith et al. (2009) refer to this cyclical process as the 
hermeneutic circle – to understand any given part, one must look at the 
whole; to understand the whole one must look at its parts.  
44 
The third key influence upon IPA is idiography. Within a traditional 
psychological context, this term is associated with the study of an individual: 
however, within IPA it refers to the detailed examination of an individual case 
(Smith et al., 2009). Idiography wants to know in detail what the experience is 
like for a specific person, and seeks to detail the particular experiences of 
single individuals. IPA also strives to understand particular people’s 
experiences within their individual social and cultural context (Smith et al., 
2009; Willig & Stainton- Rogers, 2008). Whilst it is beyond the scope of this 
chapter to provide a detailed account of each of the three areas,  Larkin et al. 
(2006), Shinebourne (2011) and Smith et al. (2009) can be referred to for a 
number of papers and texts that illuminate and further explore the theoretical 
underpinnings. 
3.3.4  Methods 
Whilst methods such as diaries and focus groups have been used to collect 
data in IPA studies, semi-structured interviews tend to be the preferred 
approach (Brocki & Wearden, 2006; Reid, Flowers & Larkin, 2005; Smith et 
al., 2009). For this study, semi-structured interviews were chosen as they 
were most appropriate for in-depth and personal discussion.  
Sampling 
IPA samples tend to be homogenous, and whilst the research question will 
have a bearing on selection factors, novice researchers have been 
encouraged to find a sample which is as uniform as possible so that patterns 
of similarities and differences can be explored (Smith et al., 2009). In this 
study, a set of inclusion criteria were developed to ensure a reasonably 
homogenous group of women who could illuminate the lived experience of 
coping with SSRI related sexual side effects based on relationship status, 
sexual orientation, age and length of time on SSRI medication. 
The inclusion criteria were as follows:  
 Women under 45 years old who were currently in a heterosexual 
relationship, and who had been taking SSRI medication for longer 
than three months. 
45 
 Women who self-identified as experiencing sexual difficulties that were 
believed to be attributable to the SSRI medication. 
 Women who were experiencing sexual difficulties that they perceived 
to cause problems or distress to themselves and/or their partners. 
Women aged 45 years and under were selected as the appropriate age cut-
off for this study as prevalence and treatment rates of affective and anxiety 
disorders decline rapidly after this age (Hollingworth, Burgess & Whiteford, 
2010). As lesbian relationships operate on different principles with respect to 
power and affect, compared to their heterosexual counterparts (Richards, 
Naveen & Kim, 2015), it seemed inappropriate to merge lesbian and 
heterosexual women in this study. As such, only heterosexual women were 
included in the sample. The three-month timeframe for taking SSRIs as an 
inclusion criteria has been based on recommendations from other studies. As 
stated by Moret, Isaac and Briley (2009), this timeframe distinguished the 
sexual side effects of the medication from the residual depressive symptoms. 
The term ‘sexual difficulty’ was not defined for this study; each woman 
brought her own understanding and identification of what sexual difficulty 
meant to her. Unlike previous studies that have investigated women’s sexual 
experiences (Marriot & Thompson, 2008; Svedhem, Eckert & Wijma, 2013), 
participants for this study were not recruited through health professionals or 
clinics but directly through a mental health website (depressionnet.com), 
social media sites and snowball sampling (Liamputtong, 2013).  Given that 
women are often reluctant to seek help for sexual difficulties (Moreira et al., 
2008; Shifren et al., 2009), it was important to ensure the experiences of 
women who may not have sought help were captured.  
Interested women were emailed a brief questionnaire (to capture 
demographic information and further details relating to type of medication), 
and a participant information sheet (Appendix C) to complete. Those who 
met the inclusion criteria (ten women) were invited to participate in the study. 
Each woman who participated signed a consent form before data collection 
commenced. Whilst no definitive criteria exist for sample size in IPA, a 
sample of ten women adequately captured patterns of similarity within the 
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group whilst recognising the particularities of individual lives. This sample 
size is in keeping with IPA’s commitment to an idiographic approach, with 
eight or fewer being interviewed in previous studies reporting women’s 
sexual experiences (Holt & Slade, 2003; Lavie-Ajayi &Willig, 2005; Marriott & 
Thompson, 2008; Svedhem et al., 2013). Since the results of this research 
are presented through three published papers, one in Chapter 4, 5, and 6, 
further details about participants are provided in Table 3.1 below 
(pseudonyms have been assigned to protect anonymity). 
Table 3.1: Demographic information  
Name Age Diagnosis and SSRI Length of 
time on 
SSRI 
Relationship 
status  
Education 
level 
Alison 29 Mild depression 
(Escitalopram) 
6 months De Facto Bachelor 
Degree 
Charlotte 45 Severe depression  
(Sertraline) 
13 years Married Postgraduate 
Diploma 
Helen 23 Moderate depression 
(Escitalopram) 
11 months Married  Grade 12 
completion 
Julie 44 Severe depression 
(Fluoxetine) 
7 years Married Postgraduate 
Degree 
Lisa 44 Severe depression  
(Sertraline) 
15 years De facto Postgraduate 
Degree 
Mandy 38 Moderate depression 
(Escitalopram) 
2 years Married Grade 12 
completion 
Nadia 42 Moderate depression, 
panic disorder 
(Paroxetine) 
12 years Married Postgraduate 
Degree 
Phoebe 40 Mild depression, panic 
disorder 
(Paroxetine) 
13 years Married Grade 12 
completion 
Sonia 30 Moderate depression  
(Sertraline) 
10 months Married Bachelor 
Degree 
Tahlia 26 Severe depression 
(Sertraline) 
10 months De facto Bachelor 
Degree 
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Data Collection  
As previously mentioned, ethical approval was obtained and then informed 
consent was acquired from each woman before data collection commenced. 
Two interviews were carried out with each woman over an eight-week period. 
Each interview was audio recorded with consent. During the first interview, 
six questions and a set of prompts for each question were used as a guide 
during the interview. Before the formal interview questions were asked, the 
woman were encouraged to talk about their personal history and experience 
of depression. Women were also asked to rate the severity of their 
depression (mild, moderate or severe) (Appendix E).  First interviews lasted 
between 1 hour and 1 hour 45 minutes in length. When using IPA, the 
interviewer interacts closely with the respondent to elicit meanings; hence, 
the interview schedule was used flexibly allowing the respondent to take the 
lead where appropriate. Questions focused on the women’s personal 
experiences of coping with the sexual side effects of SSRI medication, and 
were open-ended to generate discussion. Example interview questions 
included the following, ‘Can you tell me about your experiences of coping 
with the sexual side effects of your medication?’ and ‘What coping strategies 
do you feel are particularly helpful?’ Throughout the interview, non-verbal and 
non-behavioural communication was noted in the researcher’s field notes. 
The second or follow-up interviews with each woman were between 45 
minutes and 1 hour 15 minutes. Whilst second interviews are not essential 
within IPA, a small number of studies have used a second interview to gain 
clarity and greater richness from the participants (Wagstaff & Williams, 2014).  
During this interview, the transcript from the first interview was reviewed with 
each woman and emergent themes were discussed to clarify any issues and 
ensure accurate interpretation. An interview schedule was not required for 
this interview.  Additionally, women were given the opportunity to further 
elaborate on their lived experiences; this led to enriched data as women had 
time to reflect on their experiences after the first interview. Whilst most of the 
women agreed with the emergent themes, one of the women (Charlotte) did 
not agree with one particular theme ‘Acceptance’. Whilst she felt able to 
tolerate the situation, she felt that she had not fully accepted the situation, but 
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was in the process of trying to accept it. Upon further probing, she highlighted 
how she was trying to accept the situation, however, she felt her husband’s 
lack of acceptance hindered her attempts to move forward. As such, it was 
decided that the theme ‘Attempting to Accept’ was more appropriate for this 
particular participant. Identical to the first interview, after each second 
interview, field notes were made to highlight noteworthy issues; for example, 
non-verbal communication.  
Data Analysis  
The process of analysis for this study followed the guidelines for IPA put 
forward by Smith et al. (2009), and involved reading and re-reading the 
transcript, initial noting, developing emergent themes, searching for 
connection across emergent themes, moving to the next case and looking for 
patterns across cases.  
Re-reading and noting phase – a key tenet of IPA involves an iterative and 
inductive cycle of analysis, which involves moving back and forward between 
individual parts and the whole transcript in an attempt to interpret the whole 
(Biggerstaff & Thompson, 2008; Larkin et al., 2006; Smith, 2007). Neither the 
whole text nor any individual part can be understood without reference to one 
another; this is an iterative process and is referred to by Heidegger (1971) as 
the ‘hermeneutic circle’ or a metaphor that guides the process of inquiry on 
several levels. The analysis began with reading each transcript several times 
for an overall sense of the data. Coding in IPA consists of initial noting in 
which the researcher writes their analytic observations about the data (Smith 
et al., 2009). Once the transcript had been read several times, reflections and 
comments (initial noting) were made in the left hand margin of the transcript, 
noting any striking issues such as contradictions or connecting comments.  
Identifying emergent themes – this was a challenging process and involved 
focusing on discrete sections of the transcript; moving from individual 
passages of text to the whole transcript, this process was informed by the 
hermeneutic circle. Rather than naming themes directly from the data, as is 
suggested for thematic analysis, data were interpreted by asking questions 
about the nature of what was happening. Having analysed an entire transcript, 
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I looked for a number of particularly resonant passages and moved to a more 
detailed reading and analysis of that part. In one of the passages in Table 3.2, 
Julie talks about how her husband “really likes sex”, and how she fakes 
pleasure to meet her husband’s needs.  By examining the language used, it 
became evident that her language shifted from talking about a strategy she 
specifically employed  to cope with her husband’s sexual needs “I find 
myself....faking pleasure and all that to meet my husband’s needs” to a 
generalised coping strategy of “letting them have their way...... and you’re not 
getting anything out of it”. As can be seen from researcher’s notes in Table 
3.2, the comments made by the researcher with respect to the language shifts, 
move beyond descriptive comments which highlighted key words and phrases, 
to more interpretative comments which analysed the transcript at a conceptual 
level and started to acknowledge social and cultural contexts.  To illustrate this 
process in more detail, a section of the transcript is provided in Table 3.2 
 
Table 3.2: Extract from an interview with Julie 
Researcher’s  
Notes  
Transcription of Interview  Emergent themes 
 
 
 
 
 
Feelings of 
inadequacy 
here...clear sense 
that she is not good 
enough? 
 
Tough on him (not 
her?)  
 
 He would be 
happier with other 
women.  She feels 
that men need sex to 
be happy (social 
scripts coming into 
play here – check 
this interpretation!) 
  
 
 
 
 
 
Interviewer: Ok, so you talk about this (sexual 
difficulties) impacting on him, are you able  
to expand on this a bit more? 
 
Woman: Yeah....well (pause) look (pause)he 
 really likes sex and wants it a lot so I think it’s  
tough on him. One of the thoughts I had  
(whisper in quiet voice) when I was going  
through  one of these really bad periods and 
 tried suicide, is  that  he would be happier with 
 another women. Not that I’d ever tell him that  
(laughing). You know he’d have lots  more sex  
(both laughing) and he’d just be happier.  
 You  know and he would have somebody  who 
 would enjoy it and want it as much as he does. 
  
 
 
Interviewer: Right, that’s really interesting...  
 
Woman: ...so now I find myself just engaging n  
sex, you know, faking pleasure and all that just  
to meet my husband’s physical needs (l pause) 
 
 
 
 
 
 
 
Protecting partner 
 
Non 
communication 
 
 
 
 
 
 
 
Pretending all is 
OK 
 
Protecting partner 
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Faking pleasure to 
meet his needs. 
(What about her 
needs?) 
 
 
 
Having their way 
with you. Highlights 
her sexual needs 
and role as passive, 
his needs as central.   
 
Language shift from 
him to they – this is 
common to all men, 
‘they can get their 
rocks off’ not just 
her husband. You’re 
getting nothing out 
of it - Convincing 
herself this is a 
social norm? (Every 
body fakes it don’t 
they? This is normal 
isn’t it?) 
Interviewer:  Yeah.  
 
Woman: ...and it can set up a bit of a thing of  
resentment, because, you know, just letting 
them have  their way with you so that they can 
get their rocks off  (slight laughing) and you’re 
getting nothing out of it (pause) do you know 
what I mean? 
 
 
 
 
Protecting  partner 
Faking pleasure 
Protecting self 
Pretending all is 
OK 
 
 
 
 
 Emerging themes such as ‘protecting partner’; ‘protecting self’  and ‘faking 
pleasure’ were noted during this stage. Upon completion of this stage, the 
second interview was undertaken with each woman, and the transcript from 
the first interview was reviewed. Emergent themes were discussed during this 
interview to clarify any issues and ensure accurate interpretation. The second 
interview provided enriched data as women had time to reflect on their 
experiences after the first interview. After each second interview, the re-
reading and noting phase was repeated, and emergent themes were revisited.  
Searching for connections across themes – during this stage, patterns 
and connections among emergent themes were noted in order to showcase 
important or interesting aspects of the woman’s experience. For example, 
one of the emergent themes from Julie’s transcript (Table 3.2) reflected her 
commitment to protecting her partner and not communicating her own 
feelings and sexual needs. At this stage, the emerging themes protecting 
one’s self’ and ‘protecting partner’ were grouped together and labelled 
‘Suffering in Silence’ as she later revealed how she struggled to confide in 
her partner or friends about the extent of the problem and its impact. A 
subsequent interpretative analysis highlighted the influence of social and 
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cultural context. Her coping strategies were influenced not only by a need to 
protect her husband, but a need to protect herself from i) the perceived threat 
of losing her husband if she did not actively engage in sexual activity and ii) 
social discrimination as a result of confiding in others about her use of SSRIs.  
Moving to the next case and looking for patterns across cases – the 
next step involved moving to the next participant’s transcript to repeat the 
process. Once each transcript had been analysed individually, patterns 
among emergent themes were explored across all transcripts, and themes 
were clustered to develop a set of final super-ordinate (master) themes. 
Whilst Smith et al. (2009), do not define how to determine a theme, for 
samples larger than six, it is suggested that a super-ordinate theme should 
be present in at least a third of all participants. These guidelines were 
adhered to in this study. See Table 3.3 for final list of themes. 
 
Table 3.3: Overview of super- ordinate and sub- ordinate themes. 
 
Super- ordinate theme 
 
Sub-ordinate themes 
 
‘Suffering in silence’ 
 Avoiding sexual encounters 
 Protecting one’s partner 
 Protecting one’s self 
 
‘Trying to resolve’ 
 Communicating  with partner 
 Altering medication  
 Taking steps to enhance sexual pleasure 
 
‘Accepting what is’ 
 Counterbalancing the positive and negatives of 
SSRI medication 
 Embracing positives within the relationship 
 Altering expectations about how sex ‘should be’ 
 
‘Searching’ 
 Searching for answers 
 Searching for validation of problem 
   
 
 
52 
3.4 Yardley’s (2008) principles for assessing the quality of 
qualitative research  
Although reliability and validity are important aspects of IPA research, the 
appropriateness of applying quantitative criteria to qualitative research has 
been questioned by a number of authors (Kvale, 1996; Roulston, 2010; 
Yardley, 2008). For this reason, Yardley (2008) developed a set of 
guidelines, based on four broad principles, which are particularly suited to 
assessing the quality of qualitative psychological research. These four 
principles were used as a guide throughout the research process and are 
detailed below. 
Sensitivity to context 
Yardley (2008) identified two important ways in which a qualitative study can 
show sensitivity to context; both were applied to this research. The first, 
‘consideration of relevant theoretical and empirical literature’, (p. 247) 
involved a comprehensive literature review. The detailed literature review 
highlighted gaps in understanding and informed the development of the 
research question. The second, ‘sensitivity to perspective and socio-cultural 
context of participants’ involved ensuring the research design and 
implementation was sensitive to individual women’s needs. In this research, 
consideration was given to the setting in which the interviews took place 
(women chose the most appropriate setting), and to the choice of researcher 
(women were interviewed by a female researcher who had experience of the 
phenomenon and in interviewing women about issues relating to sexuality). 
Open-ended questions were used in both interviews to ensure the research 
did not confine and direct women’s responses, but was sensitive to and 
accepting of women’s perspectives.  
Commitment and rigour 
Yardley (2008) identifies four key factors for consideration in this area: 
thorough data collection, depth/breadth of analysis, methodological 
competence/skill, and in-depth engagement with the topic. Consistent with 
these factors, a thorough explanation of research design, data collection and 
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analysis is provided throughout this chapter to provide a clear description of 
the processes undertaken. Smith et al. (2009), referred to rigour as the 
‘thoroughness of the study’ (p. 181), and recommended researchers keep an 
audit trail to enhance rigour. An audit trail involves filing all data from the 
research project in such a way that someone could follow the chain of 
evidence that leads from the design of the study through to the research 
findings. Thus, this research project includes a file of material including the 
initial research proposal, revised research proposal, an interview schedule, 
audio recordings, field notes, reflective journal, annotated transcripts, tables 
of themes and the final papers that will be kept in a secure locked location for 
seven years after the thesis has been published. 
Coherence and transparency 
Yardley (2008, p. 248) defined coherence of a study as ‘the extent to which it 
makes sense as a consistent whole’. She emphasised that a coherent piece 
of qualitative research must have a solid grounding in the methodology and 
methods used and the theoretical background needs to be outlined. A 
detailed rationale for this study is provided in the literature review and 
introduction; the theoretical background of IPA is discussed earlier in this 
chapter. According to Yardley (2008), the transparency of a qualitative study 
is concerned with how well a reader can understand what was done and why. 
In addition to the audit trail discussed earlier, peer review was also utilised 
and a supervisor with expertise in qualitative research simultaneously audited 
one of the transcripts. Furthermore, transcripts from first interviews were 
member-checked with each woman and emergent themes were discussed to 
ensure accurate interpretation and clarify any issues. This led to enriched 
data as women had time to reflect on their experiences after the first 
interview. This also provided the space to ensure themes were coherent and 
to reflect on how the researcher’s assumptions and biases may have 
influenced the data.  As reflexivity is considered an important aspect of an 
IPA study (Smith et al., 2009), the researcher’s position is outlined in the 
introduction chapter, and a section on self-reflexivity has been included, to 
illustrate the researcher’s values, interests and assumptions. 
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Impact and importance 
According to Yardley (2008), there is no value in conducting research unless 
the findings have the potential to make a difference. The relevance and 
significance of this research are outlined in the introduction and the literature 
review. Suggestions have been made regarding how this research can inform 
women and professional practice in order to enhance the management of 
SSRI-related sexual difficulties in women. Three papers have been published 
to disseminate the findings. 
3.5 Reflexivity   
Within IPA, the researcher plays an active role in interpreting data. The 
importance of reflexivity (where the researcher reflects on how their 
experiences may influence the research) has been highlighted by Smith et al. 
(2009). As such, it is imperative that IPA researchers reflect on how their 
involvement affected the research process.   
 As a woman who had experienced the sexual side effects of SSRI 
medication; I was conducting the research from an insider or emic 
perspective. The impact and advantages of insider epistemology have been 
considered by a number of researchers (Cooper & Rogers, 2015; Dwyer & 
Buckle, 2009; Taylor, 2011), however there are also challenges to be 
considered. As an inside researcher, I was better placed to identify an 
appropriate research question, and I felt this membership role afforded 
increased access, acceptance and a common ground from which to begin my 
research. As I was researching a particularly sensitive subject, I felt the 
women were more open with me, and considered me to ‘be one of them’; I 
strongly believe this allowed me to explore the topic in greater depth and 
breadth. Although this shared status was beneficial, my perceptions were 
sometimes clouded by my own personal experience, however, I ensured that 
steps were put into place to reduce any potential concerns associated with 
insider status.  
At the start of each interview, I briefly touched upon my experiences of 
sexual difficulties whilst emphasising that the purpose of the study was to 
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explore participants’ individual stories and unique experiences of coping. 
Women were given the opportunity to ask questions about my experiences at 
the end of each interview although no one did. Whilst I endeavoured to begin 
each interview with an open mind, I do acknowledge that non-verbal 
communication may have encouraged or discouraged certain responses and 
that a different researcher may have elicited a different response. 
During the data collection process, I also utilised a reflexive journal to 
acknowledge my preconceptions and assumptions before and immediately 
after each interview.  By attempting to set aside my preconceptions 
immediately before the interview, I felt able to listen attentively to the 
participant’s story rather than being distracted by my own experiences. An 
example of a journal entry (written after an interview) is provided below:  
I was actually quite shocked when (name) talked about not being 
interested in receiving any type of pleasure from sex. I found it hard to 
believe that a young woman (older women, maybe?) would only be 
having sex out of duty, or because she was scared her husband might 
leave her. Fortunately, I don’t think my response came across as one of 
shock or of being judgmental – but it has made me more aware of my 
assumptions and the need to revisit these before and during the analysis 
stage. 
Throughout the analysis stage, I continued to use reflexive journaling in order 
to highlight preconceptions and assumptions. 
3.6 Chapter summary 
This chapter reviewed the methodology used to guide this study. It explored 
IPA as a research approach and outlined the reasons for this choice. This 
was followed by an in depth discussion of methods employed throughout the 
study, data analysis and a section on reflexivity. In summary, IPA offers a 
structured approach to phenomenological research, and is particularly 
relevant for exploring women’s sexual experiences and difficulties as it can 
further existing understandings that have emerged from biomedical 
approaches to research.  
In the following three chapters, the research findings will be presented in the 
form of one published paper per chapter.   
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CHAPTER 4: 
Women’s experiences of coping with the sexual 
side effects of antidepressant  medication 
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Chapter overview 
This chapter is the author-accepted (post-print) version of the article 
published in the journal of Psychology and Health. Publisher copyright 
policies relating to this article are supplied in Appendix F.  Co-author 
statements are provided in Appendix H.   
This chapter presents the overall findings from the study and reports on the 
four broad themes, namely i) searching; ii) suffering in silence; iii) trying to 
resolve and; iv) accepting what is. The themes provide insight into the 
different strategies used by women to cope with the sexual side effects of 
SSRI medication and have practical implications for women on SSRIs and for 
clinicians, therapists and other relevant health professionals. The findings 
highlight the importance of contextualising these difficulties as part of an 
overall approach to improve the management and treatment of SSRI-related 
sexual side effects. 
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Abstract 
A growing body of evidence has highlighted the sexual side effects of 
selective serotonin reuptake inhibitor (SSRI) medication. Whilst most of the 
research has focused on the prevalence and treatment of sexual difficulties, 
little is known about how individuals cope with the SSRI related sexual side 
effects. The objective of this study was to explore women’s experiences of 
coping with the sexual side effects of SSRI medication and interpretative 
phenomenological analysis (IPA) was employed for an in-depth exploratory 
study of a sample of ten women. Four broad themes emerged which are 
discussed under the following headings: searching, suffering in silence, trying 
to resolve and accepting what is. The themes provide an insight into the 
different strategies used by women to cope with the sexual side effects of 
SSRI medication and highlight the importance of contextualising these 
difficulties as part of an overall approach to improve the management and 
treatment of SSRI related sexual side effects. 
Key words: SSRI, sexual side effects, females, coping strategies, qualitative 
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Introduction 
Depression is a leading contributor to the non-fatal burden of disease, and 
evidence suggests antidepressant drug use is increasing in developed 
countries (Saragoussi et al., 2012; Zhang et al., 2010).  Although a variety of 
antidepressants are available, including tricyclics (TCAs), and monoamine 
oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs) 
are the most frequently prescribed antidepressant in Australia (Wong, Taylor, 
Ashby & Robinson, 2010).  This paper focuses on the side effects of SSRIs 
including fluoxetine (Prozac), paroxetine (Aropax/Paxil), sertraline (Zoloft), 
citalopram (Celexa), escitalopram (Lexapro) and fluvoaxamine (Luvox). 
SSRIs differ from older antidepressants in their chemical structure and 
method of action; the side effects of this newer medication are more tolerable 
making these a first line treatment for depression and anxiety (Moret, Issacc 
& Briley, 2009). Whilst SSRIs are generally well tolerated, they are not devoid 
of side effects. Several authors have reported on treatment emergent sexual 
side effects and state how these adverse side effects are a common cause 
for non-adherence to long- term treatment (Basson, Rees, Wang, Montejo 
&Incrocci, 2010; Serretti & Chiesa, 2009). Widespread use of SSRIs and 
concerns relating to adherence rates have prompted an emerging body of 
research into the sexual side effects (Basson et al., 2010; Grover et al., 
2012) and have been the focus of a recent Cochrane review (Taylor et al., 
2013).  
As sexual difficulties may occur for a number of reasons, it remains difficult to 
obtain statistics relating to the prevalence of treatment emergent sexual 
difficulties resulting from this medication (Clayton & Balon, 2009; Safarinejad, 
2011). What is becoming evident, however, is that sexual side effects are 
more common than initially perceived.  Studies have reported treatment 
emergent sexual side effects of over 50% (Fisher & Thomson, 2006; Grover 
et al., 2012; Serretti & Chiesa, 2009). According to Basson et al. (2010), side 
effects were related to all aspects of sexual functioning but the main effects 
were loss of desire and delay of orgasm. As women are at increased risk of 
mental health problems, and have higher levels of  SSRI use (Hollingworth, 
Burgess & Whiteford, 2010; Zhang et al., 2010), recent studies have focused 
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specifically on the treatment of SSRI related sexual difficulties in women in 
an attempt to improve quality of life and to increase adherence to medication 
(Demmyttenaere & Jaspers, 2008; Safarinejad, 2011). To date, treatment 
and management approaches have included a number of strategies including 
drug holidays, natural supplements, switching antidepressants and 
augmenting antidepressant treatment with other medications including 
buproprion and sildenafil (Nurnberg et al., 2008; Safarinejad, 2011). In the 
Cochrane review undertaken in 2013, 23 randomised studies focused on 
managing sexual difficulties associated with antidepressant use were 
reviewed (Taylor et al., 2013). Twenty-two of these studies investigated the 
addition of further medication to treat sexual difficulties and one study 
investigated switching to an alternative antidepressant. According to this 
report, augmenting antidepressant treatment with buproprion at high levels 
appeared to be the most promising strategy for treating women, however, the 
authors called for more evidence to guide the management and treatment of 
sexual difficulties (Taylor et al., 2013). 
Numerous scholars have critiqued the biomedical approach to sexuality 
research (Farrell & Cacchioni, 2012; Moynihan, 2003; Tiefer, 2012), yet this 
approach has dominated most of the research into SSRI related sexual 
difficulties (Safarinejad, 2011; Taylor et al., 2013; Williams et al., 2010). One 
major criticism of this approach is that it fails to consider the social and 
cultural construction of sexual experience. Dworkin and O’Sullivan (2007, 
p.106), revealed how traditional sexual scripts in Western culture which offer 
men ‘greater sexual freedom and rights of sexual determination’ than women, 
can affect sexual experiences and interactions. Weiderman’s (2005) article, 
relating to male and female sexual scripts in Western culture, highlighted how 
women have felt pressured to follow traditional sexual scripts, adjusting their 
behaviour to meet cultural and social norms. Another limitation of the 
biomedical approach, according to Bahrick and Harris (2009, p.136), was that 
psychosocial aspects of antidepressant related sexual difficulties have been 
largely ignored; little is known about how the addition of sexual difficulties 
may potentially ‘complicate and confuse the clinical picture, exacerbate client 
distress and destabilise intimate relationships.’ From the literature review, it 
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became obvious that investigating women’s subjective experiences of coping 
with SSRI related sexual difficulties was necessary. As such, the focus of this 
research was on the coping aspect of heterosexual women’s experiences 
and the research question was, ‘What are the lived experiences of coping 
with the sexual side effects of SSRI medication?’ The findings from this 
research provide further insight into the types of strategies that may be 
relevant for women on antidepressant medication and for clinicians, 
therapists and other health professionals, in order to improve the success of 
and satisfaction with SSRI treatment. 
 In this study, the term ‘sexual difficulty’ was used.  A definition was not 
provided as each participant brought her own understanding and 
identification of what sexual difficulty meant to her. Whilst female sexual 
difficulties relating to desire, arousal, orgasm and pain are currently grouped 
under the term ‘sexual dysfunction’ in the most recent Diagnostic and 
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5R) (American 
Psychiatric Association, 2013), sexual dysfunction is a contested term which 
aligns with a medicalised view of sexual difficulties. This approach has been 
criticised for pathologising women and often disregarding the social and 
cultural contexts of sexuality (Farrell & Cacchioni, 2012; Tiefer, 2012). 
Method 
Methodology 
The study used Interpretative Phenomenological Analysis (IPA) as a 
research approach. Three key areas of philosophy of knowledge namely, 
‘phenomenology, hermeneutics and idiography’ have informed this approach 
(Smith, Flowers and Larkin, 2009). IPA has been used for over a decade to 
capture women’s experiences of intimate topics relating to their sexual health 
(Holt & Slade, 2003; Lavie & Willig, 2005; Marriott & Thompson, 2008) and 
was therefore particularly suited to this study as it captured the unique voices 
and experiences of women and situated those experiences within a social 
and cultural context.  
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Sampling 
The intention was to recruit a purposive sample – that is, using criteria 
relevant to the research question, rather than necessarily being 
representative of the population living with SSRI related sexual difficulties. 
Whilst recognising that it is difficult to ensure complete homogeneity, 
especially with respect to factors such as relationship dynamics, a degree of 
homogeneity was sought by recruiting potential participants through the 
application of inclusion criteria.  This criteria included the following i) 
Australian females under 45 years old who were currently in a heterosexual 
relationship and who had been taking SSRIs for longer than 3 months; ii) 
females who self described as experiencing sexual difficulties that were 
believed to be attributable to SSRIs; iii) females who were experiencing 
sexual difficulties that were causing problems or distress to them and/or their 
partners. The authors selected 45 years as the appropriate cut off for this 
study as prevalence and treatment rates of affective and anxiety disorders 
decline rapidly after this age (Hollingworth, Burgess & Whiteford, 2010).  
Participants for this study were recruited via a mental health website 
(depressionnet.com), social media sites and snowball techniques 
(Liamputtong, 2013). As reported by Moreira, Glasser, King, Duarte and 
Gingell (2008) and Shifren et al. (2009), women have often been reluctant to 
seek help for sexual problems, therefore, we did not recruit through health 
professionals or clinics. Whilst a number of participants had sought help for 
sexual problems in the past, I did not want to exclude women who had 
decided not to seek professional help. This allowed me to explore potential 
self- management strategies used by women who had not sought assistance. 
Interested women were emailed a brief questionnaire to capture 
demographic information and to ensure inclusion criteria were met. Those 
who met the inclusion criteria (ten women), were invited to participate in the 
study. 
Whilst no definitive criteria exist for sample size in IPA, its commitment to an 
idiographic approach results in such studies generally being conducted with  
small sample sizes of ten or less (Smith et al., 2009). The authors perceived 
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that the sample of ten women adequately captured patterns of similarity 
within the group whilst recognising the particularities of individual lives. 
Data collection 
Prior to data collection, ethical approval was obtained from the relevant 
university human research ethics committee. Data were collected through 
two semi-structured interviews comprised of questions that related to 
heterosexual women’s experiences of coping with the sexual side effects of 
SSRI medication. The interview schedule comprised of eight open-ended 
questions, which were informed by the literature review and professional 
experience of the first author. Informed consent was obtained from each 
woman prior to the first interview. First interviews were face-to-face and 
lasted between 1 hour and 1 hour 45 minutes in length. Follow up interviews 
were between 45 minutes and 1 hour 15 minutes. During this second 
interview, the lead researcher and each woman reviewed the transcript and 
discussed emergent themes arising from the first interview to ensure 
accurate interpretation of the participant’s experience. In addition, women 
were given the opportunity to further elaborate on their lived experiences; this 
led to enriched data as women had been given an opportunity to reflect on 
their experiences after the first interview.  
Data analysis 
Data analysis followed guidelines put forward by Smith et al. (2009), and 
involved the following: reading and re reading the transcript, initial noting, 
developing emergent themes, searching for connection across emergent 
themes, moving to the next case and looking for patterns across cases. As 
this research was interpretive, the lead researcher’s comments whilst 
analysing and noting emergent themes, moved beyond descriptive words 
and phrases to a deeper conceptual analysis to acknowledge social and 
cultural contexts.  Upon completion of analysis from both interviews, a 
description of the themes was given to each woman to check the 
interpretation. Once data analysis was completed for all cases, the next 
stage involved analysing for recurrent themes across all ten cases; this 
resulted in four super- ordinate themes. Eleven corresponding sub-ordinate 
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themes were nested within these super-ordinate themes. The super and sub-
ordinate themes are discussed under Findings. 
Reflexivity 
Within IPA, the researcher plays an active role in interpreting data. Smith et 
al. (2009) highlighted the importance of reflexivity (where the researcher 
reflects on how their experiences may influence the research). As the lead 
researcher had experienced the sexual side effects of SSRI medication, the 
experience meant that the interviewer was conducting the research from an 
insider emic perspective. She briefly touched upon her experiences of sexual 
difficulties with each woman at the beginning of the first interview while 
emphasising that the purpose of the study was to explore their individual 
stories and unique experience of coping. Women were given the opportunity 
to ask questions about the researcher’s experiences at the end of each 
interview.  
During data collection, the researcher utilised a reflexive journal to 
acknowledge her preconceptions and assumptions before and immediately 
after each interview.  By attempting to set aside her preconceptions 
immediately before the interview, the researcher felt she was able to listen 
attentively to the participant’s story rather than being distracted by her own 
experiences. Smith et al. (2009) highlight the importance of attentive listening 
and engagement with the participant, and argue that such close attention 
during the interview process limits the influence of the researcher’s 
preconceptions. During the data analysis phase, the researcher obtained the 
support of a colleague to read through the transcripts and subsequent 
analysis of two women to ensure the analysis reflected the women’s stories 
adequately. As part of this process, a number of questions were posed with 
respect to assumptions that had been made, and potential areas of bias were 
discussed. By asking questions such as “How do you feel when women talk 
about having sex to meet the needs of their partner?” the researcher was 
able to reflect on how her personal beliefs and worldview impacted on data 
analysis. Consequently, throughout the data analysis phase, reflexive 
journaling enabled the researcher to continually reflect upon the data to 
65 
ensure it reflected the experiences of women rather than her own 
experience.  
Findings 
The following is an account of the lived experiences of women coping with 
the sexual side effects of SSRI medication. The four separate but 
overlapping super-ordinate themes and eleven sub-ordinate themes that 
emerged from the data analysis are supported with quotations from the 
women’s accounts. At various stages throughout their journey, women 
adopted one or more of the coping strategies and the combination of 
approaches used by the women tended to vary over time. Pseudonyms were 
assigned to protect each woman’s identity. 
Searching 
This theme describes the processes women engaged in as part of their 
coping mechanism when first experiencing what they identified as sexual 
difficulties associated with SSRI medication, and at times throughout their 
journey. The theme searching, included two sub-ordinate themes i) searching 
for answers and ii) searching for validation.  
Searching for answers 
A search for reasons behind the sexual side effects frequently underpinned 
the coping experience of most women in this study, with women commonly 
commenting on how GPs had neglected to inform them about the side effects 
when the medication was prescribed. Consequently, these women 
particularly struggled with sexual side effects at an early stage in their 
journey, and frequently questioned whether they had psychological problems 
and/or whether their experiences were normal.  
I guess for me, finding that information [on the internet], that was a real 
turning point, I   finally had my answer. ......if you go back to the leaflet in 
the medication it says that you may experience side effects but there’s 
about 5 million side effects on there. Initially I thought they’re just 
covering their back you know just in case, and I thought, well you know, 
reality is it’s probably 1 in a million chance that you’re going to have 
sexual sides effects, and then I started reading about it and I thought... 
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hang on a minute, the amount of women that are experiencing this is not 
one in a million, there are thousands of us. (Nadia, 42)   
The women talked about the difficulties of sharing their problems due to the 
perceived public stigma of mental illness, and the sensitive and emotive 
nature of their problem. As women were unable to communicate with friends 
or trusted others, information about their side effects was predominantly 
sought from the internet. By searching on the internet, women discovered 
sexual side effects were frequent amongst users of SSRIs. For these women, 
having a legitimate reason for their sexual difficulties and finding they were 
not alone with their experiences proved a positive turning point: 
Once I realised that the sensation wasn’t there, I started to freak out, I 
did actually quite freak out about for a while and then I think I Googled 
about possible female side effects, and I didn’t find much on it, but found 
something, there was something. I don’t know if there was a forum or 
something, where I kind of read about women not being able to reach 
orgasm. At the time, yeah I’m thinking relief, just relief that at least I 
knew why it was happening, it wasn’t just me, I wasn’t some kind of 
freak. (Mandy, 38)  
The primary motivation for searching for information stemmed from a desire 
to protect current relationships. Having answers about the sexual side effects 
had positive implications for both their relationship, as well as their identity as 
a sexual person:  
When I did eventually find the articles on the net, I would show him and say 
“Look it’s not just me, lots of women are going through this. It’s not your fault, 
it’s got nothing to do with you, it’s got nothing to do with our relationship” to help 
him understand. Because I guess you worry, you think well you know, they 
might think that I’m frigid or I’m not interested in them anymore. I guess I don’t 
want him having a complex. (Tahlia, 26) 
The majority of women felt having more information at an earlier stage, would 
have assisted them in coping. Alison, who had received information from her 
general practitioner, talked about feeling prepared and her experiences 
highlighted the importance of knowing about the side effects in advance: 
I remembered exactly what she had told me um, so (pause) I guess to 
an extent it did help because you know I sort of had that awareness up 
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front that this could be an issue.....when it actually came up as an issue I 
was kind of a bit more prepared for it. If she hadn’t even said those 
couple of sentences to me I would be thinking “What the hell is wrong? 
What’s going on? I don’t understand this at all?” um, and be pretty 
confronted and scared by that I guess. (Alison, 29) 
Searching for validation  
For the women, having their sexual concerns validated played an important 
part in helping them to cope. They felt the difficulties were serious enough to 
consider seeking professional help but their experiences of not having 
concerns validated by GPs had an impact on how they understood and 
hence coped with difficulties initially. Charlotte mentioned about ‘psyching 
herself’ to build the courage to raise the issue with her GP, her comment 
below typifies the dismissive comments and reactions experienced by the 
women in this study: 
When I eventually went to the Drs, it’s like "Oh you know, it's a typical 
women thing. You've got kids, life’s stressful deal with it". Well I've been 
through a lot more stress in my life and it didn't do that to my libido! I 
asked him if there was a Viagra for women or something - he laughed 
and said he'll get back to me - that's 6 months ago and I'm still waiting. 
(Charlotte, 45) 
Furthermore, women reported that GPs appeared unwilling to accept their 
sexual side effects as a legitimate problem. This led them to seek validation 
and support through online discussions forums. Nadia commented: 
But deep down I’ve always been really angry about that [GPs dismissing 
sexual concerns] and thought, “No that’s not quite right.” So I guess 
validating that and finding that other women on there [internet] also are 
saying you know “I haven’t got a good sex life and I want to do 
something about it” makes me feel better. (Nadia, 42) 
Suffering in Silence 
For the women in this study, the theme suffering in silence emerged as a 
coping strategy and captured the women’s sense of not being able to 
communicate about their experiences.  The sub-ordinate themes of avoiding 
sexual encounters, protecting one’s partner and protecting one’s self were 
often intertwined, but are discussed separately to enhance conceptual clarity.  
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Avoiding sexual encounters 
The women coped with sexual side effects by avoiding sexual encounters 
either through passive or proactive avoidance strategies. Whilst most women 
viewed this strategy as temporary, and recognised they were not adequately 
addressing the problem, Mandy considered this to be an appropriate strategy 
for a short term problem: 
Well my husband works away so I mean his last stint away was for four 
weeks and I really could not have been interested, it was the best time of 
my life (pause) because he wasn’t home annoying me about sex. If I 
could keep avoiding it for 4 weeks, wow, before I know it, I’ll be off the 
medication again! (Mandy, 37) 
Other women talked about the importance of not wanting to reject openly 
their partner’s advances; hence, a number of proactive avoidance strategies 
were used which enabled women to avoid sexual activity without actually 
saying ‘No’:  
I’d go to bed half an hour before him so I’d be asleep when he came in, 
or half an hour after so that he’d be asleep. Just so I could avoid sex in 
any way. (Charlotte, 45)  
One woman talked about avoiding all forms of intimate contact, fearing such 
encounters would automatically lead to sex:  
Sometimes I just feel like a kiss and cuddle, especially at night, but then 
I think "Am I leading him on?" 'cos I know I don't want sex. It's hard, I still 
want to be intimate but I'm scared because I know it will lead to other 
stuff. (Sonia, 30) 
Interestingly, the avoidance strategies put into place by the women, 
highlighted again, the separate but overlapping nature of sub-ordinate 
themes grouped under ‘Suffering in Silence’. By adopting avoidance as a 
coping strategy, women succeeded in protecting their partners (from 
rejection) and protecting themselves (from an unwanted sexual experience). 
Protecting one’s partner 
Having sex was perceived as being central to the women’s relationships in 
this study. Believing their partner would be upset if there was a sexual 
problem, many women were compelled to protect their partners and viewed 
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the problem as their ‘own problem’ as opposed to a shared problem. More 
than half of the women, predominantly those who had been taking 
medication for less than one year, made a conscious decision to cope with 
sexual difficulties alone. Most women held the view that they were obliged to 
have sex with their partners thereby placing his sexual needs as more 
important than their own: 
I didn’t want to tell him, that when I was having sex with him I’d rather be 
sleeping. That would have just killed his ego. It would have been very 
detrimental to him. There was no way I could say that I’m just going 
through with this just for your benefit. (Helen, 23) 
Women also talked about the need to reciprocate as part of a healthy 
relationship and to be sensitive to their partner’s needs: 
My husband is so wonderful and I feel so guilty that I don’t have a libido 
for him. I do feel obligated though, he’s so gentle and kind – sometimes 
after sex I just end up crying, but I manage to hide it - he’s my husband, 
I love him, so I let him do it. (Charlotte, 45) 
Faking orgasm was a common coping strategy to manage the potential 
relationship impact of the sexual side effects. Although many women talked 
about feeling guilty and even deceptive within their relationship, in contrast, 
one woman considered this to be an acceptable and effective strategy:   
It works well for our situation, I mean, you can fake sexual pleasure, but 
you can't fake the weight gain can you? (Mandy, 38) 
Reasons why women engaged in non-pleasurable sex were driven by a need 
to protect their partner and the relationship, but also to protect themselves 
from unwanted consequences.  
Protecting one’s self 
Women revealed how they chose to be silent about their experiences as a 
self-defence strategy to protect themselves from potentially negative 
consequences. Two women described how they chose not to communicate 
with their partner for fear their partner’s reaction would lead to unwanted 
consequences:  
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I suppose there’s a small fear that he would say “Oh go off those 
antidepressants that’s crap.” You know, “You shouldn’t have to deal with 
it, go off them.” But the thing is, is that I’m getting so many good 
benefits, and I don’t want to yet, but I am planning to eventually.  
(Mandy, 38) 
If I speak to him, how do I put this? He’s a typical truck driver – you 
know, take a spoon of concrete and “Harden the Fuck Up’. If they’re (the 
medication) doing that to you, just come off them. Of course, I can’t do 
that. (Charlotte, 45) 
Women often emphasised the importance of sex within their relationship, and 
mentioned the need to hide their sexual difficulties for fear they would 
illuminate other problems within their relationship or their partners would look 
elsewhere for sex:  
I think generally, that would be a fear of whether to communicate that 
issue [with my husband], ‘cause if you bring it up, you know, are they 
going to go elsewhere type thing. Do you know what I mean? Have 
affairs and stuff like that? (Mandy, 38) 
Suffering in silence, and the high levels of secrecy surrounding the use of 
SSRIs appeared to be fuelled by the perceived public stigma of mental health 
problems and fear of being discriminated against. Women talked about being 
able to protect themselves from the negative public image of mental health 
problems and the ramifications in terms of their daily interactions and 
experiences. In Phoebe’s case, she applied corresponding stereotypes and 
prejudices to herself when explaining her reluctance to communicate with 
others: 
It’s not something you go “Hi, how’re you? I’m on anti-depressants”. You 
know people will turn and walk the other way and go “Well you’re 
screwed or something” - that’s what they think - like you’re an axe 
murderer or something. (Phoebe, 40) 
Trying to resolve 
The theme trying to resolve included self-help strategies aimed at trying to fix 
or at least minimise sexual side effects of SSRIs. Sub-ordinate themes 
included altering medication, communicating with partner and taking steps to 
enhance sexual pleasure. All women, with exception of one, attempted to fix 
or at least try to resolve the problem and increase sexual pleasure; however, 
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the type of approach was strongly influenced by length of time on medication. 
Women who had been on the medication for longer than two years used a 
combination of three approaches.  
Altering the medication 
For women who had been on medication for more than two years, altering 
the medication was identified as one of the major strategies. Many women 
adopted a self-help approach to altering the medication, using a range of 
different strategies including, taking drug holidays (a brief period where the 
woman stops taking the SSRI to regain sexual feelings), reducing the dosage 
and quitting the medication in an attempt to restore sexual feelings. Julie 
said:   
I’ve resigned to the fact that, it’s almost like being on par to being a 
diabetic, I need the insulin to just keep functioning on a day to day basis 
and, um (pause) um, and yeah, it’s also led me to play with the dosage 
as well and try and decrease it so I can get some sexual function back, 
um, yeah. (Julie, 44) 
Nadia described how she stumbled across this strategy and highlighted how 
she successfully self-managed her dosage of medication to suit her particular 
situation: 
I forgot to bring my pills with me, and I started to experience really strong 
sexual dreams, and I almost like had an orgasm, it woke me up and I 
thought “oh” I’ve got these sexy feelings back again that’s really weird. 
So I guess I figured on my own that if I stopped taking the medication for 
a couple of days those sexy feelings would come back again. No one 
told me about this, but then again no one told me about the sexual 
affects either. So I kind of cottoned on to this idea that if I have a bit of a 
break then I’m more likely to have an orgasm or for sex to be more 
pleasurable. So I guess now what I do is I guess try to anticipate when 
we might be more likely to have sex and I just stop taking the medication 
a couple of days before. (Nadia, 42) 
Other women disagreed with the idea of self-managing their medication, 
highlighting the importance of taking the medication correctly and citing the 
fear of a relapse as a major reason for not altering the medication. This was 
the case even if they believed this strategy could work for them: 
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 I did hear that you could take a few days off on some of them[ 
medication], I just wouldn’t, couldn’t even think about that, no way, I 
mean this sucks, but it does work and there’s just no way I ever want to 
risk get back to where I was. It was not a good place. (Helen, 23) 
 
 
Communicating with partner 
In contrast to the theme suffering in silence, some women on medication for 
more than two years, communicated with their partner about the sexual 
difficulties they were experiencing to resolve their sexual problems after other 
coping strategies had been attempted. For these women, communication 
with their partner was identified as being a necessary component of a longer-
term coping strategy:  
It really does, um get in the way of your relationship and um, yeah it 
does.  You do have to talk a lot about it and you do have to 
communicate with your partner about it. ...and get across to them that 
it’s not them, it’s you, it’s these pills.  It’s yeah, it’s not them, they’re not 
less physically appealing or less effective in the bedroom, yeah. (Julie, 
44) 
Lisa, who described how she finally opened up and started to communicate 
about both her mental health problems and the associated side effects of the 
medication, echoed this point. In her case, communication was triggered by a 
major depressive episode: 
So it wasn’t until I hit the ground in December last year where I went off 
the medications and then I had a massive terrible episode, I nearly 
ended up in hospital and then obviously he saw me.  Like he saw me, he 
saw the deal, we saw what I was like and I honestly thought he was 
going to dump me but he didn’t.  He was fantastic, and that’s when after 
that I’ve been more open with him about it. It's only the past 3 months 
I've been this open about the medication, how it wipes out the sex 
feelings, the everything really, but it has been so much better since I’ve 
been open. (Lisa, 44) 
Taking steps to enhance sexual pleasure 
The women commonly reported their desire to experience sexual pleasure 
again; however, they recognised that sustained efforts were needed to make 
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this happen. Women sought to enhance pleasure by using sex toys, 
pornography, masturbation, changing sexual positions and trying herbal 
supplements. For some women, sexual difficulties were considered to be a 
shared problem rather than the woman’s problem; hence, this was a strategy 
that involved open and honest communication and cooperation between both 
partners: 
Um, I don’t know, I think in our case or my case I’ve just become more 
aware of what does really work for me, the big points that work for me, 
so I suppose not being afraid to (pause) use sex toys, pornography or 
anything else that particularly works for me. Um, (pause) you know and 
because my partner is aware, he doesn’t feel that it’s um, his failure, it’s 
just that this is what we have to do at the moment to make it work. So 
we do that. (Tahlia, 26) 
For other women, the search for sexual satisfaction involved trying to resolve 
the issue on their own: 
Um, well I guess this is a bit uncomfortable to talk about but, you know 
there are certain positions where I know I can reach orgasm much 
quicker and easier so I kind of move my body into that position, you 
know, and it does work sometimes. (Alison, 29) 
I did search on the internet for potions and supplements and stuff – I 
even bought Horny Goatweed, that Gingko Biloba is meant to work for 
sexual problems too, but you have to take a lot of it I think. (Lisa, 44) 
Accepting what is 
A further theme, particularly amongst women who had been on medication 
for over two years, related to acceptance of their particular situation. This 
theme included  three sub-ordinate themes  i) counterbalancing the positive 
and negatives of SSRIs ii) embracing the positives in the relationship and iii) 
altering expectations about how sex ‘should be’. Sub-ordinate themes two 
and three were more commonly used as a strategy by women in longer- term 
relationships. Acceptance did not imply that the women have given up hope. 
This is exemplified by a comment from Nadia: 
I don’t see this getting any better so I don’t think there is going to be a 
magic solution, I really don’t believe there is going to be a pink Viagra or 
a pill that we are going to be able to pop that makes everything better.  
I’d love to think there would be and that would give other women and 
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myself something to look forward to.  I don’t think that’s gonna happen 
but every now and then I do jump onto Google in case there is 
something new on the market that might help. In terms of how I cope 
overall though, I guess I focus on the positives in my relationship and 
what’s working well and what’s good. (Nadia, 42)  
 
 
Counterbalancing the positive and negatives of SSRI medication 
Women in the study acknowledged the benefits from the medication, and 
although the sexual side effects were problematic, at least two women chose 
to focus on benefits:  
Sex isn’t as enjoyable as it was before I was on it [the SSRI] but I’m 
actually feeling better, like I’m feeling well so I kind of balanced it I guess 
you know with kind of going well yeah this side effect does really suck 
but look at what I’m gaining as well. (Alison, 29) 
In terms of coping, I think um, just um, acceptance is the thing that 
works for me the most, yeah. The medication has worked wonders for 
me, after my attempted suicide, well.... I don't want to go there again you 
know so the sex stuff, well I kind of just deal with it. (Julie, 44)  
Others highlighted how sex had been relegated as less important, while they 
focused on recovering from either anxiety or depression. There appeared to 
be a high level of acceptance that the medication would have positive and 
negative outcomes associated with it: 
I guess you have to sort of accept that you aren't going to have great 
sex...well you have to accept that I think. I think there’s no alternative, I 
think, you know well what are you gonna do? Stop the medication 
altogether? Well that’s not the right thing to do is it, I mean that stuff 
works.... it keeps me sane do you know what I mean? So you have to, 
you have to just take the positives with the negatives don’t you? 
(Phoebe, 40) 
Embracing the positives in the relationship  
As part of an ongoing coping strategy, women in longer-term relationships 
described how they had started to focus on positives within the relationship, 
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particularly the relational aspects of sexuality such as companionship and 
intimacy, rather than the physical act of sex. Mandy stated:  
I'm lucky, I guess, I actually get a lot out of just cuddling and kissing and 
being affectionate and the big thing that we always hear about is you 
know when the man puts the garbage out, you know I love all that stuff 
(both laughing). You know he’s been home the last week and he’s been 
making breakfast every morning and I find that really just wonderful. And 
to me that’s more than sex. (Mandy, 38) 
Similarly, Phoebe noted:    
At the end of the day, the sex you know, only goes for what minutes? 
But it’s that other stuff, hugging, intimacy, talking, helping each other - 
there’s all that sort of stuff happening which is still really important for 
both of us. (Phoebe, 40) 
Altering expectations about how sex ‘should be’ 
The women in this study discussed how they lowered their expectations 
about sex, and used positive self-talk to challenge social and cultural 
expectations of what sex should be like: 
I guess I have a tendency to think back to how it was in my 20’s and how 
amazing it was. And maybe that’s not realistic, even when you’re not on 
Aropax. I mean, how many of my 41 year old friends are having amazing 
sex, hanging from the chandeliers and multiple orgasms three times a 
week? Just not happening, I don’t think, you really need to just accept 
that I guess. (Nadia, 42) 
Sonia commented how her and her partner’s expectations about sexual 
frequency were altered as a result of their current circumstances. She also 
used positive self-talk:   
When I had brought up the topic to with him [about the infrequency of 
sex], he just said “Oh well this is how it is now with the kids and..” yeah, 
so I suppose we’re kind of just accepting that this is how it is, and how it 
would be, even if I wasn’t on medication. (Sonia, 30) 
Discussion 
Managing and treating the sexual side effects of SSRIs have presented a 
challenge to women, clinicians/ health professionals and researchers; to our 
knowledge, this is the first qualitative study to investigate how women cope 
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with such side effects. Four discrete but overlapping super-ordinate themes 
emerged during analysis i) searching, ii) suffering in silence, iii) trying to 
resolve and iv) accepting what is. Women’s experiences of coping with 
sexual difficulties were similar to those reported by Mitchell, King, Nazareth & 
Wellings (2011), that both men and women manage sexual difficulties by 
using a number of coping strategies simultaneously but a combination that 
varied over time. The choice of coping strategy for women in this study was 
commonly influenced by the length of time on medication, the partnership 
context and external influences, particularly the socio-cultural context of their 
experiences. Consistent with findings from other studies  into female sexual 
difficulties (Ayling &Ussher, 2008; Holt & Slade, 2003; Marriott & Thompson, 
2008), difficulties experienced by women in this study carried personal and 
relational meanings which impacted on their self-identity and influenced the 
type of strategies employed to cope with side effects.  
Whilst coping strategies have been classified in a number of different ways 
(Brandtstadter & Renner, 1990; Suls & Fletcher, 1985, Lazarus and Folkman, 
1984), the strategies employed in this study, fit well with the two broad coping 
classes put forward by Lazarus and Folkman (1984), namely, problem and 
emotion-focused coping. Problem-focused coping involves efforts to alter the 
situation or circumstances; in this study, the efforts included the strategies of 
‘searching’ (for information and validation) and ‘trying to resolve’ (the 
problem). Whilst problem-focused coping strategies are considered to be 
adaptive or associated with positive coping actions (Levahot, 2012), the 
debate about whether a strategy is adaptive or not is contested.  Indeed, 
studies have argued that all strategies potentially have an adaptive purpose 
(Bergvik, Sorlie & Wynn, 2010; Mitchell et al., 2011). Emotion-focused 
coping, on the other hand, involves efforts to manage emotional rather than 
physical distress associated with the situation or circumstance, and tends to 
include both active (generally perceived to be adaptive) and avoidant 
strategies (considered to be maladaptive or detrimental) (Levahot, 2012). In 
this study, emotion-focused coping comprised the active strategy of 
‘accepting what is’ and the avoidant strategy of ‘suffering in silence’. Although 
avoidant approaches (faking orgasm, avoiding sexual encounters, not 
77 
communicating with partner) could typically be labelled as maladaptive, the 
findings revealed they did serve an adaptive purpose for those women who 
were on medication for two years or less.  
Searching  
The theme searching was identified as a key coping strategy in this study; 
women frequently reported that they searched for both information and 
validation to help make sense of their experience and to interpret their 
situations. This finding is consistent with other studies which have focused on 
living with an intimate problem which impacts upon female sexuality (Holt & 
Slade, 2003; Marriot & Thompson, 2008). Once women had an explanation 
and could attribute their difficulties to SSRI medication, they reported feeling 
relieved and more capable to adjust to the sexual side effects. This finding 
corroborates the ideas of Happell, Manias and Roper (2004), who highlighted 
how individuals with mental health problems want to know about side effects 
from their medication in order to be better prepared. It also supports later 
research by Bahrik and Harris (2009), and Quinn, Happell and Browne 
(2012) that called for individuals to be better informed about the sexual side 
effects of antidepressants given their pervasiveness and potential to impact 
upon treatment and quality of life. Indeed, Mitchell and Selmes (2007) 
suggested that increased knowledge about side effects of medication may 
improve adherence rates in individuals with mental health problems. 
Suffering in Silence  
The theme suffering in silence included three strategies and the idea that 
relationships were at risk, was central to those selected. The sub-ordinate 
themes of protecting one’s partner and protecting one’s self were identified 
by Hinchliff, Gott and Wylie (2012), who reported that women with sexual 
difficulties used strategies to avoid sexual encounters to protect their partner 
from the disappointment of being let down but also to protect themselves 
from the consequences associated with actively rejecting their partner. Social 
scripts privileging men’s wants and needs in a sexual relationship also 
strongly impacted most of the strategies used by the women in this study, 
particularly with respect to suffering in silence when they reported faking 
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orgasm, avoiding sexual encounters and choosing not to communicate with 
their partners. Whilst individualistic and reductionist approaches to women’s 
sexual difficulties have been critiqued (Cacchioni & Tiefer, 2012; Tiefer, 
2012), the women in this study attributed their sexual difficulties to SSRI 
medication, and viewed the problem as their ‘own problem’ as opposed to a 
shared problem. This is not surprising given the current biomedical approach 
to female sexual problems, which emphasises the importance of individual 
factors and ‘renders the complexity of factors affecting women’s sexual lives 
less visible’ (Nicholls, 2008, p. 516; Tiefer, 2012). 
Our findings concur with studies that argue the socially constructed nature of 
women’s sexuality, and highlight the dominance of the male sexual drive 
discourse in Western culture (Ayling & Ussher, 2008; Davison & Huntington, 
2010). The findings further our understanding of how social and cultural 
factors, such as dominant discourses of sexuality can influence how women 
cope with sexual side effects of SSRIs.  Additionally, reluctance to 
communicate with their partner and others also featured prominently, and the 
women talked about how the perception of public stigma relating to mental 
health problems and/or a sexual problem led them to suffer in silence. Prior 
studies have noted that individuals with a stigmatised condition have been 
more likely to self-manage information or, to at least assess the costs and 
benefits of disclosure to others, citing risk, embarrassment and impact on 
social identity as key factors (Davison & Huntington, 2010; Goffman, 1963; 
Holt & Slade, 2003).  
Trying to Resolve  
Women on long-term medication frequently attempted to resolve sexual 
difficulties. Women attempted to self-manage the problem and did not seek 
help or report it to a clinician, therapist or health professional because of 
previous inadequate help-seeking experiences, and embarrassment about 
the sensitive nature of sexual difficulties. This finding supported the work 
undertaken by Rosenberg, Bleiberg, Koscis and Gross (2003) which reported 
that 80% of women with mental health problems did not seek formal help for 
sexual side effects of medication. Despite the sexual side effects, women in 
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this study continued to take their medication. However, those women on 
longer-term medication altered the dosage or took a drug holiday in an 
attempt to restore sexual feelings, which are consistent with strategies 
reported through biomedical research aimed at managing sexual side effects 
(Clayton & Balon, 2009; Schweitzer, Maguire & Ng, 2009). 
Although switching antidepressant medication has been highlighted by 
Baldwin (2004) and Clayton and Balon (2009) as a legitimate strategy to help 
manage antidepressant related sexual difficulties, surprisingly, none of the 
women in this study considered this to be a realistic strategy. Our findings 
revealed that women made a conscious decision to continue their prescribed 
medication highlighting the perceived benefits and fear of potential relapse, 
which supports the work by Clayton and Balon (2009) that reported 
individuals might be fearful of therapeutic failure with a new drug. Other sub-
ordinate themes aimed at trying to resolve the problem included 
communicating with their partner and taking steps to enhance sexual 
pleasure. Although prior studies have highlighted how increased 
communication with a partner has positively impacted how women cope with 
sexual difficulties (Hayes, 2008; Mitchell et al., 2011), it was somewhat 
surprising that the women on medication for less than 12 months in this study 
chose not to communicate with their partner. This was a deliberate strategy 
to protect both their partner and themselves.  
Accepting What Is 
For women on long-term medication, acceptance of their situation helped 
them to cope with the sexual side effects. Attempts to embrace the positives 
within their relationship, and to change expectations about sex, were 
commonly employed findings which support the study on coping with sexual, 
side effects conducted by Mitchell et al. (2011). These two coping strategies 
fit with the ‘Good Enough Sex Model’ proposed by Metz and McCarthy 
(2007), which encourages positive and realistic expectations about the role 
and meaning of both intimacy and sexuality across the lifespan. Proponents 
of this model argued such a perspective can provide a positive and genuine 
foundation for relationship and sexual satisfaction (McCarthy & McDonald, 
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2009; Metz & McCarthy, 2007). Our findings also support calls by other 
researchers to consider a therapeutic approach to managing female sexual 
difficulties, an approach based on questioning and challenging rigid sexual 
scripts and normative heterosexual practices (Farrell & Cacchioni, 2012; Mc 
Cormick, 2010; Mitchell et al., 2011).  Consistent with findings from 
Sutherland’s (2012) study into women’s experiences of sexual pain and 
discomfort, the women in this study had not given up hope that their situation 
would eventually improve; indeed those who employed acceptance as a 
coping strategy also continued to search for information in the hope of finding 
a solution. 
Implications and limitations 
Implications  
The findings from our study have practical implications for women on SSRIs 
and for clinicians, therapists and health professionals, and provide further 
insight into the types of strategies that could be promoted to women in order 
to improve the success of and satisfaction with SSRI treatment. Our findings 
call for open and proactive communication between clinicians/health 
professionals and women with respect to sexual side effects, and highlight 
the importance of having sexual concerns validated. An authentic 
commitment is needed to ensure that clinicians, therapists and health 
professionals have the necessary education and skills to work effectively with 
women to enhance the management of sexual difficulties; the authors 
suggest such issues are highlighted by relevant professional associations 
and included in professional development programs. It is also evident from 
this study that women’s lack of knowledge relating to the sexual side effects 
of SSRIs impacted on their ability to cope. It is imperative, therefore, that 
information materials, which outline sexual side effects and common 
concerns, be developed and made available in a variety of formats.   
Our findings also emphasise the need to recognise and address 
psychological, social and cultural factors, which may have an influence on 
how women cope with sexual side effects. Effective management of SSRI 
related sexual difficulties calls for a collaborative approach, which moves 
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beyond biomedical interventions relating to the treatment of sexual 
difficulties. A psychological intervention, which recognises the influence of 
social and cultural context on women’s experiences, may be effective in 
helping individual women to work through the influence of context on their 
experience, explore multiple meanings they may have around sex and help 
develop a positive sense of themselves as women. Such an approach also 
needs to be complemented by couple therapy, which explores relationship 
dynamics and how best to work with them to achieve mutually satisfying 
outcomes within the relationship. Understanding the complex interaction 
among the various psychological, cultural and social factors is essential for 
helping women to effectively manage the sexual difficulties associated with 
SSRIs and to ultimately improve treatment outcomes.  
Limitations 
The limitations to this study include the relative homogeneity and self-
selected nature of the sample. The women in the study were purposefully 
selected to ensure a degree of homogeneity and to enable us to explore the 
phenomenon of coping with SSRI related sexual difficulties across a 
particular target group (heterosexual, in a relationship, under 45 years old). 
Hence, the findings cannot be generalised to all women who experience 
SSRI related sexual difficulties. Indeed, the diverse age range of women in 
the study (23 to 45 years) further limits this study, as the potential differences 
in sexual experiences across the lifespan were not addressed. Furthermore, 
it is also probable the women who chose to participate in the study had 
reached a stage of adjustment, as they were willing to talk openly about their 
coping experiences. Women who were struggling to cope may not be 
represented here. 
The researchers recognise that this study does not represent the 
experiences of all women who experience SSRI related sexual difficulties; 
however, the purpose was to provide a detailed exploration of experiences 
from individual perspectives.  
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Conclusion 
This study has captured the shared elements and unique voices of women 
who are coping with the sexual side effects of SSRI medication and has 
situated their experiences within a social and cultural context. It has provided 
an insight into what coping strategies women use, factors influencing choice 
of coping strategy, and how women use different strategies to manage the 
sexual side effects of SSRIs. Furthermore, it has illuminated the importance 
of contextualising these difficulties as part of an overall approach to improve 
the management and treatment of these sexual side effects.  
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CHAPTER 5: 
Searching for Answers and Validation:  
Australian Women’s Experiences of Coping with 
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Chapter overview 
This chapter is the author-accepted (post-print) version of the article 
published in the Australian Journal of Primary Health. Publisher copyright 
policies relating to this article are supplied in Appendix G. Co-author 
statements are provided in Appendix H. 
As discussed in Chapter Four, the research identified four discrete but 
overlapping coping strategies namely i) searching; ii) suffering in silence; iii) 
trying to resolve and iv) accepting what is. This chapter explores and 
expands on one particular theme ‘searching’ and provides and details the 
findings related to women’s experiences of searching for answers and 
validation relating to their concerns. Most women found that early interactions 
with GPs were inadequate, and therefore hindered their attempts to prepare 
for the sexual side effects and adopt strategies to move forward. As such, 
this chapter discusses and contextualises these particular findings for 
general practitioners (GPs). 
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Abstract 
Sexual difficulties relating to selective serotonin reuptake inhibitor (SSRI) 
medication have an impact on quality of life and are a common cause for 
non- adherence to medication. Whilst most research has focused on the 
prevalence and treatment of sexual difficulties relating to SSRIs, little is 
known about how individuals cope with the adverse sexual effects. This 
qualitative study, using Interpretive Phenomenological Analysis (IPA), 
investigated the experiences of ten Australian women currently coping with 
the adverse sexual effects of this antidepressant by conducting semi- 
structured interviews. This paper presents one major theme from the study 
and reports the findings specifically related to women’s self-reported 
experiences of interacting with general practitioners (GPs) in their search for 
answers and validation of their concerns. Findings from the study add to the 
current literature by providing an insight into how interactions with GPs affect 
women’s abilities to cope with adverse sexual effects. Empathic discussions 
and shared decision making between GPs and women can provide the 
opportunity to improve the management of the adverse sexual effects of 
SSRIs and may lead to improved outcomes for women. 
What is known about this topic? 
Female sexual difficulties associated with selective serotonin reuptake 
inhibitors are well- documented but women’s experiences of coping with such 
difficulties have not been explored. 
What does this paper add? 
This study provides insight into how interactions with GPs affect women’s 
abilities to cope with the adverse sexual effects of selective serotonin 
reuptake inhibitors, creating an opportunity to improve the management of 
sexual difficulties. 
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Introduction 
Antidepressant prescribing in Australia has increased substantially over the 
past decade. Despite controversy surrounding the influence of the 
pharmaceutical industry, adverse drug effects and questions about efficacy 
(Fournier et al., 2010; Spence, 2013), antidepressants have become the 
most commonly dispensed psychotropic medication in Australia 
(Stephenson, Karanges & McGregor, 2013). Selective serotonin reuptake 
inhibitors (SSRIs) are the most widely prescribed category of antidepressant, 
and according to Stephenson et al., their use doubled in Australia between 
2000 and 2011. Whilst there have been calls to reconsider medication as a 
first line treatment for mental health problems (Carlat, 2010), an increasing 
reliance on medication and indeed, patient reluctance to discontinue 
medication for fear of relapse (Spence, 2013) have led to an increased focus 
on the management of adverse drug effects.  
Although a number of adverse effects have been associated with SSRIs 
(Moret, Isaac & Briley, 2009), sexual difficulties remain an underestimated 
but important problem (Safarinejad, 2011). Concerns relating to quality of life 
and adherence to medication have prompted an emerging body of research 
into the sexual difficulties associated with this medication; such difficulties 
were the focus of a recent Cochrane review (Taylor et al., 2013). Given that 
women have higher levels of SSRI use (Hollingworth, Burgess & Whiteford, 
2010), several studies have focused specifically on managing female sexual 
problems associated with the medication (Safarinejad, 2011; Zhang et al., 
2010).Whilst such studies have identified a number of management and 
treatment strategies, the evidence to support these approaches is somewhat 
limited (Taylor et al., 2013).  
Therefore, current attention has focused on strengthening the therapeutic 
alliance between GPs and the patient. Researchers have highlighted the 
importance of a patient-centred approach to the management of sexual 
difficulties, calling for GPs and mental health clinicians to inform patients 
about potential sexual problems (Kikuchi, Uchida, Suzuki, Watanabe & 
Kashima, 2011) and to encourage shared decision making with respect to the 
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management of such difficulties (Quinn, Happell & Browne, 2011; van 
Servellen, Heise & Eiliis, 2011).  Whilst attention has been drawn to the 
importance of informed consent when prescribing medication and the 
adoption of a patient-centred model (Gopal et al., 2012; van Servellen et al., 
2011), such approaches have not been widely adopted.  
Indeed, research has shown that treatment emergent sexual problems are 
infrequently discussed by GP’s and mental health clinicians; personal 
discomfort, lack of time or expertise, and the belief that treatment options are 
limited have been cited as prohibitive factors (Goldstein, Lines, Pyke & 
Scheld, 2009; Quinn et al., 2011; Shifren et al., 2009). In addition, Quinn et 
al. (2011) highlighted that fear of non-adherence has prompted the deliberate 
withholding of information about adverse sexual effects in spite of findings 
revealing such knowledge can actually improve adherence rates (Smith & 
Henderson, 2000). Furthermore, women have been reported as generally 
reluctant to seek help for sexual problems citing personal embarrassment, 
lack of time and perceptions that sexual problems are not taken seriously as 
reasons for this lack of disclosure (Macdowall et al., 2010; Shifren et al., 
2009). Subsequently, it has been reported that women who are taking 
antidepressants have been unlikely to report such adverse effects (Kikuchi et 
al., 2011).  
 Although there is a growing body of research on the adverse sexual effects 
of SSRIs, there is a dearth of research on women’s self- reported 
experiences of coping. The aim of our study was to complement existing 
research by using Interpretative Phenomenological Analysis (IPA) to explore 
the subjective experiences of coping with sexual difficulties amongst women 
who chose to continue on SSRIs despite adverse drug effects. Within the 
field of health psychology, IPA has been gaining attention as a flexible and 
inductive research approach which allows the researcher to move beyond a 
biomedical model of disease and illness to explore self- reported experiences 
and meanings that individuals assign to those experiences (Brocki & 
Weardon, 2006; Smith, Flowers & Larkin, 2009). To offer detailed, nuanced 
analyses of lived experience, IPA utilises an idiographic approach that 
focuses on the individual or specific situations either in a single case study or 
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through a small number of participants (Larkin, Watts & Clifton, 2006). Unlike 
other qualitative approaches such as grounded theory which use larger 
sample sizes and seek to generate theory (Pringle, Drummond, Mc Lafferty & 
Hendry, 2011), the individual case is central to the inquiry in IPA. The overall 
analysis remains faithful to the individual through illustrating the particular 
lived experience of participants who have recounted their experiences whilst 
also illustrating more generalised themes (Smith, Flowers & Larkin, 2009).  
This paper presents one major theme from the study and reports the findings 
related to women’s experiences of searching for answers and validation 
relating to their concerns. This paper adds to the current literature by bringing 
to light an increased understanding of how interactions with GPs influence 
women’s abilities to cope with adverse sexual effects. 
Methods 
Australian women were recruited to this study through homogeneous 
sampling and selection was based on the following inclusion criteria: 
heterosexual, under 45 years, in a relationship and currently taking SSRIs for 
depression and/or anxiety disorders. Participants for this study were recruited 
via a mental health website (depressionnet.com), social media sites and 
snowballing techniques (Liamputtong, 2013). As reported by Shifren et al., 
(2009), women have often been reluctant to seek help for sexual problems 
hence we did not recruit through health professionals or clinics. Participant 
details are provided in Table 1 (pseudonyms have been used to protect 
anonymity). 
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Table 1: Demographic information 
Name Age Diagnosis and SSRI Length 
of time 
on SSRI 
Relationship 
status  
Education 
level 
Alison 
 
29 Mild depression 
(Escitalopram) 
6 months De Facto Bachelor 
Degree 
Charlotte 45 Severe depression  
(Sertraline) 
13 years Married Postgraduate 
Diploma 
Helen 23 Moderate depression 
(Escitalopram) 
11 
months 
Married  Grade 12 
completion 
Julie 44 Severe depression 
(Fluoxetine) 
7 years Married Postgraduate 
Degree 
Lisa 44 Severe depression  
(Sertraline) 
15 years De facto Postgraduate 
Degree 
Mandy 38 Moderate depression 
(Escitalopram) 
2 years Married Grade 12 
completion 
Nadia 42 Moderate depression, 
panic disorder 
(Paroxetine) 
12 years Married Postgraduate 
Degree 
Phoebe 40 Mild depression, panic 
disorder 
(Paroxetine) 
13 years Married Grade 12 
completion 
Sonia 30 Moderate depression  
(Sertraline) 
10 
months 
Married Bachelor 
Degree 
Tahlia 26 Severe depression 
(Sertraline) 
10 
months 
De facto Bachelor 
Degree 
 
Ten women were included in this study; each woman had made a conscious 
decision to continue medication despite adverse sexual effects. This enabled 
us to focus on coping strategies and explore these strategies in detail.  
According to Smith et al. (2009, p. 51), given the complexity of most human 
phenomena, ‘it is more problematic to meet IPA’s commitments with a 
sample size which is too large than with one that is too small’. Whilst no 
definitive criteria exist for sample size in IPA, the authors felt a sample of ten 
women adequately captured patterns of similarity within the group whilst 
recognising the particularities of individual lives.  Whilst it is acknowledged 
that the findings are not able to be generalised, the study provides important 
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information about women’s lived experiences.  It also lays the groundwork for 
future research. 
Data were collected through two semi-structured interviews comprising of 
open-ended questions. The interview schedule was informed by the literature 
review and the professional experience of the first author. The data were 
analysed following IPA guidelines put forward by Smith et al. (2009), namely, 
reading and re-reading the transcripts separately for each woman or case, 
initial noting, developing emergent themes, and searching for connection 
across emergent themes.  The themes that emerged from the first interview 
were discussed during the second interview to check the interpretation. The 
next stage involved looking for recurrent themes across the data from the ten 
women and this resulted in four super-ordinate themes.  
 Results 
The four super-ordinate themes were:  i) searching, ii) suffering in silence, iii) 
trying to resolve and iv) accepting what is.  This paper expands on the first 
major theme, ‘searching’, as this theme was reported by all the women and 
has particular relevance for improving experiences in a primary care setting. 
The theme searching, included two sub-ordinate themes i) searching for 
answers and ii) searching for validation.  
Searching for answers 
With the exception of one woman, women were not informed about the 
adverse sexual effects of SSRIs when the medication was prescribed, 
leaving them feeling confused and ‘searching for answers’ about the cause of 
their sexual problems. As such, this lack of information left some women 
feeling angry: 
At one stage, I went to the doctor and said, “You need to see my 
husband, he has bad anxiety and needs this medication”. She said, “Oh 
the sexual side effects are really bad for men”. Nothing about women 
though. I’d been on them for years and she had never spoken about 
those side effects. Looking back, I feel a bit ripped off, yeah, a bit 
peeved to be honest. (Mandy) 
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Despite feelings of anger, a few women reflected on their situation and 
perceived withholding of information about adverse sexual effects to be 
deliberate, believing GPs actively did this to protect their mental health.  
Mandy added: 
I wonder if doctors look at women and think if I tell them they might not 
take them. I mean doctors have to consider the children and if a woman 
comes in and says, ‘I’m depressed’, it’s just easier to hand over the 
medication, do you know what I mean?  
Interestingly, a few women said they were ‘owed an explanation’ (Helen) and 
emphasised how having information about untoward sexual effects would not 
have deterred them from taking medication.  Helen continued: 
I really hate the fact that no one told me about this [the sexual side 
effects]. I reckon I would have still taken the medication even if I had 
known what it would do. At some stage, I would have then decided if it 
was still worth it.  
As the majority of women perceived they did not have a legitimate medical 
reason for their sexual problems, they spent time questioning whether the 
adverse effects were psychological or caused by factors such as weight gain 
or other aspects related to their current relationship. For some women, 
‘searching for answers’ continued for several years as outlined by Nadia:  
Once I found out that the Aropax was causing the lack of libido, and all 
the other sexual problems, I started to look for remedies to try and 
resolve the problem. Until then, I was just, you know, hiding...I guess. 
For quite a few years I was secretly hoping it would go away.  
Women were often embarrassed about the sexual nature of their problem 
and felt uncomfortable communicating with others, which affected their ability 
to seek help. For Tahlia, the internet became a source of information:  
I found out about the sexual side effects through my group [mental 
health support group]. This guy, in his 50s said something about “... the 
side effects they don’t tell you about” and he mentioned sex problems 
and libido. That’s when I jumped onto the net to find out more. All the 
information about Zoloft and the associated sex problems were on there 
- that was a turning point in my journey.   
In contrast with most of the women’s experiences, Alison, who had received 
information from her GP, talked about feeling prepared. Her experiences 
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highlighted the importance of knowing about the adverse sexual effects in 
advance: 
I remembered exactly what she had told me um, so (pause) I guess to 
an extent it did help because you know I sort of had that awareness up 
front that this could be an issue....when it actually came up as an issue I 
was kind of a bit more prepared for it. If she hadn’t said those couple of 
sentences to me I would be thinking “What the hell is wrong?  What’s 
going on?  I don’t understand this at all?” I’d be pretty confronted and 
scared by that I guess.  
Searching for validation  
Despite being embarrassed about their sexual problems, women described 
how they sought to address their problem by raising issues directly with their 
GP; however, their experiences of not having their concerns validated 
affected how they coped with their difficulties: 
I went to the doctor in the end and said “My sexual desire is really low 
and they go “yeah, that happens” they kind of shrug their shoulders you 
know “You can have good mental health or good sex but you can’t have 
both” kind of attitude. What they don’t tell you is that this is one of the 
main things that can tear you apart.  (Phoebe)  
Tahlia, who received a positive reaction, revealed how this helped:   
It really helped to have the doctor support the idea, that yes, this {sexual 
problem} could be a side effect. When I had raised it before, she was a 
bit non- committal about whether it was a side effect, I felt quite relieved 
to be honest when she agreed with me – I knew then that it wasn’t in my 
head!   
Some women commented that their concerns had not been validated 
because of their gender. These women found it hard to cope with the 
implication that sex was somehow less important for women. As Charlotte 
explained: 
I felt as though I was the only woman in the Universe who was 
concerned about the sex problems. I really got the impression that I 
should just put up with it, you know, go away and just deal with it. I often 
wonder if a doctor would treat a man the same way?  
Most women reported feeling concerned that GPs believed their problem was 
psychological; this lack of validation by GPs led these women to seek 
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validation elsewhere. As Lisa highlighted, ‘it’s the type of problem you keep 
to yourself’, as such, women turned to online support groups, which helped 
reduce their sense of isolation: 
I couldn’t believe it when I found a support group on the net, there were 
literally hundreds of women on there talking about this stuff and feeling 
distressed about it-  just reading their comments, I’m thumping the desk 
shouting “yes, this is me, this is my story”. It was such a good feeling to 
know I was not alone….. (Sonia)  
In contrast, Nadia experienced a positive outcome because her concerns 
were validated. She provided insight into a conversation that gave her 
perspective and helped her to cope with the long-term sexual problems she 
had been experiencing: 
After a while, I had a long conversation with my GP and he really 
listened to me and helped me to get my head around it all. He said to me 
“So, how many friends at your age with kids, mortgage and busy lives 
are having amazing sex all the time? Maybe you are missing something 
that’s not a reality anymore”. That was a bit of a wake -up call to be 
honest.  
Discussion 
Women found that interactions with GPs when they were initially prescribed 
the SSRIs, set the scene for how they coped with adverse sexual effects.  
Most women described their experiences as inadequate, and in an attempt to 
reduce feelings of isolation, confusion and distress, they actively tried to 
make sense of their situation and spent prolonged amounts of time searching 
for an explanation. This hindered their attempts to prepare for adverse side 
effects and adopt strategies that would help them to move forward. Our 
findings support previous research, which found withholding information 
about adverse sexual effects had the potential to increase isolation and 
distress amongst patients and inadvertently damage the therapeutic 
relationship between clinician and patient (Bahrick & Harris, 2009; Higgins, 
Barker & Begley, 2006). Whilst the specific reasons for withholding 
information were not included in the aim of our study, recent literature has 
identified a number of personal, structural and organisational factors that 
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impede or facilitate a proactive discussion of sexual problems (Dyer & das 
Nair, 2013; Quinn et al., 2011). 
According to Heider’s (1958) attribution theory, people attempt to provide a 
causal explanation for unexpected events; hence, it is not surprising women 
sought a causal explanation for their side effects. Furthermore, Roesch and 
Weiner (2001) reported that having an explanation for an illness or health 
problem positively affects coping and psychological adjustment. Our study 
also supports this finding; women who had positive interactions with GPs, 
and who were informed about potential sexual problems, felt supported and 
better able to cope. Happell, Manias and Roper (2004) concurred and 
highlighted that patients with mental health problems want to know about the 
adverse drug effects from their medication in order to be better prepared. 
Indeed, several researchers have suggested that increased knowledge about 
the adverse effects of medication may improve patient outcomes in patients 
with mental health problems (Gray, White, Schuklz & Abderhladen, 2010; 
Quinn et al., 2011). Once the women in our study had an explanation for the 
adverse effects, they reported being relieved and able to move forward and 
adjust to these effects. 
Women have reported that their experiences of not having concerns 
validated also impacted on how they understood and initially coped with their 
difficulties. In some cases, this lack of validation appeared to reinforce the 
‘double standard’ sexual script that views females as sexually passive 
(McCormick, 2012, p.99). There are similarities between this study and other 
studies that reported how mental health clinicians, in particular, perceive 
iatrogenic sexual difficulties as a male problem (Phillips, 2009; Quinn et al., 
2011). Indeed, our findings seem to be consistent with one particular study 
by Higgins et al. (2006), which reported that mental health clinicians 
perceived women to be less concerned about iatrogenic sexual difficulties 
and more willing to tolerate the adverse sexual effects. Our findings suggest 
that the inadvertent reinforcement of traditional sexual scripts had a negative 
impact on women’s coping experiences and acted as a barrier to the 
therapeutic relationship. These findings further support the need for GPs to 
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take a proactive and empathic role in discussing sexual problems and to 
create a safe space for disclosure and validation of such problems.  
Conclusion 
The adverse sexual effects resulting from SSRI use impact quality of life and 
are a common cause for non- adherence to medication. Current efforts by 
GPs to address this issue are most likely inadequate and have an impact on 
how women cope with their medication.  In this context, there needs to be a 
continual shift towards a patient-centred approach, which emphasises 
women’s active participation in decisions about their health, and seeks to 
strengthen the therapeutic alliance. Empathic discussions with women and 
collaborative decision- making can provide an opportunity to improve the 
management of sexual difficulties associated with SSRI use. 
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CHAPTER 6: 
Accepting what is: An approach for managing the 
long-term sexual side effects of selective 
serotonin reuptake inhibitors (SSRIs) in women. 
 
 
This manuscript was published in the journal of Sexual and Relationship 
Therapy, April 2015. 
 
 
O’Mullan, C, Doherty, M, Coates, R & Tilley, P.J.M. (2015).  Accepting what 
is: an approach for managing the long-term sexual side effects of selective 
serotonin reuptake inhibitors (SSRIs) in women. Sexual and Relationship 
Therapy, http://dx.doi.org/10.1080/14681994.2015.1032236 
  
106 
Chapter overview 
This chapter is the author-accepted version (post-print) of the article 
published in the journal of Sexual and Relationship Therapy. Publisher 
copyright policies relating to this article are supplied in Appendix G. Co-
author statements are provided in Appendix H.   
As discussed in Chapter Four, the research identified four discrete but 
overlapping coping strategies namely i)searching; ii) suffering in silence; iii) 
trying to resolve and iv) accepting what is. This chapter explores and 
expands on one particular response “accepting what is”. For women on 
longer-term medication, although a number of different strategies were 
employed as part of the coping process, acceptance based strategies were 
perceived to be most effective. In recent years, there has been growing 
interest in acceptance-based strategies within the field of sex therapy; 
indeed, there is a recognition that approaches that encourage women to 
accept and work around their sexual difficulties, may be more effective whilst 
treatment options are limited. This chapter aims to increase understanding of 
how ‘accepting what is’ can be a step forward, particularly for women who 
have chosen to remain on long-term medication. As such, this chapter 
contextualises the findings for sex and relationship therapists 
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Abstract  
Sexual difficulties may not be a pressing issue for women on antidepressants 
during the early phase of selective serotonin reuptake inhibitor (SSRI) 
treatment; however, this can emerge as a substantial problem once women 
are stabilised on medication. Little is known about how women cope with the 
adverse sexual effects of SSRIs. This qualitative study used Interpretative 
Phenomenological Analysis to explore the experiences of Australian women 
currently coping with the sexual side effects of this antidepressant.  
Interviews were conducted with ten heterosexual women, aged 45 years and 
younger. Four major coping strategies were identified; “searching”, “suffering 
in silence”, “trying to resolve” and “accepting what is”.  This paper explores 
one particular response “Accepting what is”, which includes a number of 
strategies commonly employed by women on long -term medication. Findings 
from the study have particular relevance for sex and relationship therapists 
and may assist women in managing sexual side effects that are perceived to 
be beyond their control. This paper adds to the current literature by 
increasing understanding of how ‘accepting what is’ can be a step forward, 
particularly for women who have chosen to remain on long-term medication. 
In theoretical terms, a deeper understanding of how women cope, could 
inform debate about the appropriate management of long-term sexual side 
effects in the absence of effective pharmacological interventions. 
 
Key words: SSRI, sexual side effects, women, coping strategies, 
phenomenology, acceptance 
  
108 
 Introduction 
Sexual difficulties may not be a pressing issue for women during the early 
phase of antidepressant treatment; however, a number of authors have 
highlighted how this can emerge as a substantial problem once women are 
stabilised on medication (Nurnberg et al., 2008; Schweitzer, Maguire &Ng, 
2009). Amongst women, sexual problems arising from the use of SSRIs 
typically include loss of desire, arousal difficulties, delayed orgasm or 
anorgasmia (Safarinejad, 2011; Zhang et al., 2010). According to Segraves 
and Balon (2014) and Moret, Isaac and Briley (2009), these side effects can 
impair a woman’s sense of self-worth and negatively affect intimate 
relationships and quality of life. Consequently, it is not surprising that sexual 
side effects are frequently cited as a reason for non-adherence to medication 
(Kennedy & Rizvi, 2009). Although the growing research focuses on restoring 
physiological sexual functioning through a pharmacological approach 
(Clayton et al., 2014), the evidence to support biomedical approaches is 
somewhat limited (Taylor et al., 2013). As such, efforts to identify alternative 
ways of managing sexual side effects are critical, particularly for women who 
have chosen to remain on long-term medication. 
According to Berry and Berry (2014), the shift towards pharmacological 
intervention is relatively recent, however, it threatens to undermine more 
holistic approaches. As the limitations of biomedical approaches to managing 
and treating women’s sexual problems become evident, there have been 
calls for psychosocial approaches that allow assessment of all aspects of 
women’s experiences (Farrell & Cachionni, 2012; Kaschak & Tiefer, 2014).  
Bahrick and Harris (2009) claim that the psychosocial aspects of 
antidepressant related sexual difficulties have been largely ignored; indeed, 
little is known about how sexual difficulties may complicate the clinical 
picture, increase personal distress or affect intimate relationships. 
Furthermore, there has been limited research into how women cope with the 
sexual side effects of antidepressants. Although previous research has 
focused on coping with the general side effects of antidepressants (including 
sexual difficulties), these studies were based on either physician’s 
experiences (McElroy, Keck & Friedman, 1995) or they employed large-scale 
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internet surveys to elicit data, thereby limiting the ability to explore and 
understand the personal experiences of participants (Kikuchi et al., 2012). 
Whilst a number of recent studies have used in-depth interviews to explore 
the experiences of coping with sexual difficulties from the woman’s 
perspective (Hinchliff, Gott & Wylie, 2012; Mitchell et al., 2011; Sutherland, 
2012), qualitative research into SSRI- related coping experiences were 
notably absent from the literature. 
The aim of our study was to complement existing biomedical research by 
using Interpretative Phenomenological Analysis (IPA) to explore the 
subjective experiences of coping with sexual difficulties amongst women who 
chose to continue on SSRIs despite adverse drug effects. Although coping 
strategies have been classified in a number of different ways (Brandtstater & 
Renner, 1990; Lazarus & Folkman, 1984; Suls & Fletcher, 1995), the coping 
strategies in our study aligned with the transactional model of coping put 
forward by Lazarus and Folkman (1984). This model has been used 
previously to explore how people respond to and cope with sexual difficulties 
(Tang, Lai and Chung, 2010). As part of this model, Lazarus and Folkman 
(1984) proposed two broad coping classes: problem- focused and emotion- 
focused coping. Problem-focused efforts involve altering the situation or 
circumstances, whereas emotion-focused efforts attempt to manage the 
emotional rather than physical distress associated with the situation or 
circumstance. Whilst problem-focused coping strategies are considered to be 
adaptive or associated with positive coping actions (Lehavot, 2012), Lazarus 
and Folkman (1984) argue that every form of coping can be adaptive under 
certain circumstances, or maladaptive under others. 
Our findings highlighted a number of different problem and emotion- focused 
coping strategies (themes) including “searching”, “suffering in silence”, “trying 
to resolve” and “accepting what is”, the overall findings have been reported 
elsewhere (O’Mullan et al., 2014). This paper focuses in detail on one aspect 
of the research findings; it translates this finding into meaningful information 
for sex and relationship therapists. It explores one theme, “accepting what 
is”, an emotion-focused strategy employed by women on long-term 
medication who had reached a stage of acceptance as part of the coping 
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process. This theme was chosen for further analysis as it has particular 
relevance for therapists working with women on long-term medication 
(defined as consecutive use of SSRIs for more than 12 months), and offers 
insight and practical coping strategies that may be incorporated into 
therapeutic practice. This paper adds to the current literature by bringing to 
light an increased understanding of how “accepting what is” as a coping 
strategy may be a step forward, particularly for women who have chosen to 
remain on long-term medication. In theoretical terms, a deeper understanding 
of how women cope, could inform debate about the appropriate management 
of long-term sexual side effects in the absence of effective pharmacological 
interventions. 
Method 
Participants for our study were recruited through purposive sampling. An 
invitation flyer explaining the study was posted to a mental health website 
(depressionnet.com), and via social media sites. Two women were recruited 
through snowball sampling (Liamputtong, 2013). For inclusion in the study, all 
three of the following criteria had to be met. The inclusion criteria were as 
follows: i) women under 45 years old who were currently in a  heterosexual 
relationship ii) women who self-identified as experiencing sexual difficulties 
believed to be attributable to the SSRIs, iii) women who were experiencing 
sexual difficulties they perceived to cause problems or distress to themselves 
and/or their partners. The authors selected 45 years as the appropriate cut 
off for this study as prevalence and treatment rates of affective and anxiety 
disorders decline rapidly after this age (Hollingworth, Burgess & Whiteford, 
2010). A brief questionnaire and participant information sheet were emailed 
to interested women; upon receipt of the completed questionnaire, those who 
met the criteria and believed their sexual difficulties were attributable to 
SSRIs were included in the study.  The term “sexual difficulty” was not 
defined for this study; each woman brought her own understanding and 
identification of what sexual difficulty meant to her.  
The study used Interpretative Phenomenological Analysis (IPA) as a 
research approach (Smith, Flowers & Larkin, 2009).  IPA is concerned with 
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an individual’s perception of a phenomenon, it is informed by the theoretical 
perspective of symbolic interactionism and understands that meanings are 
negotiated within a social context (Willig, 2008). Other qualitative approaches 
were considered, however, this approach allows a rigorous exploration of 
individual health experiences and is therefore particularly suited to exploring 
intimate topics such as sexuality (Marriott & Thompson, 2008). Another 
valuable benefit of IPA is its capacity to investigate human experiences within 
a social and cultural context (Smith et al., 2009). In IPA, research questions 
are typically broad and open-ended, hence the research question for our 
study was, “What is the lived experience of coping with the sexual side 
effects of SSRI medication?” 
Ten women participated in this study, their details are recorded in Table 1 
below. Pseudonyms were allocated to protect the identity of each woman. 
The age of the women ranged from 23 to 45 years of age and the length of 
time on SSRI medication ranged from 6 months to 15 years. Whilst no 
definitive criteria exist for sample size in IPA, we found a sample of ten 
women adequately captured patterns of similarity within the group whilst 
recognising the particularities of individual lives. 
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Table 1: Demographic information 
Name Age Diagnosis and SSRI Length of 
time on 
SSRI 
Relationship 
status  
Education 
level 
Alison 
 
29 Mild depression 
(escitalopram) 
6 months De Facto Bachelor 
Degree 
Charlotte 45 Severe depression  
(sertraline) 
13 years Married Postgraduate 
Diploma 
Helen 23 Moderate depression 
(escitalopram) 
11 months Married  Grade 12 
completion 
Julie 44 Severe depression 
(fluoxetine) 
7 years Married Postgraduate 
Degree 
Lisa 44 Severe depression  
(sertraline) 
15 years De facto Postgraduate 
Degree 
Mandy 38 Moderate depression 
(escitalopram) 
2 years Married Grade 12 
completion 
Nadia 42 Moderate depression, 
panic disorder 
(paroxetine) 
12 years Married Postgraduate 
Degree 
Phoebe 40 Mild depression, panic 
disorder 
(paroxetine) 
13 years Married Grade 12 
completion 
Sonia 30 Moderate depression  
(sertraline) 
10 months Married Bachelor 
Degree 
Tahlia 26 Severe depression 
(sertraline) 
10 months De facto Bachelor 
Degree 
Data collection 
Prior to data collection, ethical approval was obtained from the relevant 
university human research ethics committee. In total, two semi-structured 
interviews were undertaken with each woman, both of these interviews were 
conducted over an an eight-week period. The interviews were conducted at 
the woman’s home or at another location chosen by the woman. As IPA aims 
to enable participants to share their experience of the phenomenon under 
investigation, Smith et al. (2009) consider semi- structured interviews to be 
the most appropriate form of data collection. Questions focused on personal 
experiences of coping with the sexual side effects of SSRI medication, and 
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were open-ended to generate discussion. Eight questions and a set of 
prompts for each question were used as a guide during the first interview; 
interviews lasted between 1 hour and 1 hour 45 minutes in length, and were 
audio recorded. The follow-up interviews were between 45 minutes and 1 
hour 15 minutes. During this interview, the transcript from the first interview 
was reviewed with each woman and emergent themes were discussed to 
clarify any issues and ensure accurate interpretation. Women also provided 
additional comments that had emerged since the first interview. 
 Data analysis  
The interviews were transcribed verbatim and the analysis followed the 
guidelines for IPA put forward by Smith et al. (2009). The analysis involved a 
number of stages. The first stage involved a detailed and repeated reading of 
each transcript to elicit ideas and meaning expressed by each woman. The 
left margin of the transcript was used to make note of comments that were 
particularly significant, and salient quotes were underlined. Emergent themes 
associated with key phrases were noted in the right- hand margins. These 
themes were then checked with each woman at the start of the second 
interview. The next stage involved looking for recurrent themes across the 
data from the ten women; during this step, themes were rationalised and 
removed if they did not align closely with the research question or could not 
be linked to any other theme. This led to a smaller final set of four super-
ordinate themes and eleven sub- ordinate themes.   
Reflexivity 
Researchers using IPA recognise their analysis is characterised by 
subjectivity; indeed their main task involves offering their interpretations of 
participants’ accounts. Several authors have discussed the importance of 
reflexivity in IPA, given how the researcher’s presuppositions have the 
potential to influence the interpretation of another’s lived experience (Shaw, 
2010; Smith et al., 2009). As the lead researcher had experienced the sexual 
side effects of SSRI medication, the experience meant she was conducting 
the research from an insider perspective. Whilst collecting data, the 
researcher was conscious of the need to use neutral and open- ended 
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questions such as “Can you tell me about your experiences of coping with 
the sexual side effects of your medication?”, to draw out each woman’s  
story. The researcher also acknowledged her preconceptions and 
assumptions through jotting down thoughts in a reflexive journal (cyclical 
bracketing) before and immediately after the interview, and by revisiting her 
responses to participants’ comments after transcribing the interviews. By 
attempting to set aside her preconceptions immediately before the interview, 
the researcher felt she was able to listen attentively to the participant’s story 
rather than being distracted by her own experiences. 
Results 
The four super-ordinate themes generated from our study included:  i) 
searching, ii) suffering in silence, iii) trying to resolve and iv) accepting what 
is. It is important to note that women used a number of different strategies as 
part of the coping process; the overall findings from the study have been 
reported elsewhere (O’Mullan et al., 2014). The theme “searching” describes 
the process women engaged in when they first experienced sexual 
difficulties; a search for reasons behind the sexual side effects frequently 
underpinned the coping experience of most women. Having a legitimate 
reason for their problem and finding they were not alone with their 
experiences, often proved to be a positive turning point. “Suffering in silence” 
captured the women’s sense of not being able to communicate about their 
experiences. A number of women who had chosen to remain silent used 
avoidance strategies to prevent intimate contact; others felt obligated to 
engage in non- pleasurable sex driven by a need to protect their partner and 
the relationship. In most cases, this approach was recognised as a temporary 
strategy for a short- term problem. The theme “trying to resolve” included a 
range of self- help strategies aimed at trying to fix or at least minimise the 
sexual side effects. At various stages throughout their journey, all women, 
with the exception of one, had tried to resolve their difficulties using a 
combination of approaches. These included altering medication, taking 
herbal supplements and/or taking steps to enhance sexual pleasure through 
use of pornography, sex toys or masturbation. 
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 This paper reports on one theme, “accepting what is”, a strategy commonly 
adopted by women on long-term medication who had reached a stage of 
acceptance as part of the coping process. This theme has particular 
relevance for sex therapists working with women on long-term medication, 
and offers insight and practical coping strategies that may be useful in 
therapeutic practice.  As part of this overall theme, three specific coping 
strategies (sub-themes) were identified. These included: i) counterbalancing 
the positive and negatives of SSRIs, ii) embracing the positives in the 
relationship, and iii) altering expectations about how sex “should be”.   
Counterbalancing the positives and negatives of SSRI medication 
Women in the study who had been on medication for more than twelve 
months, came to accept the benefits of medication. For a number of women, 
the acceptance of their situation stemmed from unsuccessful attempts to quit 
medication, the alternative to medication often meant a return to a debilitating 
illness. As Julie explained: 
I guess I’ve accepted the situation to some extent. I dug myself into a 
really big hole a couple of years ago, um, I don’t ever want to get back to 
that point. The medication has saved me, it really has. I’ve accepted that 
this is how it is; the medication works, and after my suicide attempt I 
realised just how much this medication, this little pill, has saved me. 
Similarly, Lisa, who had unsuccessfully attempted to quit medication in the 
past, also learnt to accept she needed the medication. She also recognised 
the importance of maintaining her mental health irrespective of the adverse 
impact on sexual satisfaction:  
You’ve got to balance it, the good and the bad I mean. You know I had a 
prolapsed disc in my back recently for the second time, believe me this 
is nothing you know. The physical is nothing compared to depression, I 
would never, ever come off this medication again, it has saved me.  OK, 
so I have a low libido and I can’t orgasm …….yes it makes me angry, 
but I think no point dropping your bundle over it, it’s not the be all and 
end all.    
For other women, engaging in positive self-talk and maintaining a perception 
of control helped them to cope more effectively with the situation. For 
example, Nadia talked about her choice to remain on the medication for “the 
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foreseeable future” and explained how she used positive self-talk to remind 
herself to “focus on how this tablet has changed my life”. Charlotte talked 
about “reaping the benefits” from her medication and again, illustrated how 
her choice was very much a conscious one: 
I do have a choice – I can come off the medication and have a good 
libido but be a manic lunatic or I can stay on them and have a crap sex 
life but a cool, calm and collected relationship. Sometimes you just have 
to accept what is, and now I need to accept that this medication is 
working for me.  
Interestingly, although the women talked about “accepting what is”’, 
acceptance did not imply the women have given up hope. This is exemplified 
by a comment from Nadia: 
I don’t see this getting any better so I don’t think there is going to be a 
magic solution, I really don’t believe there is going to be a pink Viagra or 
a pill that we are going to be able to pop that makes everything better.  I 
would love to think there would be and that would give other women and 
myself something to look forward to.  I don’t think that’s gonna happen 
but every now and then I do jump onto Google in case there is 
something new on the market that might help.  
Embracing the positives in the relationship  
As part of an ongoing coping strategy, women in longer-term relationships 
described how they had started to embrace the positives within the 
relationship, particularly the relational aspects of sexuality such as 
companionship and intimacy, rather than the physical act of sex.  Mandy 
stated:  
I'm lucky, I guess, I actually get a lot out of just cuddling and kissing and 
being affectionate and the big thing that we always hear about is you 
know when the man puts the garbage out, you know I love all that stuff. 
You know he’s been home the last week and he’s been making 
breakfast every morning and I find that really just wonderful. And to me 
that’s more than sex.  
A focus on non-genital intimacy and maintaining an emotional connection 
were commonly reported by women on long-term medication. As Phoebe 
explained, by focusing on the emotional rather than the physiological 
experience, the sexual difficulties she experienced became less important: 
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The intimacy’s still good, we still talk a lot and cuddle, we’re very close.  I 
do like the physical closeness of sex though and the feeling afterwards 
of connecting with somebody.  So I guess it’s more about, um, yeah kind 
of recognising that the pleasure’s not there, the physical pleasure’s not 
there but the intimacy still can be, and I can still feel connected to 
someone, so for me, that’s a real positive”.  
Similarly, although sex for Julie lacked “the sexual release, the climax”, it 
occurred within a caring and supportive relationship and she still derived 
emotional satisfaction from her sexual life:  
Nowadays, I focus on the intimacy and the closeness we have. When 
we have sex, I think it’s a way to re-connect; otherwise, it’s just so busy 
and stressful. We just love feeling close, falling asleep together.  It’s a 
real bonus when you ah, get the physical pleasure from it too, but that’s 
not why I do it anymore. 
Nadia focused on the positive attributes in her marriage and described the 
mutual respect and adoration within their relationship; she also highlighted 
the importance of a sympathetic partner. Despite her sexual difficulties, she 
described her marriage as “wonderful” and emphasised the relational 
aspects:   
Yeah, the pleasure stuff is lacking but I’m fortunate that I do have 
a partner that understands, and when we do have sex we still 
have the intimacy, or even without the sex we still have the 
intimacy. I mean, we have different ways of being intimate, things 
that don’t necessarily involve sex per se.  So yeah, I guess we 
hold hands a lot and we like to cuddle and hug. We’re so lucky, we 
do have a great marriage – we make each other laugh all the time 
and we really do adore each other.  
In contrast to women in long-standing relationships, Lisa, who was in a de 
facto relationship for less than two years, was able to give perspective to her 
sexual problems by focusing on the exhilarating aspects of her new 
relationship: 
In the past, it may have been a bigger deal – you know, the lack of 
orgasms and physical sensations but I’m grateful for what we have –it’s 
more than just sex.  I mean, I waited 42 years for this man - I just love 
looking at him, touching him, smelling him, breathing him in. I love him, 
he is my best friend.  Even if you took the sex away, I would still love him 
and would still be attracted to him.  
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Altering expectations about how sex “should be” 
The women in this study discussed how they altered their expectations about 
sex, and used positive self-talk to challenge perceived social and cultural 
expectations of what sex should be like. Nadia commented: 
And something he {the GP} said really resonated, really helped me to 
question my expectations you know. He said ‘You know at the end of the 
day most people with kids and busy lives aren’t having brilliant sex lives’. 
It’s like, you know, I guess again it comes back to the culture that we live 
in, we watch Sex and the City and we read sex in the magazines and I 
guess we’re in a very sexualised culture where we feel as though 
everyone’s having great sex all of the time, and he reminded me I guess 
of the reality. ‘…. what you’re experiencing, you know, maybe not that 
much different to what everyone else is experiencing’ he said. I guess I 
have a tendency to think back to how it was in my 20’s and how amazing 
it was. And maybe that’s not realistic, even when you’re not on Aropax.  
Other women chose to acknowledge the impact of life cycle factors such as 
having children or stressful jobs. Whilst the SSRIs did affect desire and 
contribute to a number of sexual difficulties, a number of women questioned 
whether their expectations about sex were unrealistically high. Nadia referred 
to the misconceptions around sex and regularly used positive self-talk to 
challenge her own expectations, “How many of my 42 year old friends are 
having amazing sex, hanging from the chandeliers and multiple orgasms 
three times a week?  Just not happening… ”.  For Sonia, open and honest 
communication with her partner, and understanding, was a key factor in 
helping her to alter her expectations about sex and be more accepting of the 
situation:  
When I had brought up the topic with him [about the infrequency of sex], 
he just said “Oh well this is how it is now with the kids and..” yeah, so I 
suppose we’re kind of just accepting that this is how it is, and how it 
would be, even if I wasn’t on medication.   
In contrast, although Charlotte was able to alter her own expectations about 
how sex should be, her husband had different expectations. This lack of 
support and understanding was problematic for Charlotte and made it difficult 
for her to accept the situation: 
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I still do the romantic dinner thing, candlelight, massage, bath –  I have  
a bath and a few drinks, get a little tipsy and  yeah, it can sometimes feel 
really nice. Although I do try to recreate that sexy feeling, part of me 
realises that sex does change as you get older and when you have kids 
and lots of other things going on. I don’t have a problem with that, but 
my husband still thinks we need to be doing it 2-3 times a night, 7 nights 
a week. That is the problem for me. 
Discussion 
Given the scarcity of evidence-based treatments for the sexual side effects of 
SSRIs, sexual difficulties arising from this medication require a careful and 
multifaceted management approach. To date, none of the previous research 
has investigated how women, particularly those on long- term medication, 
cope with the sexual side effects. In our study, women on long-term 
medication commonly employed acceptance- based strategies as part of 
their coping repertoire; these were perceived to be effective in helping 
women to cope with enduring sexual problems. Whilst further research is 
needed to ascertain the circumstances in which acceptance strategies be 
considered as a preferred coping strategy (Kohl, Rief & Glombieweski, 2012), 
our findings are consistent with other studies suggesting that acceptance can 
enhance the treatment and management of enduring health conditions and 
decrease psychological distress (Jensen et al., 2014; Kohl et al., 2014; 
Thompson, Arnkoff & Glass, 2011).  
 In recent years, there has been growing interest in acceptance-based 
strategies within the field of sex therapy. Mindfulness-based behavioural 
therapy, which encourages acknowledgement and acceptance of what is in 
any given moment, has been shown to reduce distress amongst women with 
sexual difficulties arising from childhood sexual abuse, gynaecological cancer 
and provoked vestibulodynia (Brotto, et al., 2008; Brotto et al., 2012; Brotto et 
al., 2014). Likewise, acceptance and commitment therapy (ACT) which seeks 
to change the function of psychological events and the individual’s 
relationship to them, rather than the event itself  (Hayes, Pistorello & Levin, 
2012), is showing promise for the treatment of problematic pornography 
viewing and for reducing distress caused by self-stigma relating to sexual 
orientation (Twohig & Crosby, 2010; Yadavaia & Hayes, 2012 ). Extrapolated 
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to sex therapy, Meana (2012) argues acceptance is useful in the regulation of 
emotions and can assist clients who live with limitations that are beyond their 
control.  For most of the women in our study, there was recognition they were 
unable to achieve previous levels of sexual functioning whilst remaining on 
medication; as such, their coping strategy fits well with Meana’s suggestion 
that accepting certain realities is as important as embracing change where 
change is possible (Meana, 2012).  
By choosing to employ acceptance -based coping strategies, women 
highlighted how they were able to turn the experience of a less- than- perfect 
sexual interaction into an experience that was emotionally, if not physically, 
satisfying. Attempts to embrace the positives within their relationship and to 
challenge idealistic expectations of sex are consistent with findings from 
other studies focusing on the management of sexual difficulties (Mitchell et 
al., 2011; Svedhem, Eckert & Wijma, 2013). Our findings also fit with the 
“Good Enough Sex Model”, a framework proposed for male, female and 
couple sexuality (Metz & McCarthy, 2007). This model recognises there is a 
trade-off between “drama/intensity and integrated/relational congruence” and 
provides a perspective that can be used to build a positive and genuine 
foundation for relationship and sexual satisfaction (McCarthy & Farr 2012, 
p.229). Some women in our study were able to reconceptualise sex and 
target unhelpful thoughts by using positive self-talk to challenge the explicit 
and implicit messages “sexual scripts” (Simon & Gagnon, 1984), regarding 
appropriate sexual behaviour and how sexual experiences should unfold. Our 
findings further support the idea of incorporating sex script modification into 
therapeutic interventions, and echo calls by other researchers to work openly 
with cultural assumptions around sex, and to challenge unrealistic and 
potentially damaging sexual scripts (Barker, 2011; Mc Cormick, 2010; 
Mitchell et al., 2011).  
Since healthy sexuality requires both partners to value and develop a 
mutually comfortable level of physical and emotional satisfaction (McCarthy & 
Wald, 2012), we can assume the partner’s norms and values also affect her.  
Although women’s accounts of their partner’s reactions to coping with the 
sexual side effects were varied, it became apparent that most couples had 
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developed a sexual style that balanced each other’s needs. In our study, 
open and honest communication with a partner, and support and 
understanding appeared to play a key role in helping women to alter their 
expectations about sex and be more accepting of the situation. Other studies 
also highlight the importance of a supportive and understanding partner 
(Sutherland, 2012; Svedhem, Eckert & Wijma, 2013), and the value of open 
communication about sexual matters (Coffelt & Hess, 2014). Their findings 
are of significance to therapists, as women could be encouraged to reflect on 
their sexual difficulties in the context of their relationship. Where appropriate, 
couple therapy aimed at enhancing sexual communication, exploring 
psychosexual concerns and expanding definitions of sex and intimacy, may 
offer a useful approach to help the couple discover new ways to cope with 
the sexual difficulties arising from SSRI use.  
Whilst it is important to accept limitations beyond our control, it must be noted 
that acceptance- based strategies do not involve a passive resignation in the 
face of the problem, and are not an end in itself. Rather, the goal of such 
strategies is to increase the “flexibility of responding in the presence of 
previously repertoire-narrowing experiences” and to enhance the 
psychological freedom of the individual (Hayes et al., 2012, p.982). Our 
findings revealed that although women employed acceptance as a coping 
strategy, this certainly did not imply they had given up hope. Active coping 
behaviours such as acknowledging the limitations of treatment for their 
difficulties, yet choosing to focus on the positives of their particular situation 
were regularly employed. In line with self -determination theory (Deci & Ryan, 
1985), women who perceived they had choices and a sense of control over 
the situation, reported being able to move forward. For therapists who work 
with women on long-term medication, although acceptance based strategies 
are not a panacea, an approach that encourages women to accept and work 
around their sexual difficulties, rather than a symptom reduction approach, 
may be more effective whilst treatment options are limited. 
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Limitations and advantages 
The limitations to this study include the homogeneity and self-selected nature 
of the sample. The women in the study were purposefully homogenous to 
enable us to explore the phenomenon of coping with SSRI- related sexual 
difficulties across a particular target group (heterosexual, in a relationship, 
under 45 years old), however, this resulted in an over representation of highly 
educated women. It is also probable that the women who chose to participate 
in the study had reached a stage of adjustment, as they were willing to talk 
openly about their coping experiences; women who were struggling to cope 
may not be represented here. The researchers recognise this study does not 
represent the experiences of all women who experience SSRI- related sexual 
difficulties; however, the purpose was not to generalise but to provide a 
detailed exploration of experiences from individual perspectives. Future 
research would benefit from interviewing diverse groups of women about 
their experiences, including lesbian or bisexual women, women from varied 
educational or ethnic backgrounds and women over the age of 45 years. 
Conclusion  
Limitations aside, this study has provided an important contribution to a 
growing discussion on the management and treatment of sexual side effects 
relating to SSRI use. In the absence of current effective biomedical 
interventions for SSRI -related sexual difficulties, acceptance -based coping 
strategies may offer an effective approach for women who have chosen to 
remain on long-term medication. Whilst acceptance is not an end in itself, it 
has potential to be an important therapeutic addition for professionals to 
consider in a sex therapy context.  
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CHAPTER 7: 
Summary and Recommendations 
7.1 Introduction 
Treating and managing the sexual side effects of SSRIs have presented a 
challenge to women, clinicians/health professionals, therapists and 
researchers. Whilst most of the research has focused on the prevalence and 
treatment of SSRI-related sexual difficulties, there is a paucity of research 
exploring how women cope specifically with the SSRI-related sexual side 
effects. The aim of this research was to enhance understanding of the coping 
experiences of women who were experiencing SSRI-related sexual 
difficulties that were causing problems or distress to them and/or their 
partners.  IPA was employed as the research approach; this qualitative 
approach enabled women’s voices and unique experiences of sexual 
difficulties to be captured, and ensured their sexual concerns were 
acknowledged and validated. 
This research aimed to address the following question:  
“What are the lived experiences of coping with sexual difficulties amongst 
heterosexual women who take SSRI medication?” 
The specific objectives of the study were to: 
 Explore the lived experience of coping with sexual difficulties amongst 
heterosexual women who had been taking SSRI medication for at 
least three months.  
 Characterise the types of strategies used to cope with the sexual 
difficulties arising from SSRI use in order to assist women who are 
experiencing such difficulties.  
 Provide recommendations to inform professional practice amongst 
clinicians, therapists and other relevant health professionals. 
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This chapter provides a brief summary of the findings in relation to the first 
two objectives, and outlines recommendations for practice and for further 
research to address the third objective. 
7.2 Summary of research 
This research explored the experiences of ten women who were coping with 
the sexual side effects of SSRI medication. By using Interpretative 
Phenomenological Analysis as the research approach, this study captured 
the unique voices of women and shared elements among them, and situated 
their experiences of coping within a social and cultural context.  This 
investigation identified four discrete but overlapping themes: searching; 
suffering in silence; trying to resolve and accepting what is. These themes 
illuminate the importance of contextualising difficulties as part of an overall 
approach to improve both the treatment and management of these sexual 
side effects. They also provide an insight into the factors influencing the 
choice of coping strategy.  
In relation to the second objective, the coping strategies employed by women 
in this study can be characterised by using  the two broad coping classes put 
forward by Lazarus and Folkman (1984), namely problem- and emotion-
focused coping. Problem-focused coping involved efforts to alter the situation 
or circumstances; in this study, the efforts included the strategies of 
‘searching’ (for answers and validation) and ‘trying to resolve’ the problem. 
‘Searching’ was identified as a key coping strategy in this study by women on 
both short and long-term medication, particularly during the early stages of 
the journey. Women frequently reported that they searched for both 
information and validation to help interpret their situations and to make sense 
of their experiences. Early interactions with GPs set the scene for how 
women coped; most women described their experiences as inadequate and 
this hindered their attempts to move forward. With the exception of one 
woman, women were not informed about the potential sexual side effects of 
SSRIs and spent prolonged amounts of time searching for answers to their 
problem. Consistent with previous research (Bahrick & Harris, 2009, Higgins 
et al., 2006), the withholding of information about sexual side effects led to 
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feelings of isolation, distress and confusion. Similarly, when women 
attempted to raise the issue of sexual side effects, their experiences of not 
having concerns validated by GPs led some women to cope alone or to seek 
support elsewhere.  
For women on longer- term medication (defined as consecutive use of SSRIs 
for more than 12 months), problem- focused coping involved attempts to 
resolve sexual difficulties. Consistent with Kikuchi et al.’s (2011) study, most 
of these women attempted to self-manage their difficulties, in part due to the 
sensitive nature of their problem, but also because of previous inadequate 
help seeking experiences.  At various stages throughout their journey, all 
women on longer-term medication, with the exception of one, had tried to 
resolve their difficulties using a combination of approaches aimed at 
minimising sexual side effects and enhancing sexual pleasure. Although 
switching medication has been identified in a number of studies as a 
legitimate strategy to manage SSRI-related sexual difficulties (Baldwin, 2004; 
Clayton & Balon, 2009), in this study, women made a conscious effort to 
continue medication, whilst taking steps to enhance sexual pleasure through 
the use of herbal supplements, pornography, sex toys or masturbation. 
Furthermore, in an attempt to minimise the sexual side effects, a few women 
on long-term medication self-managed their medication by either reducing 
the dosage or using drug holidays; such strategies are consistent with 
recommendations arising from biomedical  research (Clayton & Balon, 2009; 
Schweitzer et al., 2009).   
Emotion-focused coping involves efforts to manage the emotional rather than 
physical distress associated with the situation or circumstance; in this study, 
the efforts included the strategies of  ‘accepting what is’ and the avoidant 
strategy of ‘suffering in silence’. For women on longer-term medication, 
although a number of different strategies were employed as part of the 
coping process (including searching at the start of the coping journey, and 
trying to resolve during the later stages), acceptance based strategies were 
perceived to be most effective. For most of these women, they recognised 
they were unable to achieve previous levels of sexual functioning whilst 
remaining on SSRIs; as such, their coping strategy aligned with Meana's 
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suggestion that accepting certain realities is as important as embracing 
change where change is possible (Meana, 2012). It is important to note that 
although women on longer-term medication in this study employed 
acceptance as a coping strategy, this certainly did not imply they had given 
up hope. Instead, women consciously employed active coping behaviours 
such as acknowledging the limitations of treatment for their difficulties, and 
they chose to focus on the positives of their particular situation. Whilst 
acceptance is not an end in itself, these findings are consistent with other 
studies (Jensen et al., 2014; Kohl et al., 2014) suggesting acceptance-based 
strategies can enhance the treatment and management of enduring health 
conditions and decrease psychological distress.  
The emotion-focused strategy ‘suffering in silence’, captured the women’s 
sense of not being able to communicate about their experiences. This 
strategy was commonly employed by women on short term medication and 
the avoidant approaches typically included faking orgasm, avoiding sexual 
encounters and not communicating with a partner. Central to these 
approaches was the idea that relationships were at risk; hence, women 
perceived the need to protect their partner from disappointment, but also to 
protect themselves from the potential consequences of rejecting their partner. 
These findings are consistent with those reported by Hinchliff et al. (2012), 
and highlight the socially constructed nature of women’s sexuality and 
indeed, the supremacy of the male sexual drive discourse (Ayling & Ussher, 
2008). Whilst ‘suffering in silence’ could be labelled as maladaptive (Levahot, 
2012), the findings revealed it did serve an adaptive purpose for those 
women who were on medication for less than two years.  
Overall, the findings from this study were similar to those reported by 
Mitchell, King, Nazareth and Wellings (2011), that women generally manage 
sexual difficulties by using a number of coping strategies simultaneously but 
a combination that varied over time. For women coping specifically with the 
sexual side effects of SSRIs, the choice of coping strategy was commonly 
influenced by the length of time on medication, the partnership context and 
external influences, particularly the sociocultural context of their experiences. 
Consistent with findings from other qualitative studies (Ayling & Ussher, 
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2008; Holt & Slade, 2003; Marriot & Thompson, 2008) sexual difficulties also 
carried personal and relational meanings for the women; this had an impact 
on self-identity and influenced the type of coping strategy. Whilst the findings 
from this study highlighted the need for a patient-centred approach to the 
management of sexual difficulties, there is also a need to move beyond a 
biomedical approach, and recognise and address the psychological, social 
and cultural factors, which may influence how women cope. 
7.3 Recommendations for practice 
In addressing the third objective, the findings from this study have practical 
implications for women on SSRIs, clinicians, therapists and other relevant 
health professionals. For women, the findings may assist with the 
identification of strategies which could be used to help manage the sexual 
side effects of SSRIs. The findings may also provide women with a better 
understanding of the various factors such as psychological, social and 
cultural that impact their ability to cope. Additionally, by raising awareness of 
this important issue, this study can help to validate women’s experiences, 
promote the realisation that they are not alone and provide reassurance. For 
clinicians, therapists and other relevant health professionals, a number of 
recommendations can be made in light of the findings from this study:  
 Most women were not informed about the potential sexual side effects 
of SSRIs; hence, this hindered their attempts to move forward. As 
highlighted by several researchers, a number of prohibitive factors 
have been identified for this lack of communication about side effects 
including personal discomfort, lack of time or expertise and/or the 
belief that treatment options are limited (Goldstein, Lines, Pyke & 
Scheld, 2009; Quinn, Happell & Browne, 2011; Shifren et al., 2009). 
As a number of qualitative studies involving women with mental health 
problems have revealed, withholding information about adverse drug 
effects can increase distress and isolation, and potentially damage 
therapeutic relationships (Gray, White, Schulz & Abderhalden, 2010; 
Quinn et al., 2011). As such, it is proposed that sexual side effects are 
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discussed openly with women during the initial consultation and/or 
when the medication is prescribed. 
 Women reported that their experiences of not having their concerns 
validated by GPs also impacted on how they understood and initially 
coped with their difficulties. In some cases, this lack of validation 
appeared to reinforce the ‘double standard’ sexual script that views 
females as sexually passive (McCormick, 2012, p.99). As noted by 
other studies, mental health clinicians, in particular, appear to perceive 
iatrogenic sexual difficulties as a male problem (Phillips, 2009; Quinn 
et al., 2011); as such, it has been assumed that women are less 
concerned about iatrogenic sexual difficulties and more willing to 
tolerate the adverse sexual effects (Higgins et al., 2006). This study’s 
findings support the need for clinicians, therapists and other health 
professionals to take a proactive and empathic role when discussing 
sexual difficulties and to create a safe space for disclosure and 
validation of such problems. 
 A number of scholars have highlighted the limitations of biomedical 
approaches and have called for biopsychosocial approaches that 
allow the assessment of all aspects of women’s experiences (Farrell & 
Cachionni, 2012; Kaschak & Tiefer, 2014). Effective management of 
SSRI- related sexual difficulties calls for a collaborative approach, 
which moves beyond biomedical interventions relating to the treatment 
of sexual difficulties. Therapeutic interventions, which recognise the 
influence of social and cultural context on women’s experiences, can 
be effective in helping women work through the influence of context on 
their experience. Furthermore, such interventions provide an 
opportunity for women to explore multiple meanings they may have 
around sex and help develop a positive sense of themselves. 
 Since healthy sexuality requires both partners to value and develop a 
mutual level of physical and emotional satisfaction (McCarthy & Wald, 
2012), couple therapy, which explores relationship dynamics and 
strategies aimed at achieving mutually satisfying outcomes within the 
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relationship, can also be a useful complementary approach. Couple 
therapy aimed at enhancing sexual communication and expanding 
definitions of sex and intimacy, can therefore offer a useful approach 
to help the couple discover new ways to cope with sexual difficulties 
arising from the use of SSRIs.  
 Finally, for clinicians, therapists and health professionals who work 
with women on long-term medication, acceptance-based strategies 
that encourage women and their partners to accept and work with their 
sexual difficulties can be an effective approach whilst treatment 
options are currently limited. Meana (2012), argues acceptance is 
useful in the regulation of emotions and can assist clients who live with 
limitations that are beyond their control. There was recognition by 
many women in this study that they were unable to achieve previous 
levels of sexual functioning whilst remaining on medication; as such, 
Meana’s suggestion that accepting certain realities is as important as 
embracing change where change is possible is particularly relevant. 
Although acceptance based strategies are not a panacea, and require 
further research as a coping strategy (Kohl, Rief & Glombieweski, 
2012), in the absence of effective biomedical interventions for SSRI-
related sexual difficulties, this approach has the potential to be an 
important therapeutic addition.  
7.4 Recommendations for further research 
In light of the findings obtained in this study, recommendations for further 
research include the following:  
 This study could be replicated with women of other ethnic, cultural and 
educational backgrounds. As noted in other studies (Ayling & Ussher, 
2008; Hinchliff, Gott & Wylie, 2012) this may offer additional insight 
into social and cultural elements of the coping experience.   
 As lesbian relationships operate on different principles with respect to 
power and affect, compared to their heterosexual counterparts 
(Richards, Naveen & Kim, 2015), a replicate of this study could be 
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undertaken with lesbian women to explore whether coping strategies 
differ from those of their heterosexual counterparts. 
 It would be useful to gather data from the partners of women who are 
coping with the sexual side effects of SSRI medication. As suggested 
by Ayling and Ussher (2008), exploring the lived experience of coping 
from the perspective of the partner(s), may help researchers and 
practitioners to better understand the impact of sexual difficulties on 
relationship dynamics. 
 It is important to build a positive and genuine foundation to improve 
sexual satisfaction within a relationship (McCarthy & Farr, 2012); 
involving the partner in research may assist with this goal. A dyadic 
approach that focuses on the couple as the unit of investigation, and 
how they cope, may provide insight into joint coping efforts that may 
benefit the individuals and the relationship. 
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Appendix B: 
Recruitment Flyer 
 
 
If you are currently taking antidepressant medication (examples 
include Prozac, Aropax, Zoloft) and you are experiencing sexual 
problems or difficulties..... 
...here is an opportunity for you to take part in 
research that explores how women live and cope 
with these sexual problems. 
 
Antidepressant medication can cause sexual side effects and these side 
effects may sometimes cause women to discontinue with their medication. 
Research has focused on the treating and managing these difficulties, 
however, little is known about how women cope with and manage the sexual 
difficulties that are often associated with this medication. 
If you are eligible for this study, you will be asked to reflect upon your 
experiences of coping with the sexual difficulties or problems that are 
associated with this medication. The study is composed of several interviews 
with a researcher from Curtin University.  
 
Confidentiality is guaranteed. 
 
If you are willing to dedicate some time and feel able to share your experiences, 
please contact Cathy O’Mullan (07 4150 7153) or send an email to 
c.omullan@cqu.edu.au for more information 
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Appendix C: 
Information Sheet for Participants 
My name is Cathy O’Mullan and I am currently undertaking this research for my Doctor 
of Public Health Degree at Curtin University through the School of Public Health. This 
study has been approved by the Curtin University Human Research Ethics 
Committee (Approval Number HR 94/2012). 
Topic.  Coping with Sexual Difficulties: The Lived Experience of Women Taking 
Selective Serotonin Reuptake Inhibitor (SSRI) medication. 
Introduction. Antidepressants have been shown to cause sexual problems and these 
problems can cause people to stop taking their medication. We have information on 
how to treat and manage these problems, but we don’t know very much about how 
people cope with these problems or how these problems affect their daily lives. This 
study will explore how women on antidepressant medication cope with and manage 
their sexual difficulties or problems. It is hoped that the findings from this study will 
help us to understand how sexual problems impact on health and wellbeing, and help 
us to improve the support given to women. 
  
Who is being invited to take part?  I will be interviewing Australian women between 
18 - 45 years of age who are currently taking antidepressants, are in a heterosexual 
relationship and who are experiencing sexual problems. The women will need to have 
been taking the medication for at least 3 months.   
 
What is involved? If you are eligible for this study, you will be interviewed for 
approximately 45- 60 minutes. It is highly likely that each woman will be interviewed 
a few times (no more than 3 times) to consider further issues raised and for me to 
collate all of the information needed to acquire a greater understanding of this topic.  
 
Participation is voluntary. Your participation is voluntary and you have the right to 
withdraw at any time without consequence. I greatly appreciate your consideration to 
be involved in this research and hope you decide to take part.  
 
Privacy will be protected.  I will be recording and transcribing all of the interviews to 
make sure that I capture everything we talk about. Only my supervisors and I will have 
access to this confidential information and it will be stored in a password protected 
file. The transcripts will be coded and you will not be able to be identified at any stage. 
Transcripts will be stored at CQUniversity (Bundaberg campus), and permanently 
destroyed after 7 years. 
 
 
Further Contact Details 
 
Cathy O’Mullan Ph 07 4150 7153 or c.omullan@cqu.edu.au 
 
Supervisor contact: Assoc. Professor Maryanne Doherty. Ph 08 9266 3707 or 
M.Doherty@curtin.edu.au 
 
You are welcome to contact me or my supervisor at any time should you choose to 
do so. 
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Appendix D: 
Informed Consent Form 
Title of Research: Coping with Sexual Difficulties: The Lived Experience of Women 
Taking Selective Serotonin Reuptake Inhibitor (SSRI) medication. 
Researcher: Cathy O’Mullan 
 
I _______________________________________ have read and understood all of 
the information related to this research. I acknowledge the identity of the researcher, 
the issues being explored and the reasons for undertaking this research. 
 
Furthermore, I understand that I will be interviewed and be asked to share my 
personal experiences and understanding of the issues being researched. 
Additionally, I understand that there will be a minimum of 2 and a maximum of 3 
interviews and that each interview will be approximately 45 -60 minutes in length. 
 
I am aware that this research has been approved by Curtin University of Technology 
Human Research Ethics Committee (Approval number HR94 /2012), and that my 
participation is voluntary. I also understand that I may withdraw from this study at 
any time without consequence. 
 
I accept that all communication in my interview will be voice recorded, transcribed 
and kept on a protected software file for 7 years. After such time, the file will be 
permanently destroyed. I also acknowledge that any data that could identify me will 
be removed from the final report or any publications or presentations pertaining to 
the research.  
 
I also acknowledge that my confidentiality will be maintained at all times. 
 
I understand that I may contact either the researcher or the supervisor should I 
choose to do so. 
 
Cathy O’Mullan  Associate Professor Maryanne Doherty 
c.omullan@cqu.edu.au M.Doherty@curtin.edu.au     
(07) 4150 7153  (08) 9266 3707. 
 
Therefore, I consent to participation in this research. 
 
Name: (please print) ___________________________________ 
Signature:  ___________________________________ 
Date:    ___________________________________ 
 
Researcher: ___________________________________ 
Signature: ___________________________________ 
Date:   ___________________________________ 
 
Please contact Curtin University (08 9266 9223) if you have any concerns about this project 
and quote project number HR94/2012 
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Appendix E: 
Interview schedule 
Profile Questions 
Age: 
Relationship Status (eg married, co habiting): 
Length of current relationship: 
Name of SSRI: 
Length of time on medication: 
How would you rate your depression? (Mild / Moderate/ Severe) 
Highest level of education: 
 
General Guiding Questions 
 
 Can you tell me about the sexual difficulties (side effects) you are 
experiencing?  
 
 Can you tell me if there are any specific sexual difficulties that cause more 
problems or distress than others?  
 
 How have these sexual difficulties impacted upon your life? 
 
 Can you describe to me the strategies you have put in place to cope with the 
sexual difficulties that have been experienced? 
 
 What has been the most difficult part of your overall experience of coping 
with sexual difficulties whilst taking this medication? 
 
 Is there anything else that you think is important to share? 
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Appendix F: 
Copyright/Licence to Publish Agreement  
(CSIRO – Australian Journal of Primary Health) 
 
For further details  of this agreement: 
http://www.publish.csiro.au/?nid=75&aid=4023 
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Copyright/Licence to Publish Agreement (CSIRO Correspondence) 
 
From: Helen.Pavlatos@csiro.au [mailto:Helen.Pavlatos@csiro.au]  
Sent: Friday, 23 May 2014 10:34 AM 
To: Catherine O'Mullan 
Subject: Australian Journal of Primary Health: online early PDF reprint (PY13172) 
 
Dear Cathy 
Congratulations! Your paper has now been published Online Early in Australian Journal of 
Primary Health. 
Online Early is a service being offered to our authors whereby your paper is published online 
in advance of being allocated to an issue. 
At this stage the paper does not have final page numbers, volume or issue information. 
These will be added when the paper is included in an issue. However, the Online Early 
paper is considered the ‘version of record’ and has a DOI which can be used to cite the 
paper. For convenience, the PDF version of the paper is given temporary pagination which is 
unrelated to the final pagination in the issue. You can view the your paper online from the 
journal website www.publish.csiro.au/journals/py 
A PDF of the Online Early version of the paper is attached. Please note that the use of the 
PDF is covered in the journal’s Licence to Publish, which you have signed. In summary you 
may: 
- Send copies to individual colleagues for non-commercial purposes, 
- Print out and distribute copies to colleagues attending any conference presentation 
you make 
- Include the PDF in a course pack, subject to the usual copyright licensing agency 
arrangements. 
However, you may not include the PDF on any website or on any server, including an 
institutional repository. You may place a pre-publication version of your work on your 
personal website or in your institutional repository provided that you include a link to 
the definitive version on the journal’s website. Please contact the Permissions Manager 
at publishing@csiro.au if you wish to use the PDF for any purpose other than those listed 
above.  
Thank you for choosing to publish with Australian Journal of Primary Health and CSIRO 
PUBLISHING. We look forward to receiving more good work from you. 
Yours sincerely 
Helen Pavlatos 
Production Editor 
CSIRO Publishing 
E helen.pavlatos@csiro.au T +61 3 9662 7613 F +61 3 9662 7611  
PO Box 1139, Collingwood, Vic. 3066, Australia 
www.csiro.au 
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Appendix G: 
Copyright/Licence to Publish Agreement  
(Taylor & Francis – Psychology & Health, Sex & 
Relationship Therapy Journal) 
For further details  of this agreement:  
http://journalauthors.tandf.co.uk/copyright/index.asp 
Posting your article on websites or repositories  
Author’s Original Manuscript (AOM) 
This is your original manuscript (often called a "preprint"), and you can share this as 
much or as little as you like. If you do decide to post it anywhere, including onto an 
academic networking site, we would recommend you use an amended version of the 
wording below to encourage usage and citation of your final, published article. 
Accepted Manuscript (AM) 
h 
As a Taylor & Francis author, you can post your Accepted Manuscript (AM) on your 
departmental or personal website at any point after publication of your article (this 
includes posting to Facebook, Google groups, and LinkedIn, and linking from 
Twitter).  
To encourage citation of your work we recommend that you insert a link from your 
posted AM to the published article on Taylor & Francis Online with the following 
text:  
"This is an Accepted Manuscript of an article published by Taylor & Francis in 
[JOURNAL TITLE] on [date of publication], available online: 
http://wwww.tandfonline.com/[Article DOI]."  
For example: "This is an Accepted Manuscript of an article published by Taylor & 
Francis Group in Africa Review on 17/04/2014, available online: 
http://www.tandfonline.com/10.1080/12345678.1234.123456. 
The AM is defined by the National Information Standards Organization as: 
"The version of a journal article that has been accepted for publication in a journal." 
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Copyright/Licence to Publish Agreement (Taylor & Francis 
Correspondence) 
From: Academic Journals CSMT Production [csmt-
production@tandf.co.uk] 
Sent: Wednesday, 29 April 2015 4:43 PM 
To: Catherine O'Mullan 
Subject: Re: Copyright question for Manuscripts (Taylor and Francis) 
 
Dear Cathy, 
Apologies for not getting back to you on this earlier. 
Unfortunately, it is prohibited to use the published paper as part the doctoral thesis but 
you can use the Author Accepted Manuscript (AAM). The AAM is defined as the manuscript 
in its accepted, post-peer review form, but not the final published article. 
 Do let me know if you have any questions. 
Best wishes, 
Sudeshna 
Sudeshna Nandy 
Production Editor 
Taylor and Francis 
4 Park Square 
Milton Park 
Abingdon 
Oxfordshire 
OX14 4RN 
UNITED KINGDOM 
Email: csmt-production@tandf.co.uk 
Fax: +44 (0)20 7017 6336 
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Statements of Contributions (Co-authors) 
To whom it may concern, 
I, Associate Professor Maryanne Doherty, contributed as Primary Supervisor 
of this Dr of Public Health thesis. I had an ongoing close involvement with the 
research including contributing to the project proposal, discussing the 
structure of papers, the reading of drafts and making suggestions for 
improvements to the papers entitled: 
 
1) O’Mullan, C., Doherty, M., Coates, R., & Tilley, P. M. (2014). Women’s 
experiences of coping with the sexual side effects of antidepressant medication. 
Psychology & health, 29(12), 1388-1406. 
 
2) O'Mullan, C., Doherty, M., Coates, R., & Tilley, P. M. (2014). Searching for 
answers and validation: Australian women’s experiences of coping with the adverse 
sexual effects of antidepressants. Australian Journal of Primary Health (ahead of 
print). 
 
3) O'Mullan, C., Doherty, M., Coates, R., & Tilley, P. M. (2015). ‘Accepting what is’: 
an approach for managing the long-term sexual side effects of selective serotonin 
reuptake inhibitors (SSRIs) in women. Sexual and Relationship Therapy, (ahead of 
print), 1-13. 
 
with Catherine O’Mullan. 
 
Signed:  
Associate Professor Maryanne Doherty (Primary Supervisor/co-author) 
 
Signed:  
Catherine O’Mullan 
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